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Abstract
The innate immune system senses pathogens via germ-line encoded proteins called
pattern recognition receptors (PRRs), which include Toll-like receptors (TLRs) and
C-type lectins. They are able to distinguish a vast range of microbial signatures or
pathogen associated molecular patterns (PAMPs) and induce both adaptive and
innate, pathogen specific/tailored immune responses. The repertoire of PRRs
expressed by each cell type has a bearing on its ability to recognize a specific array
of PAMPs on a pathogen and thus mount a specific immune response against such
challenge. The cellular content of a tissue thus has a bearing on its ability to mount a
competent immune response against pathogens. Age-related differences in immune
competence are well documented. Neonates are known to have immature immune
systems (and thus increased susceptibility to infections) and postulated to have lower
PRR expressions. A discernment of the expression of PRRs in normal cells/tissues
enables us understand the significance of these receptors play in immune response
development and form a basis for understanding disease pathogenesis. Baseline data
also allows deviations from normal to be identified in diseased states. Johne's disease
(JD) is a chronic disease of ruminants caused by Mycobacterium avium
paratuberculosis (Map) and has three clinical forms - asymptomatic, paucibacillary
or multibacillary. The innate immune system is known to have a pivotal role in the
control of the dissemination in mycobacterial diseases though the precise
mechanisms are not well defined. 1 hypothesized that antigen recognition via PRRs
has a definitive role in the development of the different forms of JD.
For part one of this study, blood and tissues were obtained from clinically healthy
sheep for RNA extraction. Blood subsets were immuno-stained with specific
monoclonal antibodies and DCs into CD172a~" populations. Definitive populations
were obtained using Flow cytometry assisted cell sorting followed by RNA
extraction.
To explore PRR expression in foetal immune system, second trimester foetal skins
and spleens were collected for PRR mRNA expression determination. Archival,
RNAlaterk stabilized ileum samples were used to investigate PRR expression
profiles of different JD forms.
xiii
PRR specific mRNA expression was evaluated using reverse transcriptase
quantitative real time PCR.
The spleen, lung and lymph nodes express all TLRs; the kidney expresses high levels
of TLR1, 2, 3, 4, 5, 6, but very low levels of TLR8, 9 and 10. The skin expresses low
levels of TLR5, 6, 9 and 10 mRNA. CD172a^ DCs express most PRRs and MyD88
while CD 172a" DCs express TLR2, 6 and MyD88.
Foetal spleens have comparable levels of PRRs except for CD 14. Significant
differences were observed with TLR1, 4, 5, CD 14, CARD 15 and Dectin-1 between
foetal and adult skin tissues.
Results from the present study show the importance of the following PRRs in ovine
Johne's disease discrimination; TLR2, CD14, TLR8, CARD15, dectin-1 and dectin-
2. These findings provide an insight into one facet of Map innate immune
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1 Chapter 1 - Introduction
1.1 Host pathogen Interaction
The interaction between a host and an invasive micro-organism is crucial to the
outcome of infection. These host-pathogen relationships are characterized by a
complex interplay between the host's defence mechanisms and attempts to
circumvent these defences by pathogens. Optimal defence against the gamut of
micro-organisms such as viruses, bacteria, fungi and parasites, which may invade an
animal's body, requires specialized classes of non-specific and antigen specific
immune responses. The interactions can range from benign/symbiotic, such as that
occurring in the gut to commensals, to fatal competition that may result in the death
of the host, the micro-organism or both. These micro-organisms are capable of
adapting to, and utilizing elements from, within the host's environment to establish
infection and persist. The organisms have developed many methods for ensuring
their survival in the host, ranging from evading the host's immune system to down-
regulating the immune system. More specific mechanisms used by microbes to avoid
host immune responses include:
Inhibition of antigen presentation (Human cytomegalovirus; (Basta and
Bennink, 2003); Mycobacterium spp (Berger and Griffin, 2006; Tobian et
al., 2003), Salmonella (Cheminay et al., 2005)).
Evasion of host antibodies (Trypanosomes; (Mansfield and Paulnock,
2005)).
Complement evasion (Vaccinia virus (Kotwal and Moss, 1988)).
Inhibition, or overproduction, of cytokines (Toxoplasma gondii; (A 1 iberti
et al., 2004; Denkers Eric Y. et al., 2003; Denkers, 2003))
Survival and multiplying in host cells such as phagocytes (Mycobacteria;
(Pieters and Gatfield, 2002)) or undergoing latency by persisting in host
cells without dividing ( Herpes viruses (Novak and Peng, 2005)).
Phase/antigenic variation (Trypanosomes; (Mansfield and Paulnock,
2005)).
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The immunological balance at the interface between a host and its environment is
fundamental to the host's well-being. This interface must protect the host from
pathogens and also maintain a balance with commensals. It is made up largely of
skin, mucosae and cells of the immune system. The cells are divided into sensors and
effectors. Dendritic cells (DCs) are the best characterized sensors which also include
macrophages and B cells. These cells sense the environment via pattern recognition
receptors (PRRs) and PRR engagement causes the cells to respond to environmental
changes. PRRs are found on a range of cells and tissues that can respond to and
influence the host's response to infection. Upon sensing of pathogens by these cells,
immune mechanisms are set into motion that lead to elimination or containment of
these pathogens. Paradoxically, hosts also develop mechanisms to ensure the survival
of commensal organisms. A fine balance between the effector and regulatory arms of
the immune system are required to meet a host's need for pathogen removal and that
of tolerance to commensals.
Host defence against pathogenic challenge requires an integrated response from both
the innate and adaptive wings of the immune system. Available data adequately
demonstrates that Dendritic cells are pivotal in linking the two components of the
immune system and determining the shape of the emerging immune response. It has
been shown that, upon infection with a pathogen or interaction with an antigen (Ag),
antigen presenting cells (APCs) such as DCs and macrophages modulate their PRRs
expression. The PRRs bind to pathogen-associated molecular patterns (PAMPs) on
the pathogen, and initiate cellular signalling pathways that lead to an immune
response via mechanisms such as reactive oxygen and nitrogen intermediates,
cytokines, chemokines and co-stimulatory molecules. However, it has also been
shown that some organisms have evolved strategies to infect the DCs directly or to
evade or usurp their normal function (Humphreys et al., 2006; Jiao et al., 2002).
Based on what is known about DCs, the outcome of a pathogenic challenge will be
determined by factors such as the identity of DC subpopulations that are engaged, the
tissue microenvironment in which activation takes place and the specific signalling
molecules involved in the recognition and processing of a particular pathogen or its
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product (Kelsall et al., 2002). Pathogen-host interactions will lead to induction of T
cell responses that may be more balanced or highly polarized in terms of their
Thl/Th2 profiles and this phenomenon is particularly striking with gastrointestinal
helminth infestations (Gause et al., 2003; Sher et al., 2003) where there is a strong
Th2 response. This polarization may be important for the resolution of certain
diseases but may lead to pathologies such as autoimmune disease (Thl) or asthma
(Th2). Differences in Thl/Th2 type balance will result from engagement of different
DC subsets and this will lead to different immune responses. The importance of this
interaction is that it determines the outcome of disease and whether or not micro¬
organisms are controlled and/or cleared from a host. Differences in the composition
of dendritic cell subsets may therefore be associated with resistance and
susceptibility to infection with a given pathogen (Moll, 2003).
1.1.1 The immune system
The immune system is tasked with the responsibility of detecting and eliminating
invading pathogens. It is able to do this by discriminating between self, non-self and
altered self. The mammalian immune system has traditionally been divided into
innate immunity and the adaptive immunity. However, it has now come to light that
these two wings of the immune system are complexly and tightly interwoven (Degli-
Esposti and Smyth, 2005; Vivier and Malissen, 2005) and interdependent. The
adaptive immune system depends on the existence of T and B cell antigen receptors,
followed by clonal selection and expansion of these receptors with appropriate
specificities. This culminates in the development of immunological memory. It takes
four to seven days for this process to be fully functional. If this were the only method
of combating infection, microbes would overrun the immune system due to this
delay. Fortunately, the adaptive immune system does not work in isolation, but in
association with the innate immune system that detects the presence and nature of
infection, thus providing the first line of defence (Medzhitov, 2001; Reis e Sousa,
2004). Despite its crucial role, the importance of the innate immune system has been
overshadowed by the adaptive immune system for over a century (Medzhitov, 2001).
It was thought to be a non-specific immune response based on the engulfment and
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digestion of microbes and antigen by leucocytes. The discovery and characterization
of the mammalian Toll-like receptor (TLR) family and other additional PRRs,
together with the important role played by antigen presenting cells, have re-activated
interest in the discipline of innate immunity. Innate immunity has also been shown to
have considerable specificity, ability to discriminate between self and non-self; to be
a prerequisite for the activation of adaptive immunity and to determine the nature of
the acquired immune response (McNeela and Mills, 2001). Thus, effective host
defence against antigenic challenge and optimal protection depends on a joint
response from the two inter-related innate and adaptive wings of the immune system.
The innate immune system, being engaged first, is considered to be on top of the
hierarchy for the development of immunity. Without the innate immune system, a
host is not able to develop a robust and optimal immune response to pathogens.
1.1.2 Innate Immunity.
Greater than 98% of all multicellular organisms lack a functional adaptive immune
system. Adaptive immunity is only found in vertebrates (Takeda and Akira, 2003),
thus other organisms are entirely dependent on the innate immune system for
responding to pathogenic challenge. Similarities between plant and animal innate
immune systems have also been demonstrated (Ausubel, 2005; Jones and Takemoto,
2004) and the conserved nature of the innate immune system would thus imply its
higher ranking in the immunological hierarchy.
The innate immune system has a mechanical and chemical/cellular component. The
mechanical component comprises the epidermis and the mucosae lining the
gastrointestinal, respiratory and urogenital tracts that provide a physical barrier to
pathogens. The mechanical component includes responses such as cilial movement
and peristalsis and also the secretion of antimicrobial substances such as defensins,
cathelicidins, secretory leucocyte protease inhibitor (SLPI), lactoferrin and lysozyme
(Wira and Fahey, 2004) to aid in pathogen defence. The chemical component
comprises a) the cellular constituent which includes mast cells, NK cells, DCs,
macrophages and epithelial cells b) pattern recognition molecules and c) proteins or
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peptides that hydrolyse pathogens and chemokines (Basset et al., 2003). Early in the
study of immunology, the complement system was identified as important in host
protection and a key component of the innate immune system. The complement
system was originally identified as a heat-labile component in normal plasma that
augments or 'complemented' the action of antibodies in the lysis of erythrocytes and
bacteria by Bordet and Gengou in 1901.
Thus, broadly, the innate immune system is mediated by phagocytic and cytotoxic
cells. In concert, the above lead to the 'first line' of defence to protect a host against
pathogenic challenge by destroying or limiting the pathogen and also by alerting the
adaptive wing of the immune system.
In light of pathogenic challenge, expression of pattern recognition molecules has
recently been shown to increase in cells of the innate immune system and also lead
the secretion of antimicrobial substances such as P-defensins (Froy, 2005; Vora et
al., 2004; Voss et al., 2006). Paradoxically, defensins have also been shown to
activate DCs via TLR4 (Biragyn et al., 2002) which could form a regulatory positive
feedback loop. This linking of PRRs of various aspects of innate immunity has
strengthened our understanding of the role that PRRs play in overall immunity.
Innate immune mechanisms are however limiting and do not result in increased
protection over time, or memory. The ability of the innate immune system to mediate
induction of adaptive immunity via PRRs enables the subsequent immune response
to be specifically tailored to the sensed pathogen.
1.2 Pattern Recognition Receptors
The first step towards the development of an immune response is the recognition of
an antigen/pathogen. PRRs are germ-line encoded receptors that act as primary
sensors of conserved microbial structures or PAMPs (Janeway, 1992) and PRRs may
be cell-surface expressed, located intracellularly, or secreted into tissue fluids.
Precise recognition of pathogens is a critical phase in the induction of protective
immunity in a host. Accurate recognition determines the initiation, type and extent of
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the resulting pathogen-specific adaptive immune response. This activates signalling
pathways that lead to the activation of immune and inflammatory mechanisms.
There are three broad groups of PRRs based on cell localization and function:
- secreted molecules that circulate in blood and lymph, such as complement,
CD14 and lipopolysaccharide binding protein (LBP);
- surface receptors on phagocytic cells like macrophages that bind the pathogen
to facilitate engulfment, such as complement receptors and C-type lectins;
- cell receptors that bind the pathogen initiating a signal leading to the release of
effector molecules, such as TLRs.
Recent work has now shown that most PRRs will have two of the above broad
characteristics , e.g. C-type lectins are involved in facilitating engulfment, but are
also responsible for initiating immune responses. Likewise, a host's reaction to a
named pathogen will usually involve PRRs in all these broad groups simultaneously
or sequentially.
Pattern recognition receptors also include scavenger receptors, mannose and glycan
receptors, Nucleotide-binding Oligomerization Domain proteins (NODs), Protein
kinase R (PK.R) and complement receptors (CRs) (Basset et al., 2003). PRRs may be
expressed on the cell surface or in the intracellular compartment and are not all
necessarily cell associated. Mammalian LPS binding protein (LBP), soluble forms of
CD14, and mannose binding protein are examples of peripheral sensors, secreted into
the blood stream or tissue fluid, that detect host invasion. Soluble PRRs ultimately
signal through cell surface receptors (LBP/CD14 via TLR4; MBP via C-type lectins;
complement via complement receptors). All PRRs recognize PAMPs displayed by
micro-organisms, and their subsequent activation leads to the transcription of
appropriate host-defence genes that lead to immune and inflammatory responses
aimed at destroying the pathogens. The consequences of PRR engagement therefore
include: initiation of phagocytosis (Doyle et al., 2004), activation of pro¬
inflammatory signalling and the induction of apoptosis (Into et al., 2004; Medzhitov,
2001; Medzhitov and Janeway, Jr., 2002). PRR mediated apoptosis during microbial
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challenge is an important aspect of host's defence mechanisms (Haase et al., 2003;
Inohara and Nunez, 2003). PRRs also play a role in homeostasis by sensing
endogenous ligands and tolerance induction (Gordon, 2002; Rakoff-Nahoum et al.,
2004). Rifkin and co-workers (Rifkin et al., 2005) reviewed the role played by TLRs
in endogenous ligand recognition and their role in autoimmune disorders. The ability
of PRRs to recognise endogenous ligands ('altered self) supports the 'danger theory'
of immune initiation as advocated by Matzinger (Matzinger, 1994) in response to
dead or dying cells (Shi et al., 2003).
Looking at the increasing number of PRRs discovered in the last decade from the
time TLRs were first described, one can only logically extrapolate that what is
currently known may only be a small proportion of the overall pathogen sensing
receptors in mammalian immunology. This has consequently given rise to more
complicated models of pathogen/immune system interaction, antigen recognition and
immune regulation mechanisms. As the number of PRRs grows, and the number of
endogenous and exogenous ligand increases; together with an expanding role in
homeostasis, they may be more appropriately named as 'danger sensors' to embody
their plethora of functions.
1.2.1 The Concept of PAMPs
Pathogen associated molecular patterns( are broadly defined as molecular patterns
found in pathogens but not in mammalian cells. These include molecules such as
peptidoglycan, LPS, flagellin, porins, bacterial DNA and double-stranded RNA.
PAMPs tend to be absolutely essential for the survival of a pathogen and are
generally evolutionarily conserved in micro-organisms (Barton and Medzhitov,
2003); mutations in most PAMPs are usually not compatible with survival of the
pathogen. The term PAMPs is probably a misnomer, as these molecular signatures
are also expressed on commensal organisms (Kaisho and Akira, 2004) and altered-
self cells (Matzinger, 1994; Matzinger, 2002; Shi et al., 2003). The term 'microbe
associated molecular pattern' (Ausubel, 2005), is almost all embodying, and would
probably better describe these molecular signatures. It is however, not fully
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embodying as, these 'signatures' also include endogenous host molecules termed
'danger signals' such as heat shock protein (Hsp60/70), hyaluronidase, fibrinogen
and chromatin-TgG complexes. These 'danger signals' usually indicate injury, tissue
damage or cell death (Rock et al., 2005) and pave a way for mechanisms towards
elimination of these damaged cells/tissue and tissue repair. Seong and Matzinger
(Seong and Matzinger, 2004) proposed that hydrophobicity of molecules is the
central trigger that initiates innate immune responses and not PAMPs per se. Though
controversial, this perspective attempts to unify the still unclear area of the
discrimination of common 'PAMPs' found on both pathogens and commensals and
how the immune system recognizes altered self molecules and achieves homeostasis.
Three common features make PAMPs ideal targets for innate immune recognition,
namely,
a) They are essential for microbial survival. They are conserved within a
class of microbe, since mutations tend to be lethal due to the essential
nature of the PAMPs for the microbe's basic physiological functions
b) PAMPs are invariant between organisms of a given class of microbes.
Thus, a limited number of pattern recognition receptors can detect the
presence of a broad range ofmicrobial infections
c) Host cells do not produce these unique PAMPs, they are only produced
by microbes as they perform essential physiological, 'housekeeping'
functions. In certain instances, unlike in prokaryotes, these signatures
are normally not expressed on the cell surface of host cells but in the
cytosol and are thus hidden from immune recognition. However, when
cells die by apoptosis, this exposes these signatures to the immune
system as 'danger signals'. This enables the innate immune system to
distinguish between self and non-self and altered self.
The most widely reported and best-characterized PAMP is lipopolysaccaride (LPS).
It is a major component of the outer cell membrane of Gram-negative bacteria and
induces a wide range of immune responses in host immune systems via TLR4 and its
associated molecules CD 14 and MD-2.
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A point worthy of noting is that PAMPs are not comparable to virulence factors per
se. In contrast to virulence factors that developed to ensure the establishment and
survival of a pathogen within the hostile environment of a host, PAMPs have
evolved to carry out physiological functions. Pathogens produce virulence factors, to
among other reasons, facilitate the invasion of host cells, avoid host immune
mechanisms or to a change in environmental situations. Thus virulence factors,
unlike PAMPs, may vary in different strains of the same pathogen species.
The interaction of PRRs with PAMPs may also result in the activation of the
complement (Matsushita and Fujita, 1992) and contact (Kallikrein-kinin) systems,
opsonization, induction of co-stimulatory molecule expression and the activation of
pro-inflammatory signalling pathways (Hawlisch and Kohl, 2006).
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Schematic illustration of the interaction between Pathogen associated molecular patterns (PAMPs)
with pattern recognition receptors (PRRs), both cell-associated and soluble. The resultant cascades
lead to pathogen destruction, elimination or limitation. Antigen presentation leads to Thl or Th2
responses with respective lymphokine profiles.
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1.2.2 Toll-like receptors (TLRs)
Toll-like receptors are major cell/cell-surface receptors responsible for initiating
immune responses in response to pathogens. TLRs are single-pass trans-membrane
proteins characterized by multiple copies of leucine rich repeats (LRR) in the extra
cellular domain and a cytoplasmic Toll/IL-1 (interleukin-1) receptor (TIR)
homologous domain (Zhang et al., 2004) (see Figure 1.2). TLRs are largely
expressed in tissues and cells involved in immune function such as spleen, peripheral
blood leucocytes, macrophages, dendritic cells, as well as those tissues that are
exposed to the external environment such as the gastrointestinal & urogenital tract,
and lung. Akira and co-workers, (Akira et al., 2001), describe TLRs as the most
essential signalling receptor molecules from all the PRR that recognize a variety of
microbial components resulting in cytokine response of the host. Being essential
PRRs involved in PAMP sensing, TLRs have been described as the archetypal PRR.
They represent the best-characterized family of PRRs in the evolving field of PRR
functional biology. TOLL was originally discovered in the fruit fly, Drosophilict
melanogaster, larvae as being responsible for dorsal/ventral orientation during
embryonic development. It was later found to play an important role in anti-fungal
immunity in Drosophilia (Lemaitre et al., 1996), where flies that lack TOLL were
more susceptible to Aspergillus infection. The first mammalian proteins that were
structurally related to Drosophilia TOLL were discovered in the mid 1990s and
called Toll-like receptors (TLRs). Thirteen TLRs have so far been reported in
vertebrate species, with ten in humans and thirteen in the mouse, (Takeda et al.,
2003; Zhang et al., 2004). TLR1-9 are conserved between humans and mice (Takeda
and Akira, 2005) and also in cattle. However, TLR10 is assumed to be functional in
humans and cattle but in the mouse the C-terminal half of the gene is substituted to a
non-coding sequence suggesting that it may be non-functional. TLR8 is also reported
to be non-functional in mice (Sioud, 2006). The TLR11 gene is functional in the
mouse, but in the human sequence it has an early stop codon making the human
TLR11 gene non-functional. TLRs have not been found to have any conclusive
developmental function in humans.
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Toll-like receptors have a crucial role in the recognition of 'molecular signatures' of
microbial infection, in engaging differential inflammatory signalling pathways, and
controlling dendritic cell maturation and differentiation of T helper (Th) cells
(Medzhitov, 2001). It is also postulated that TLRs may mediate the inflammatory
response that results from damaged host tissues and cells (Beg, 2002; O'Neill, 2004)
and are critical mediators of sepsis (Takeuchi and Akira, 2002). TLRs are also able
to activate phagocytosis via the co-stimulatory molecules CD80 and CD86 (Doyle et
al, 2004).
The different TLRs are distributed differentially between inflammatory cells,
recognize different classes of pathogens and induce the production of similar, but not
identical, patterns of pro-inflammatory mediators (Akira et a/., 2001) (Trinchieri,
2003b) and other specific biological responses. The specificity of TLRs for PAMPs
permits them to detect the presence of infection and then drive an appropriate
adaptive immune response against that pathogen. TLRs are also observed in other
non-immune cells such as adipocytes, cardiac myocytes, intestinal epithelial cells,
fibroblasts, platelets and endothelial cells (Akira et al., 2001; Shiraki et al., 2004).
The resultant pattern of TLR expression is thus different in different tissues/organs
(Werling and Jungi, 2003) and this has a bearing on the specific role played by each
TLR in an organ. The differing TLR expression patterns in different tissues has been
attributed to the varying complexity of each tissue with regards to somatic and
immunological components (Iqbal et al., 2005). Differential expression of PRRs may
thus have a bearing on the susceptibility of an organ, individual or species, to either
infectious or non-infectious disease (Lehnardt et al., 2003; Wells et al., 2003). To
tailor an immune response to suit a particular microbe, multiple TLRs are used to
recognize several PAMPs of a microbe simultaneously. The relative input of each
individual TLR to an immune response is yet to be quantified since any one pathogen
contains numerous ligands specific for different TLRs. There are also differences in
TLR activation and signalling between and within host species. Different forms of
the same pathogen may also elicit different TLR responses depending on available
PAMPs as may the same PAMP on different microbes (Takeuchi et al., 2001).
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TLRs may be expressed as homo- or heterodimers. According to many authors, a
single TLR is able to bind to such a variety of ligands due to their ability to form
heterodimers with other TLRs. This seems to broaden the repertoire of specificities
of an individual TLR by forming numerous distinct types of functional heterodimers
with other TLRs (Ozinsky et al., 2000) and or PRRs (Gantner et al., 2003;
Mukhopadhyay et al., 2004);. However, the full discrimination of pathogenic antigen
signals may involve various other adaptor and accessory receptors other than TLRs,
which participate in signalling and shaping the eventual immune response. The
ability to discriminate between pathogens by using combinations of multiple TLRs
has led to the so-called 'bar code' hypothesis (Portnoy, 2005). The stimulation of
TLRs by microbial PAMPs leads to downstream signalling cascades that activate
both innate and adaptive immunity via antigen presenting cells reliant or independent
mechanisms. Thus, when APC through their PRR repertoire read the 'bar code' of
PAMPs on a pathogen, they tailor an appropriate immune response.
Table 1.1 The evolvement of the TLR field in immunology
Year Reported Finding Reference
1996 Toll found to have a critical role in anti-fungal defence in 1
Drosophila
1996 First protein structurally related to Toll identified in humans 2
(TLR1)
1997 Human TLR4 characterized and its functional role in 3
mammalian immunity determined
1998 MyD88 shown to be adaptor molecule for TLR signalling 4
2001 Identification of human TLR 10 5
'
(Lemaitre et al., 1996)
2 (Taguchi et al., 1996)
3 (Medzhitov et al., 1997)
4
(Medzhitov et al., 1998)
5
(Chuang and Ulevitch, 2001)
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1.2.2.1 TLR Structure
Members of the TLR family are characterized by possessing varying number of
extracellular LRR domains. The LRR ecto-domain of TLRs is critically responsible
for PAMP recognition. It contains 20-25 contiguous copies of the LRR motif. The
LRR motif is described as a XLXXLXLXXZ amino acid chain where X represents
any amino acid and L is leucine and the Z either a C, S or T (Bell et al., 2003). The
complete LRR motif for TLR is XLXXLXLXXZXLXXLXXXXXXXLXX with the
bold portion forming the concave part of the protein and being invariant between
LRR subtypes and the italics part forming the outer convex portion of the protein and
differing slightly between LRRs subtypes. The cytoplasmic portion of TLRs have a
Toll-IL-1 and 1L-18 (TIR) homology receptor domain that is responsible for signal
transduction, via interaction with adaptor molecules like MyD88, T1RAP, TRAM
and TRIF, leading to immune responses. The LRR-ECD and TIR domain are joined
by a single transmembrane helix (Martin and Wesche, 2002). However, LRR motifs
are also paradoxically present in the virulence factors of pathogenic microbes such as
Listeria monocytogenes, Yersinia pestis, and Salmonella typhimurium. The LRR
motif is also found in Trypanosoma brucei. The functional implication of the LRR in
these pathogens is currently unknown.
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Figure 1.2 Schematic representation of the structure of Toll-like receptors
Schematic representation of the structure of TLRs. (adapted from (Ulevitch et al., 2004). The
extracellular domain has varying numbers of LRRs that are responsible for PAMP recognition and
ligand binding. The LRRs may also be essential for dimerization. The intracellular domain has a TIR
domain that is responsible for signal transduction, via numerous adaptor molecules like MyD88,
TIRAP, TRAM and TRIF, leading to biological responses.
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1.2.2.2 Toll-like Receptor Expression
TLRs collectively function to alert the immune system of the presence of danger,
thus expression is modulated by numerous factors that include pathogen invasion,
presence of pathogen products, host tissue destruction, and cytokines. TLRs are
expressed on cells involved in the first line of immune defence such as DCs,
macrophages, monocytes, neutrophils, endothelial and epithelial cells, B and T cells,
Treg, and NK cells. Tissue and cellular distribution also has a bearing on the type of
immune response capable of being elicited by a particular tissue at a particular time.
TLR expression can thus be classified as ubiquitous, restricted, or specific. Studies to
date have showed that cell surface expression of TLRs is extremely low, ranging
from a few hundreds to a few thousand molecules per cell (Janssens and Beyaert,
2003; Visintin et al., 2001) whilst expression of other surface markers like MHC
class II will be in the range of a million molecules per cell.
1.2.2.3 Pattern recognition receptor ontogeny
Studies carried out in mice have shown that there is a reduced TLR expression with
aging and this has been linked to the decreased resistance to infections in geriatric
animals (Renshaw et al., 2002). Neonates are also known to have immature immune
systems and are postulated to have a lower level of PRR expressions. This could also
be responsible for the poor immuno-reactivity state of the nascent immune system in
mammalian neonates. However, mid-gestation foetuses have been shown to be able
to mount antigen specific immune responses. Immunization of baboon foetuses has
shown that they develop specific antibody responses, independent of the mother
(Watts et al., 1999). Thus it is probably a misconception to assume that all
mammalian neonates are immunologically naTve. This has been demonstrated in
humans by the fact that antigen specific IgE has been demonstrated in cord blood as
has tetanus specific IgM in the serum of neonates born from vaccinated pregnant
mothers. Marodi (Marodi, 2006) reviews this topic in relation to PRRs and concludes
that there are no significant differences in TLR mRNA expression in neonates and
adults. Levy and co-workers (Levy et al., 2004) also did not find any difference in
basal mRNA expression of TLRs in human neonate and adult monocytes despite an
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impaired response to TLR ligands. The Abrahams and co-workers (Abrahams et al.,
2004; Abrahams et al., 2005) showed the role TLRs play in early first trimester
trophoblasts. It is thus possible that antigen recognition (and thus PRR expression) is
fully developed prior to birth but the downstream signalling and/or antigen
processing is not. Neonates are specifically known to have a nai've adaptive immune
system; they however, must possess a fully functional innate immune system in order
to protect themselves against challenges in the antigenically hostile environment into
which they are born. Functional species differences have been demonstrated in the
level of immaturity in development of the immune system at birth where humans
tend to have a more mature immune system than rodents (Durandy, 2003; Renz and
Herz, 2002). Neonatal ruminants similarly have a comparatively more developed
immune system than mice (Schultz et al., 1973) and could be more developed than
humans (Al Salami et al., 1985). Ethical reasons have however hampered the
research of many aspects of the ontogeny of the immune system in staged gestation
periods in humans.
The immature overall immunity may thus be due to a poor link between the
antigenically nai've innate immune system and the adaptive immune system. Specific
reasons that have been attributed to this are a) nai've B and T cells that are only able
to mount a primary immune response to first time challenge b) defective
phagocytosis and c) chemotaxis to infectious sites by immune cells and deficiencies
in various aspects of the complement system (Chirico, 2005; Durandy, 2003).
1.2.2.4 TLR Ligands
Most TLRs have had numerous ligands described for them. Some however, such as
TLR10 still have no known ligand. Table 1.2 shows examples of known natural and
synthetic ligands for the different TLRs.
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Table 1.2 Mammalian Toll-like receptors and examples of their ligands
Toll-like
Receptor
Natural Ligands (source) Other Ligands
(source)
TLR 1 Tri-acyl lipopeptides (bacteria) JBT3002









TLR 3 ds RNA (viruses)
Extracellular mRNA (host)
Poly (I:C)
TLR 4 LPS (gram negative bacteria)
Fibrinogen, fibronectin (host)
P-defensins (host)
Heat shock protein 60&70 (host)6
TLR 5 Flagellin (bacteria)
TLR 6 Di-acyl lipopeptides (mycoplasma)
TLR 7 ss RNA (viruses) Imidazaquinoline
Bropirimine
R-848(Resiquimod)
TLR 8 ss RNA (viruses) Imidazaquinoline
R-848(Resiquimod)
TLR 9 Unmethylated CpG DNA (bacteria)
Chromatin-TgG complexes (host)
TLR 10 Unknown
TLR 11 Profilin from T. gondii
Uropathogenic bacteria Escherichia coli
6
Controversy exists, HSP immunostimulatory effect has been ascribed to contaminating LPS (Wallin
et al., 2002)
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1.2.2.5 Toll-like Receptor Specificity
An increased degree of specificity is conferred onto TLRs by the formation of
receptor complexes which are formed between different TLRs or between TLRs and
non-TLR moieties (Ozinsky et al., 2000). It is likely that in vivo, TLRs act in concert
with other PRR and co-receptors, to fine-tune pathogen recognition and eventually
drive an appropriate immune response to the pathogen (Armant and Fenton, 2002).
The archetypal TLR-TLR heterodimers are the ones formed between TLR2 and
TLR1 or TLR6. The TLR2/TLR1 heterodimer recognizes tri-acylated bacterial
lipopeptides and mycobacterial lipoproteins whilst TLR2/TLR6 recognizes di-
acylated lipopeptides such as those found on Mycoplasma spp. (Takeuchi et al.,
2001). TLR2 forms a complex with dectin-1 to facilitate the recognition of zymosan
and Candida albicans (Gantner et al., 2003). TLR4 is known to broaden its ligand
range and increase its specificity by forming complexes with CD 14 and MD-2
molecules. It is speculated that all TLRs may form heteromeric receptor complexes
to enable them to either achieve signalling and/or to increase specificity or diversify
ligand recognition potential. Additional molecules that make up these complexes will
probably be identified in future as studies of TLR signalling progress. The sequential
activation of different TLRs that may have ligands on a particular pathogen has also
been proposed as a possible mechanism by which TLRs may tailor an immune
response to a pathogen (Weiss et al., 2004). The adaptor molecule(s) combination
utilized following ligation of a particular TLR is also proposed to introduce another
facet to the specificity of downstream immune response (Horng et al., 2002;
Yamamoto et al., 2004).
Thus any pathogen, containing several PAMPS, could be recognized by a
combination of different PRRs and accessory molecules on the cells of the host. Each
combination of PRR will trigger unique intracellular pathways that lead to an
immune response tailored for the invading pathogen. This has been likened to
information provided by the different sized lines on a barcode to a scanner.
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1.2.2.6 Cellular localization of TLRs
There is a differential spatial distribution of individual TLRs within a cell. This has
been demonstrated in mice and humans by the staining of TLRs by mAb. Murine and
human studies have shown that TLR1, TLR2, TLR4 and TLR 6 are expressed on the
cell surface whilst TLR3, TLR7, TLR8, TLR9 are expressed intra-cellularly (Figure
1.3) in structures such as the endosome/lysosome (Ignacio et al., 2005; Matsumoto et
al., 2003). This distribution has a bearing on the function of the TLRs making it
more appropriate for the expected kind of natural ligand. The location of each TLR
has a critical bearing on the ability of the TLR to access its ligand; thus the nucleic
acid recognizing TLRs (TLR3, 7, 8 and 9) are located intracellularly where viruses
reside and carry out their replication and in proximity to phagosomes, which may
contain apoptotic cells or viral particles. The intracellular location of TLR9 has also
been shown to be important in discriminating between self and non-self nucleic acids
(Barton et al., 2006). TLRs are also able to migrate from the cytosol to the surface
(Xu et al., 2005) and vice versa (Husebye et al., 2006). The exact mechanisms and
purpose for the induction of this migration are currently unknown, though Husebye
and co-workers (2006) propose that TLR4 moving into the endosome is a regulatory
mechanism that is used to terminate TLR signalling.
Chapter One - Introduction 20
Characterization of Ovine Pattern Recognition Receptors Expression
Figure 1.3 Cellular localization of TLRs
Schematic representation of TLR cellular localization. TLRs 3, 7, 8, and 9 are expressed
intracellularly in the endosome whilst all the other TLRs are expressed on the cell surface. This may
have a functional impact on what type of ligands these TLRs may be able to recognize. Thus,
depending on the cellular location, the TLR ectodomain face the cell wall's exterior or interior, for
cell surface and intracellular TLRs respectively.
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1.2.2.7 TLR Signalling Pathways
TLRs activate signalling pathways that are critical for the induction of immune
responses to various microbes. Presently, there are four known adaptor molecules
through which TLRs are able to achieve intracellular signalling. These molecules are
myeloid differentiation primary response gene (factor) 88 (MyD88), Mai (MyD88
adaptor like - also known as TIRAP)7 (Fitzgerald et al., 2001; Horng et al., 2001),
Toll receptor associated molecule (TRAM) (Yamamoto et al., 2003), and Toll
receptor associated activator of interferon (TRIF) (Yamamoto et al., 2004). All TLRs
other than TLR3 activate a common signalling pathway that includes MyD88,
Interleukin 1 receptor (IL-1 R)-associated protein kinase (IRAK) and tumour necrosis
factor receptor-activated factor 6 (TRAF6). This TLR ligation eventually culminates
in the activation of nuclear factor-kB (NF-/d?) transcription factors, as well as
mitogen-activated protein kinases (MAPKs) (Yamamoto et al., 2004) extracellular
signal-regulated kinases (ERK) and c-Jun N-terminal kinase (JNK) (Barton and
Medzhitov, 2003) leading to a downstream immune response. However, it has been
demonstrated that the signalling has at least two distinct pathways - a MyD88
dependent one that leads to the production of pro-inflammatory cytokines with rapid
activation ofNF-kB and MAPK; and a MyD88-independent one associated with the
stimulation of interferon beta and maturation of dendritic cells with slow activation
ofNF-kB and MAPK (Yamamoto et al., 2004). This activation leads to the induction
of various genes that function in host defence, including pro-inflammatory cytokines
(IL-12 and TNF-a), chemokines, major histocompatability complex (MHC) and co-
stimulatory and adhesion molecules. This activation may also lead to an increased
antigen presentation capacity in APCs. Other multiple effector molecules that
directly destroy microbes such as inducible nitric oxide synthase and anti-microbial
peptides are also induced. TLR2 signalling via MyD88 has also been shown to
induce apoptosis via the Fas associated death domain molecule and caspase 8
(Aliprantis et al., 2000). TLR3 activation signals exclusively via TRIF, although it
7Yamamoto and colleagues (Yamamoto et al., 2004) concluded that TIRAP is an adaptor molecule but
not responsible for MyD88-independent pathway. It is necessary for aspects of the TLR2 & 4
MyD88-dependent signalling.
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was earlier thought to also signal via MyD88. This has been ascribed to the fact that
TLR3 lacks a conserved proline residue found at the cytoplasmic end of other TLRs
(the BB loop) that is necessary for the recruitment of MyD88 (Xu et al., 2000) but
not needed for signalling via TRIF. Nagai and co-workers (Nagai et al., 2006), also
showed that TLR signalling has an effect on haematopoiesis by driving stem cells
towards myelopoeisis. They also proposed that via MyD88, this may be a potential
route for immune cell replenishment during infection and subsequent inflammation.
Thus, the conclusion is that each TLR signalling has an overlapping, albeit distinct
function that is largely dependent on intracellular molecules (Kaisho and Akira,
2004). MyD88 is however, the principal adaptor molecule required for most TLR
signalling, down-stream immune responses and modulation. This is aptly
demonstrated by MyD88 deficient mice that have been shown to be unable to drive
Thl responses but whose Th2 responses remain intact (Goldstein, 2004) and they
succumb easily to bacterial infections. MyD88 is also involved in IFN-y induced
cytokine and chemokine modulation (Sun and Ding, 2006) and 1L-1 mediated NF-kB
activation (Wesche et al., 1997).
The complexity of TLR signalling is summarized schematically in Figure 1.4. This is
by no means the complete signalling pathways as new aspects to TLR signalling are
still being discovered. Recently, Oda and Kitano (Oda and Kitano, 2006)
comprehensively reviewed the complex signalling pathways of TLRs.
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Figure 1.4 Toll-like receptor signalling
Schematic presentation of Toll-like receptor signalling and molecules known to regulate signalling.
Interaction between the TLR extracellular LRR domain and its specific ligand leads to the interaction
between its intracellular TIR domain and that of adaptor molecules such as MyD88/TlRAP (All TLRs
except TLRS) and TRIF (TLR3 exclusively and possibly TLR4 - there is conflicting data on TLR4 in
literature). TLR5 signals via MyD88 only without T1RAP. The MyD88 pathway leads to activation of
an intracellular cascade involving TRAF6. IRAK-1/4 and the transcription factor NF-kB that results in
pro-inflammatory cytokines. The TRIF pathway results in ty pe I interferons via activation of the
transcription factors IFN regulatory factors (IRFs) 3 and 7. Numerous molecules regulate TLR
signalling at different levels. Spliced MD-2 and RP105 (a TLR4 homologue) interfere with ligand
binding at the LRR F.CD and thus regulate TLR signalling by competing for binding sites and ligand
respectively. The same applies for spliced MyD88 (MyD88s) in the cytosol.
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1.2.2.8 Negative regulation of TLR signalling
Downstream effector immune responses generated by TLR ligation are balanced by
numerous regulatory molecules and pathways in order to maintain immune
homeostasis. Otherwise pro-inflammatory cytokines produced following TLR
ligation, when produced in excess would lead to detrimental effects to the host. An
excessive and inappropriate immune response would lead to a severe hyper-
inflammatory disorder such as inflammatory bowel disease, autoimmune syndromes
(Karin et al., 2006), or severe sepsis. Numerous molecules have recently been
identified that have a regulatory effect on TLR signalling and include Suppressor of
Cytokine Signalling SOCS (Baetz et al., 2004; Mansell et al., 2006), Single Ig-
domain containing IL-1R related (SIGIRR) (Qin et al., 2005; Wald et al., 2003), ST2
(Akira and Takeda, 2004; Kobayashi et al., 2005; Kobayashi and Flavell, 2004;
Kobayashi et al., 2006), IRAK-M (Kobayashi et al., 2002), spliced variants of
MyD88 (MyD88s) (Burns et al., 2003; Janssens et al., 2003) and MD-2(sMD-2),
A20 (Gon et al., 2004; Silverman and Fitzgerald, 2004), Tollip (Zhang and Ghosh,
2002), MIF, DAP12 (Hamerman et al., 2005), Triad3A (Chuang and Ulevitch, 2004)
and the TLR4 homologue RP105 and its accessory molecule MD-1 (Divanovic et al.,
2005). These molecules achieve immune homeostasis, by acting at different levels of
the TLR signalling pathway (Figure 1.4), to modulate the production of pro¬
inflammatory cytokines following antigenic challenge and inflammation. The exact
mechanisms by which most of these molecules regulate TLRs are not fully
understood, but are becoming clearer as TLR signalling is mechanistically dissected
by various researchers. The spliced variant of MyD88, MyD88s, functions as a
negative regulator by competitively preventing the recruitment of 1RAK-4 to the
TLR/MyD88 complex. RP105 and its accessory molecule MD-1 were thought to act
as a decoy receptor complex by taking up most of the available ligand. However,
since RP105 has no signalling domain it was thought to act as a "molecular sink' by
reducing the effective ligand interaction with TLR4 for intracellular signalling.
Recent evidence however, shows that the RP105/MD-1 complex physically
associates with the TLR4/MD-2 receptor complex making it unable to bind LPS.
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1.2.2.9 An overview of the different TLRs
TLRs induce and/or suppress the transcription of greater than 2000 host defence
genes (Aderem, 2003) that include cytokines, chemokines, co-stimulatory molecules,
antimicrobial peptides and MHC molecules. Consequently, TLR stimulation triggers
increased antigen presentation capability and DC maturation and down-stream
immune responses. TLRs have also generated interest due to their therapeutic
potential especially in tumour medicine (Lawton and Ghosh, 2003; Ulevitch, 2004)
and also in vaccine development (van Duin et a/., 2006).
Toll-like Receptor One (TLR1), Two (TLR2) and Six (TLR6) are classified into one
family due to their sequence homology and ability to form functional heterodimers.
The TLR2 gene has the highest number of known natural ligands described (Wetzler,
2003). This promiscuity has led TLR2 to be a quite widely studied TLR. Unlike
other TLRs, it is known to further its recognition spectrum and specificity by
forming functional heterodimers with the related TLRs 1 and 6. TLR2 signalling has
recently and consistently been shown to bias towards Th2 type immune responses
(Dillon et al., 2004; Redecke et al., 2004) and suppresses Thl via various
mechanisms including self Hsp (Zanin-Zhorov et al., 2006) and Tregs. A functional
soluble form of TLR2 has also been described (LeBouder et al., 2003). This family
of TLRs signals exclusively via the MyD88 adaptor molecule coupled with the
accessory molecule TIRAP.
The TLR3, 7, 8 and 9 superfamily recognizes nucleic acids. TLR3, 7 8 and 9 are also
unique in that they are not expressed on the cell surface but rather intracellularly in
endosomes (see Figure 1.3). The members of this family generally recognize viral
and bacterial nucleic acids although recent findings implicate them in the recognition
of self nucleic acids during tissue injury and apoptosis (Sioud, 2006). Species
differences in protein functionality also exist; TLR8 is purported to be non-functional
in mice but functional in humans. Other than TLR3 that signals exclusively via
TRIF, the others members of this superfamily are known to signal only via MyD88.
TLR4 was the first mammalian TLR demonstrated to function as a PRR (Medzhitov
et al., 1997) and together with TLR2 has been a widely studied TLR. TLR4 was
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shown to be a major receptor for LPS but it was quickly shown not to be the sole
receptor involved in LPS recognition. The complex recognition has been shown to
involve LBP, CD 14 and MD-2. TLR4 signals via MyD88/TIRAP and also in a
MyD88-independent manner via TRIF/TRAM.
TLR5 is expressed on epithelial cells, macrophages/monocytes, CD4+ T cells and
DCs. TLR5 recognizes extracellular bacterial flagellin of both Gram negative and
Gram positive bacteria. Flagellin is a protein ligand of TLR5 however the specific
TLR5 binding site on the flagellin has not been determined. TLR5-independent
recognition of flagellin has been described to take place in the cystosol by Ipaf, a
member of the NLR family (Franchi et al., 2006). TLR5 signals exclusively via
MyD88.
Toll like receptor ten is an orphan TLR although it is closely related to TLR1 and
TLR6. No ligand has yet been identified for TLR 10 but it is expressed preferentially
on B cells and DCs (Hasan et al., 2005). Species differences in the functionality of
TLR10 exist; it is functional in cattle and humans but not in mice. Research on
TLR10 has thus been particularly hampered by the lack of a functional receptor in
mice. It is also known to be abundantly expressed in immune-cell rich tissues such as
lymphnodes and the spleen (Chuang and Ulevitch, 2001). Human TLR10 has
recently been shown to form heterodimers with TLR1 and TLR2 (Hasan et al.,
2005). The functional implication of these heterodimers is however still unclear.
Other Toll-like receptors such as TLR11 and TLR13 have been described in the
mouse but no functional equivalents have been found in humans. TLR 11 is
functional in mice and is a receptor for uropathogenic bacteria and the ligand profilin
found on T. gondii.
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1.2.3 TLR-independent recognition of pathogens
TLRs have dominated the field of PRRs but are by no means the only mechanisms
by which the innate immune system recognizes pathogens. The innate immune
system is endowed with many other means of recognizing antigen that include the
complement system. TLRs are the most widely researched PRRs, but there are an
increasing number of other PRRs that have been reported. In the recent past,
numerous TLR-independent signalling pathways have also been well characterised as
being involved in innate immune recognition. Such non-TLR PRR proteins include
NLRs, C-type lectins (Brown, 2006), Retinoic acid inducible gene l (RIG-1) (Bird,
2005) and melanoma-differentiation-associated gene 5 (MDA5) (Kato et al., 2005;
Kato et al., 2006). However, non-TLR pattern recognition receptors have generally
been less appreciated in the earlier part of the last decade despite the initial PRRs
discovered such as complement and complement receptors, CD 14 and lectins being
non TLRs. This has however become a rapidly growing area of PRR research as it
has become evident that these PRRs are also critical in initiating and/or modulating
innate immune responses. Non-TLR PRRs may induce intracellular signalling that
leads directly to inflammatory responses or may work together with TLRs by
presenting PAMPs to TLRs (such as CD 14 and TLR4). There is growing evidence to
suggest signalling interplay and overlap between TLRs and non-TLR PRRs such as
NLRs (Creagh and O'Neill, 2006). MDA5 and RIG-1 are CARD domain containing,
cytoplasmic RNA helicases that recognize double stranded RNA. Through their
helicase domain, they are able to sense the dsRNA of viral origin independent of
TLR3 and induce type I IFN responses using the CARD domain signalling pathway.
Table 1.3 shows some examples of non-TLR PRRs.
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Table 1.3 Non-TLR pattern recognition receptors
Table showing examples of non-TLR PRR and the broad category to which they are derived (adapted
from (Brown, 2006). The cellular location and main ligands described together with organisms
possessing such PAMPs or known to activate the family of receptors.
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1.2.4 Non-TLR Pattern Recognition Receptors
1.2.4.1 Caspase Recruitment Domain 15 (CARD15)/ Nucleotide-binding
Oligomerization Domain 2 (NOD 2)
CARD15/NOD2 is a member of the NOD-leucine-rich-repeat (LRR) protein family
(also called NATCHT-LRR (NLRs) or CATTERPILLER family) (Ting and Davis,
2005). Martinon and Tschopp ((Martinon and Tschopp, 2005; Tschopp et al., 2003)
review this family of PRRs, members of which are defined as sharing a tripartite
domain structure which has a C-terminal peptide recognition (LRR) domain), a
central NOD domain and an N terminus made up of protein-protein interaction
domains such as CARDs or a pyrin domain (Figure 1.5). At the time of its discovery,
the presence of LRR suggested that, like TLRs, it could be involved in the innate
immune recognition of PAMPs. The mammalian CARD15 gene has structural
homology to plant disease resistance genes (R) (Jones and Takemoto, 2004). R genes
are known to be important in recognition of and defence against various intracellular
pathogens in plants which do not possess an adaptive immune system (Ausubel,
2005;Jones and Takemoto, 2004). CARD 15 is expressed intracellularly in monocytes
(Berrebi et al., 2003), and antigen presenting cells, and allows these cells to
recognize muramyl dipeptide (MDP), a metabolite of bacterial peptidoglycan (PGN).
CARD15 signalling leads to the enhancement of apoptosis and/or the activation of
NFkB via the CARD domains interacting with RIP2 (Inohara and Nunez, 2001;
Opitz et al., 2004). The R1P2 interacts with I-kappa B kinase (IKKy), the regulatory
unit of the IKK complex, culminating in IkBa phosphorylation and degradation. The
activated NFkB translocates into the nucleus where it mediates pro-inflammatory
gene transcription (Strober et al, 2006) and release of anti-microbial defensins (Voss
et al., 2006). In addition to the NFkB pathway, CARD 15 recruitment of RICK may
also activate MAPKs, p38, Erk, and Jnk (Kobayashi et al., 2005).
The most extensive research area of the CARD 15 gene has been its function in
bacterial sensing in the gastrointestinal tract (GIT) and on intestinal cells, but it has
also been implicated in directly having anti-bacterial properties (Hisamatsu et al.,
2003). Lack of these anti-bacterial properties in mutant CARD 15 has thus been
advanced as the reason for its association in Crohn's disease.
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Figure 1.5 The structure of normal type and a mutant CARD15.
Schematic representation of normal and mutant CARD15 Top: Schematic representation of the
structure of normal human CARD15 gene showing the LRR region that is responsible for ligand
recognition and the two CARD domains that take part in intracellular signalling. These two are
separated by a nucleotide binding domain. Total length is 1040 amino acids. Bottom: Structure of
mutant human CARD 15 gene showing the truncated LRR region that is incapable of ligand
recognition and intracellular signalling. Total length of mutant is 1007 amino acids. Other NLRs
would have amino-terminal pyrin domains instead ofCARD domains for intracellular signalling.
Counter-intuitively, CARD 15 signalling also seems to negatively regulate TLR2
intracellular signalling (Figure 1.7). Using CARD15 deficient mice (CARD15"),
(Watanabe et a/., 2004) demonstrated that CARD15 signalling inhibits TLR2 Thl
response by regulating NF-kB signalling at the c-Rel subunit. Thus, CARD 15
deficiencies tend to increase TLR2 mediated Thl responses. TLR2 is normally
located on the extra-cellular aspect of immune cells where it senses peptidoglycan
(PGN). During antigen uptake, PGN may be incorporated into the cytosol of APCs,
where it is broken down by intracellular hydrolases into muramyl dipeptide (MDP)
which is in turn detected by CARD 15. This state of affairs is usually in a modus
vivendi and coordinates the response of APC and subsequently the immune system to
pathogens presenting with PGN.
CARD 15 expression is also regulated by proinflammatory cytokines such as TNFa
and IFNy (hvanaga et ah, 2003; Rosenstiel et al., 2003) and this has a bearing on the
fine-tuning of the over all immune response mediated by CARD 15 and this may be a
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regulatory mechanism or favour a hyper-inflammatory state development. Figure 1.7
outlines the latest proposed mechanism of CARD 15 and its implication for the
CARD 15 mutations which may explain Crohn's disease (and other auto immune
granulomatous diseases such as Blau syndrome). This theory ties in with the bacterial
basis of these autoimmune diseases, although it may not be accepted by some
researchers who propose that these autoimmune diseases have no bacterial cause.
1.2.4.2 CD14
CD 14 is a 48/56 kDa glycosylphosphatidylinositol (GPI) anchored glycoprotein with
multiple LRRs. It is mainly present on the surface of myeloid cells, but also on B
cells and some other non-myeloid cells (Antal, 2000). CD 14 was first described as a
receptor for lipopolysaccaride and other bacterial cell-wall components in the early
1990s. CD 14 was initially described to typically recognize the lipid A portion of
LPS. It was purported to be expressed largely or exclusively on myeloid cells.
Recently, CD 14 expression has been ascribed to cells other than those of myeloid
origin and has been reviewed by Jersmann (Jersmann, 2005).
Other than this cell membrane-bound form (mCD14), CD14 is also present in a
circulating soluble form (sCD14) in serum. This soluble free-form arises from
cleavage of the GPI anchor of the membrane bound CD 14. sCD14 has been
postulated to be a co-stimulator molecule in modulating PRR-mediated immune
responses in cells that do not express mCD14. In the last few years it has generally
been accepted that CD 14 is a PRR for many ligands including LPS ofGram negative
bacteria, lipoarabinomannan of mycobacteria, apoptotic cells, whole bacteria,
microbial cell wall components, bacterial products, PGN and lipotechoic acid.
However, CD 14 lacks a trans-membrane domain. This shortcoming has led to the
proposition that it cannot carry out intracellular signalling to achieve an immune
response on its own but there is a need for a co-receptor or accessory molecule to
achieve downstream immune signalling. The cooperation between CD 14 and TLR4,
MD-2 and with TLR2 are well described, and this could explain the ligand range that
has been hitherto ascribed to CD 14. Recently, the synergistic association of CD 14
with enhanced TLR3 signalling has been reported (Lee et al., 2006).
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1.2.4.3 C-Type Lectins
The calcium-dependent, C-type lectin receptors (CLRs) are a large group of
receptors with carbohydrate recognition domains (CRD) that have a high affinity for
a variety of sugars and (to a lesser extent) some proteins. They are central to various
physiological processes that include enzyme trafficking, immunity, tissue homing,
and wound repair (Meyer-Wentrup et al., 2005). The main function of CLRs in
antigen presenting cells is to facilitate antigen uptake and degradation to augment
further Ag processing and presentation to B and T cells in the context of MHC. C-
type lectins bind to specific carbohydrate antigens present on the surface of
pathogens (e.g. Candida albicans, HIV and Mycobacterium tuberculosis) or
constituents of secreted products of pathogens (Gordon, 2002). They are also
postulated to be involved in the regulation of homeostatic balance and/or tolerance
via the recognition of glycosylated self antigen. Mycobacterium tuberculosis is
known to secrete glycosylated antigen targeting C-type lectins that leads to
immunosuppression of host cells. C-type lectins show great heterogeneity in mRNA
and have a tendency to be alternatively spliced into multiple isoforms.
The members of the C-type lectin family are numerous and include; DEC-205
(CD205), Mannose receptor (CD206), Langerin (CD207), DC-SIGN (CD209),
Dectin-1, L-SIGN and S1GNR1.
1.2.4.3.1 C-Type Lectin signalling
CLRs possess cytoplasmic signalling motifs such as immunoreceptor tyrosine-based
activation motif (ITAM) (Humphrey et al., 2005) or immunoreceptor tyrosine-based
inhibition motif (ITIM) that they use for downstream immune signalling. (Meyer-
Wentrup et al., 2005). Signalling is via the recruitment of a tyrosine kinase Syk,
which leads to cytokine production (Rogers et al., 2005). Syk-independent signalling
mechanisms are used by C-type lectin mediated phagocytic uptake (Hcrrc et al.,
2004b) in macrophages.
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Dectinl a form
Figure 1.6 Schematic representation of dectin structural architecture
Schematic representation of dectin receptor and the alternatively spliced variant. The normal a form
(left) with a long extracellular stalk and the (3 form (right) with a short stalk. Both forms have a similar
extracellular CRD that recognizes |3-glucans and a hitherto unknown ligand on T cells. The
intracellular N terminal contains the 1TAM domain that is used for signaling.
1.2.4.3.2Dectin-1 (C-type lectin domain family 7, member A -
CLEC7A)
Dectinl is a type II surface lectin which was initially thought to be expressed
exclusively or preferentially on dendritic cells but was later reported to be expressed
on many more cell types and tissues (Brown and Gordon, 2001). The full
physiological function of dectin-1 is still rather unclear. Dectin-1 is known to bind to
P-glucans (Herre et al., 2004a) and also a ligand on T cells that is yet to be identified
(Ariizumi et al., 2000). Recently, curdlan has been shown to be a selective dectin-1
agonist that results in NFkB induction via SyK and activation of DC maturation. Due
to the great heterogeneity in mRNA shown by C-type lectins, different isoforms of
dectin-1 are present human, mouse and cattle (Heinsbroek et a/., 2006; Willcocks et
al., 2006). The well-known spliced variant of dectin-1 is the (3-isoform with a
truncated extra-cellular stalk (Figure 1.6) but an intact functional CRD. The isoforms
may have different functions as they seem to have cell and strain-specific expression
in humans and mice (Heinsbroek et al., 2006), respectively. With murine dectin-1 (P-
isoform), functional deficits in binding zymosan were seen at temperatures lower
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than 37°C but at body temperature, functional binding was similar between the two
isoforms (Heinsbroek et al., 2006). After binding of dectin-1 with a specific ligand,
the different intracellular signalling can facilitate the uptake of an antigen by
phagocytosis (Herre et al., 2004b) and receptor mediated endocytosis and also leads
to the induction of reactive oxygen production. In collaboration with TLR2 and
TLR6, dectin-1 can also lead to higher specificity immune recognition and responses
(Gantner et al., 2003; Netea et al, 2006) and the TLR2 dectin-1 cooperation may
lead to immune tolerance (Dillon et al., 2006). Rogers and co-workers (Rogers et al.,
2005) shed further insight on the dual role that dectin-1 may possibly play in
polarizing the immune response. Dectin-1 is also postulated to play a role as a co-
stimulatory molecule during the interaction between APCs and T cells by being able
to bind to CD4 and CD8 T cells.
1.2.4.3.3Dectin-2 (C-type lectin domain family 6, member A -
CLEC6A)
Dectin-2 is a recently discovered C-type lectin about which not much is known.
Dectin 2 expression is characteristic of the arrival of monocytes being recruited into
inflammatory sites (Taylor et al., 2005). This expression related to these activated
macrophage/monocytes is unrelated to the stimulus initiating the inflammation.
Similar to dectin-1, dectin-2 shows a tendency to form a spliced variant transcript
that has 34 amino acids deleted (and consequently has a truncated extra cellular stalk
as in Figure 1.6). This stalk is reported to be necessary for dimerization, thus the
variant is supposedly incapable of dimerization. This may have a functional bearing
on the ability of the truncated variant to participate in immune mechanism involving
other molecules and/or PRRs. Dectin-2 has also been implicated in the ultraviolet
(uv) induced tolerance (Aragane et al., 2003) possibly via regulatory T cells or by
modulating Langerhans cell function in a uv dose-dependent down-regulation of
dectin-2 (Gavino et al., 2005; Sakaguchi, 2004).
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1.3 PRR polymorphisms and immune disorders
In view of the fact that the amino acid composition of a ligand binding site is critical
to its functionality and specificity; mutations within these sites could potentially
affect their response to pathogens and a host's predisposition to infection and/or
disease. Similarly, mutations in the signal transduction sites would affect the ability
of successful ligand binding achieving optimal downstream immune effects. Genetic
predisposition is usually multigenic in nature and will involve several similar
function-linked genes. Together mutations in these genes would be responsible or
account for the risk to develop a particular disease.
Recent studies have shown numerous polymorphisms associated with the PRRs. A
number of these mutations have been shown to affect the response of the PRR to the
usual ligands and some have been associated with specific disease states. Increased
susceptibility to Legionnaires disease was shown by Hawn and co-workers (Hawn et
al., 2003) ascribed to a TLR5 stop codon polymorphism that led to a defective innate
recognition of the causative pathogen. Not all polymorphisms are detrimental to
immune mechanisms; Hawn and co-workers (Hawn et al., 2005a) demonstrated a
protective association with human TLR 4 SNP A896G (D299G) to Legionnaires
disease caused by the Gram negative bacterium Legionella pneumophila. Resistance
to systemic lupus erythematosus (SLE) via a TLR5 stop codon polymorphism was
also demonstrated by the same authors (Hawn et al., 2005b). A TLR4 mutation
Asp299Gly has been described associated with poor LPS sensing leading to
inflammatory bowel diseases, Crohn's disease and ulcerative colitis (Franchimont et
al., 2004). Imahara and co-workers (Imahara et al., 2005) however, did not find any
hyporesponsiveness to LPS and concluded that this mutation is not a determinant in
endotoxin sensitivity. The same Asp299Gly mutation has been associated with
decreased risk of atherosclerosis (Kiechl et al., 2002), giving credence to the
infectious basis of autoimmune disease. TLR2 recognizes the largest variety of
described PAMPs amongst the TLRs and numerous polymorphisms have been
described; TLR2 Arg677Trp, has been associated with lepromatous leprosy (Bochud
753
et al., 2003; Kang and Chae, 2001), TLR2 Arg Gin with increased susceptibility to
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tuberculosis (Ogus et al., 2004). The TLR2 Arg753Gln mutation is also associated
with decreased immune responses to peptides from other bacteria and may
predispose people to staphylococcal infections (Lorenz et al., 2000). However, the
lack of TLR2 in mice has been shown to make them more resistant to fatal Yersinia
infections. This further goes to show that mutations in an innate immune receptor can
mediate either beneficial or deleterious inflammatory responses that will vary with
different ligands or pathogens.
Other mutations in different parts of the TLR signalling pathways have been
described. However, in view of the importance of TLRs, a complete deficiency in
one of the main TLR pathways is probably not compatible with life (Netea et al.,
2004).
A frame shift mutation at nucleotide 3020 of the human CARD 15 gene, the
3020insC, has been described (Ogura et al., 2001) in the gene's LRR region in
association with Crohn's disease (Hugot et al., 2001). This mutation in the gene has
been ascribed to impaired nuclear factor-kappa B (NF-kB) response in mutant type
immune hosts. The 3020insC results in the change of amino acid that leads to a
premature stop codon. The resultant truncated CARD 15 has 1007 amino acids
instead of 1040 amino acids (see Figure 1.5) of the normal CARD 15 protein (Ogura
et al., 2001). This mutation that results in the loss of the last 33 amino acids of the C-
terminal leucine-rich region of the protein is postulated to affect the ligand binding
ability of the molecule leading to possible inability to recognize its natural ligand.
This then prevents downstream immune signalling. Mutations elsewhere on the
CARD 15 (not in the LRR region) are thus postulated to have other effects not related
to immune recognition (Miceli-Richard et al., 2001).
Great controversies rage on whether CARD 15 contributes to the pathogenesis of
Crohn's disease in humans. The basic question is; do the CARD 15 mutations lead to
a 'loss-in-function' or "gain-in-function' phenotype? (Kelsall, 2005). Using
genetically modified mice, conflicting results have been published by two groups on
the role of mutant CARD15 proteins in regards to the predisposition to Crohn's
disease. Kobayashi and co-workers (Kobayashi et al., 2005) concluded that the
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mutations led to loss of function whilst Maeda and colleagues (Maeda et al., 2005)
concluded that the mutations lead to a 'gain of function' phenotype. A third study by
Watanabe and colleagues (Watanabe et al., 2004) also using CARD15 knock out
mice concluded that CARD 15 has a regulatory function rather than a bacterial
sensing function (mechanism summarised in Figure 1.7). Using more specific
disruptions of the CARD 15 gene Pauleau and Murray (Pauleau and Murray, 2003)
concluded that CARD 15" macrophages were not responsive to MDP, but that
CARD 15 does not have any specific regulator function in macrophage activation.
However, work done by Berrebi and co-workers (Berrebi et al., 2003) found an
increased expression of CARD 15 in epithelial cells of patients with inflammatory
bowel disease (IBD). This would link inflammatory bowel diseases with cytosolic
bacterial sensing.
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Figure 1.7 CARD15 mutation and excessive 11-12 production.
Schematic representation of proposed mechanisms involved in CARD 15 mutation mediated hyper-
inflammatory states in disease. On the right (green shaded) normal CARD15 modulates the TLR2
signalling leading to controlled inflammatory response to TLR ligation by PGN. On the left (red
shaded) the mutant CARD 15 (3020 InsC - see Figure 1.5) has a truncated LRR domain and is unable
to sense MDP. It thus, does not have the modulator) effect on the TLR2 signalling and this leads to
excessive IL-12 production and a hyper-inflammatory state.
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1.4 Cells of the Immune System
The immune system, tasked with the responsibility of protecting a host against
pathogenic challenge, has an array of cells found in the blood, lymph and tissues. In
humans, these cells have a common progenitor, the pluripotent haematopoietic stem
cell in the bone marrow or foetal liver. All cells of the immune system are produced
from here continuously and the production is antigen-independent. This pluripotent
progenitor gives rise to the common lymphoid progenitor (that gives rise to T cells, B
cells and plasmacytoid dendritic cells) and the common myeloid-erythroid progenitor
(that gives rise to eosinophils, neutrophils, basophils, monocytes, myeloid dendritic
cells).
Figure 1.8 shows a schematic representation of the development of human white
blood cells from a common haematopoeitic progenitor. However, recent evidence is
disputing the distinct 'committed two lineage model' (Kawamoto et al., 1997). The
same principal author (Kawamoto, 2006) proposes a closer relationship between the
lymphoid and myeloid lineages whereby common lymphoid progenitors retain some
myeloid potential and are thus termed common myelo-lymphoid progenitors. PRR
expression profiles based on lineage have been described with the myeloid derived
cells having the widest range (Taylor et al., 2005).
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Figure 1.8 Development of mammalian white blood cells
Schematic overview of the development of leucocytes from their stem cell derivative. The hone
marrow derived pluripotent haematopoietic stem cell divides into the lymphoid and common myeloid-
erythroid progenitor that give rise to the lymphoid and myeloid lineages respectively. Dendritic cells
are derived from both lymphoid and myeloid progenitors.
Chapter One - Introduction 41
Characterization of Ovine Pattern Recognition Receptors Expression
1.5 Dendritic Cells
Dendritic cells (DCs) are bone marrow-derived cells that possess both lymphoid and
myeloid stem cell derivation - see Figure 1.8. DCs are significantly more potent than
any other APCs in their ability to activate immunologically naive T cells to
differentiate into effector cells (Banchereau and Steinman, 1998; Hart, 1997;
Lanzavecchia and Sallusto, 2001; Stephens et al., 2003). DCs are highly migratory
cells, and although making up less than 1% of the total mononuclear cells in an
animal, they are present in their immature form in all tissues including the CNS. DCs
act as peripheral sentinels (possessing the unique capacity to sample all sites of
potential pathogen entry), detecting, deciphering and responding to signs of antigen
invasion, processing antigen and then moving into lymphoid organs where they
activate T cells. DCs are necessary for the initiation and amplification of the immune
responses due to their potent and unique ability to take up and process antigen (Ag)
from the peripheral sites to the lymph nodes. They usually take up antigen by
micropinocytosis, receptor-mediated endocytosis and phagocytosis, but Ag may also
be acquired by direct infection of the DC with a pathogen or binding the
immunoglobulin Fc or complement receptor. Numerous stimuli may induce the
activation, maturation, and migration of DCs. These stimuli include whole
pathogens, PAMPs on pathogens, and cytokines such as IL-1 and TNF-a produced
by other immune cells. As DCs migrate towards the lymph nodes, they mature; lose
their capacity for endocytosis and become more immunogenic (possessing more
dendrites and expressing a higher number of co-stimulatory & MHC peptides
molecules). By virtue of these properties, DCs are able to regulate not only the
quantitative nature, but also the qualitative nature of an immune response, mediate
Thl/Th2 polarization and immune tolerance.
DCs are a heterogeneous cell population that make up a key cellular element of the
innate immune system and also have the function of bridging the innate and adaptive
immune system (Kelsall et al., 2002; Moll, 2003; Reis e Sousa, 2004). In the lymph
nodes DCs present the processed antigen to nai've T lymphocytes in order to prime
and stimulate them. DCs are responsible for directing the nai've Th cells to
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differentiate into Thl, Th2 or T regulator effector cells (Kapsenberg, 2005; Mazzoni
and Segal, 2004; Moser and Murphy, 2000) and thus have the capacity to polarize
the immune response accordingly or lead to immune tolerance (Jonuleit et al., 2001).
The cytokine milieu secreted by DCs is able to exert polarizing effects on Th cell
polarization by exerting selective influence on the development of ThO cells. DCs are
also paradoxically responsible for the suppression of the immune system via Ag
specific T suppressor cells becoming tolerogenic and inducing T helper cell anergy.
Other than the modulation of T cell function, DCs are also known to recruit other
inflammatory cells and promote angiogenesis during the process of inflammation.
Thus, in addition to the teleological task of DCs priming na'i've T cells, they have
recently been shown to affect the function of natural killer cells during infection
(Andrews et al., 2005). In vitro studies have demonstrated that mature DCs are able
to modulate NK cytotoxicity and IFN-y production. In turn, activated NK cells seem
to enhance DC maturation and IL-12 production. Thus DCs have a unique function
in both priming an adaptive immune response and also in the induction of tolerance.
DCs have however, also been implicated in the trafficking and spread of various
intracellular pathogens such as mycobacteria (Humphreys et al., 2006).
Several DC subsets with different biological characteristics have been identified in
humans and mice. These subsets include the conventional myeloid DC and the
lymphoid DC (Hart, 1997; Shortman and Liu. 2002) based on their developmental
derivation (see Figure 1.8). DCs may also be classified according to their location in
different tissues. They are called Langerhans cells (LC) in the epidermis, dermal DCs
in the dermis and thymic DCs in lymphoid organs. Murine DCs can further be
classified according to CD4 and CD8a expression. In the mouse spleen, 5 distinct
sub-sets may be classified based on these classification criteria. DCs may also be
classified according to their maturation status. DCs may be classified as mature or
immature based on expression of co-stimulatory molecules b7 (CD80 and CD86),
CD40 and MHC class II. Immature DCs are found predominantly in the periphery
but some may migrate and be found in secondary lymphoid tissues (Shortman and
Liu, 2002). This large array of classification criteria for DCs does not translate across
species and the in depth description of these numerous sub-populations in multiple
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species is beyond the scope of this thesis. Ovine DC subsets are less well defined as
compared to human and murine subsets and the best-characterized ruminant DC
populations are the SIRPa (CD 172a) positive and negative populations (Brooke et
al., 1998; Howard et al., 1997). These subsets have different cytokine profiles
(Stephens et al., 2003), and capacities to induce T cell responses (Hope et al, 2001)
with the CD172a^ DCs preferentially producing 1L-10 and potently stimulating of
both CD4 and CD8 T cell proliferative responses, while the CD172a" DC population
preferentially produce IL-12 with poor CD8 Tcells stimulation.
Different DC subsets have the capacity to interact with and influence other cells such
as B and T cells, and NK cells of the immune system to modulate immune responses.
Dendritic cell subsets differ in their ability to prime Thl Th2 responses (Pulendran et
al, 1999; Voisine et al, 2002; Yrlid and Macpherson, 2003). In humans myeloid
DCs (DC1) are proposed to trigger Thl type immune responses whilst activation of
plasmacytoid DCs (DC2) is proposed to culminate in Th2 type responses. In the
mouse CD8+ DCs promote Thl type immune responses via the synthesis of IL-12
while other subsets are not able to make IL-12 and consequently promote Th2 type
immune responses (Pulendran et al, 1999).
Development of the DCs from their haematopoetic progenitors is poorly understood
but DC populations are of well-known heterogenicity (Jung Hoon Ahn et al, 2002).
In addition, the underlying genetic programs that determine lineage commitment and
differentiation of DCs are largely unknown and likely involve the selective activation
and/or repression of specific genes (Hacker et al., 2003; Richards et al., 2002).
Immature DCs also express a variety of PRRs including members of the TLR family
(Akira and Hemmi, 2003; Heil et al., 2004; Iwasaki and Medzhitov, 2004; Moser,
2004; Reis e Sousa, 2004; Werling et al., 2006) and cytokine profiles (Stephens et
al., 2003) and are therefore conferred with a diverse capability to interact with
pathogens and these receptors allow DCs to recognize PAMPs and thus detect signs
of infection by decoding the patterns of self and non-self. This leads to efficient
activation and maturation of DCs and induces their migration into the T cell zone of
lymphoid organs (Moser, 2004). The identification of PRRs as being a critical factor
in controlling DC activation and maturation has led to the premise that these
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receptors may regulate Thl/Th2 polarization (Sun et al., 2005). Subset-specific PRR
expression profiles of DCs have been implicated as a mechanism for differentially
sensing antigens and are thought to determine Thl/Th2 polarization. Although
specific immunological functions as well as unique repertoires of PRRs have been
attributed to these subsets, the distinctions are seldom absolute and each appears to
be capable of responding to a variety of microbial stimuli (Manickasingham et al.,
2003; Sher et al., 2003). Several studies however, challenge this view as being rather
simplistic. Contrary to the originally held notion, it has been postulated that the
ability of DCs to polarize specific T helper cell response in vivo does not seem to be
an inherent function of specific DC subsets, but that of a range of possible responses
dependent on the nature of stimuli received by DCs, antigen dose, activation state of
the DC, and the milieu in which DC interaction occurs (Anderson et al., 2004;
Kaisho and Akira, 2004; Manickasingham et al., 2003).
Dendritic cells have been described as the most useful cell tool for elucidating TLR
function (Kaisho and Akira, 2004), taking into account their pivotal role in linking
the innate and adaptive immune system (Hoebe et al., 2004). Few direct functional
comparisons of the PRR expression in different subsets of DCs in veterinary species
exist (Werling et al., 2006) and there are none for the sheep. Thus, the elucidation of
the PRR expression in the ovine immune system cells and tissues would be very
useful for the understanding of the potential role that PRRs and innate immunity
contribute to host-pathogen interactions outcomes.
Ruminant and pig lymphatic canulation has provided a unique and powerful tool that
allows the analysis of DCs ex vivo. This method available in these species, allows for
the collection of pure populations, in sufficient quantities, of DCs in their almost
natural state for functional immunological studies to answer fundamental questions
about in vivo DC biology (Haig et al., 1999). DCs show extreme phenotypic and
functional plasticity and any experimental manipulation such as culture is likely to
greatly affect direct relevance of such findings to in vivo DC biology. This tool thus,
allows access to 'steady state' DCs as they exist in vivo which in not possible in
humans and laboratory mice.
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1.6 Peripheral Blood Mononuclear Cells (PBMCs)
1.6.1 T Lymphocytes (T cells)
T lymphocytes are bone-marrow derived cells that mature in the thymus. They
constitute the cellular wing of the adaptive immune system and are responsible for
recognizing antigen peptides that are bound to MHC proteins and presented by
APCs. T cells that haven't encountered antigen are referred to as naive T cells
(CD45RA+). Based on differences in MHC class restriction, effector function and
type of accessory molecule use, two main types of T cells have been traditionally
described; helper T cells and cytotoxic T cells. Through their antigen-specific
cytotoxic action, T cells also play a vital role as effector cells. Suppressor T cells are
another subset of T cells whose function is mainly in the maintenance of homeostasis
and tolerance and include regulatory T cells (Tregs) and Th3 cells. A recently
described T cell sub type is the Thl7 type that is responsible for protective effector
and homeostatic immune responses (Harrington et a/., 2005; Harrington et al., 2006;
Park et al., 2005). Following activation, clonal expansion and death, some memory T
cells (CD45RCF) are retained that are able to respond more proficiently to the same
antigen. T cells are known to express PRRs, however, the functional expression of
PRRs on T cells is not well characterized. The expression of PRRs on T cells would
imply that these cells have a direct innate immune function and would recognize
nai've PAMPs independent ofAPCs antigen processing.
1.6.1.1 CD4 T cells (T helper cells)
T helper (Th) cells recognize antigen in the context ofMHCI1 presentation. The main
function of these cells is cytokine secretion, macrophage activation and provision of
helper signals for B cells and CD8 T cells. T helper cells may be classified based on
their cytokine production. Thl cells secrete copious amounts of IFNy and associated
pro-inflammatory cytokines such as 1L-12 whereas, Th2 cells secrete anti¬
inflammatory cytokines such as IL-4, IL-5, IL-10 and IL-13 which tend to promote
IgA and IgE antibody production by B cells.
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T helper cells are thus a vital regulator of immune response via polarization of a
stimulated nai've T cell towards Thl, Th2 or regulatory phenotype. CD4" cell
polarization is thus important in determining the outcome of disease as imbalances in
Thl/Th2 type responses are known to be crucial in the pathogenesis of certain
allergic and autoimmune diseases (Liblau et al., 1995; Neurath et al., 2002;
Romagnani, 2004).
1.6.1.2 CD8 T cells (Cytotoxic T cells)
Cytotoxic T cells recognize antigen in the context of MHC class 1 presentation on
infected cells or on APCs. The main function of these cells is the direct killing of
cells infected with intracellular organisms such as viruses, protozoan pathogens and
also killing of neoplastic cells. CD8+ T cells are able to achieve these anti-microbial
functions by the release of cytolytic molecules via perforin and Fas pathways that kill
infected cells and by activating and recruiting other immune cells.
1.6.2 B Cells
B cells are lymphoid-derived cells that develop in the bone marrow and whose
principal task is the production of protective high-affinity immunoglobulins against
invading pathogens. Following activation, B cells divide into plasma cells and
memory B cells. Their major function is thus participating in adaptive immune
responses; however, B cells also have an innate immune function by secreting IgM
following innate immune receptor ligation (Milner et al., 2005). B cells have been
shown to express an array of receptors (Bishop and Flostager, 2001) including PRRs
(Dasari et al., 2005; Hornung et al., 2002) and are able to recognize nai've antigen
and thus act as APCs (Constant, 1999; Rodriguez-Pinto, 2005).
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1.6.3 Monocytes/Macrophages
Monocytes circulate in blood and they move from the circulation into tissues where
they may be generally called tissue macrophages. They are called more specialized
names in different tissues such as microglia (brain), mesangial cells (kidney),
osteoclasts (bone) and Kupffer cells (liver). These cells express the myeloid receptor
CD 14, immunoglobulin and complement receptors and have the ability to take up
particulate antigen and dead/apoptotic cells by phagocytosis. These cells are
consequently also able to act as APCs for T cell activation. Monocytes are also able
to differentiate into fully functional DCs (Randolph et al., 1998; Randolph et al.,
1999; Randolph et al., 2002). Besides taking part in phagocytosis and antigen
presentation, macrophages also secrete cytokines such as 1L-1, IL-6, IL-10, 1L-12
and TNFa during an inflammatory process and thus able to modulate immune
responses.
Other cells such as gamma delta T cells (y8 T cells) and NK cells take part in innate
immune mechanisms. Gamma delta T cells have been shown to respond directly to
PAMPs (Hedges et al., 2005) and are thus postulated to be able to drive an immune
response independently of APCs. NK cells are large cytotoxic lymphocytes that,
unlike B cells or T cells, do not secrete antibodies nor express T cell receptors at
their cell surface. NK cells are important innate immune cells and represent a first
line of defence to infections with viruses or intracellular organisms, and "alterations
of self and are unique in that they are cytotoxic in the absence of prior stimulation.
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1.7 The Epitheliae (Skin and Mucosae) - The first line of
defence
The skin and mucosae have pleiotropic responsibilities that include forming the first
line of physical defence, sensation, selective permeability and secretory/absorption
functions. Other than the physical/mechanical barrier that these surfaces provide,
complex immunological processes take place that provide a link between the
adaptive and innate immune systems. These surfaces are sites for antigen uptake,
processing, presentation, co-stimulatory signalling and tolerance induction. An adult
human has approximately 400 m2 of mucosal surface (predominantly that of the
gastrointestinal, respiratory and urogenital tracts) and this presents a very large area
for potential pathogen entry. Different epithelial surfaces each have a unique
population of 'normal' resident microflora, the commensal organisms, which have
evolved to co-exist with the host in a beneficial and symbiotic manner.
Commensal organisms and the mucosal immune system co-exist in a delicate
balance. This is achieved by the multifaceted role that the immune system plays in
protecting against auto-pathology whilst maintaining local immune proficiency.
1.7.1 Immunity at the Skin
The skin is made up of keratinized stratified squamous cell epithelium. This unique
tissue is arranged in layers with the top most layer being made up of dead keratinized
cells and most of the intervening cells are not in contact with the basement
membrane. The skin represents a principal aspect of innate immune defense against
disease, firstly as an anatomical/physical barrier to infection and secondly as a site
for the induction of adaptive immune responses. The skin is the largest and most
directly exposed boundary with the externum. However, despite its obvious daily
exposure to the environment, widespread, persistent skin infections are rare. To
maintain this healthy status poses unique demands on the local immune system of the
skin to be able to withstand and respond rapidly and effectively to numerous
challenges.
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In order for the skin to function effectively, it recruits immune system resources from
non-cutaneous sources such as lymphoid and myeloid cells from blood when such a
need arises. The superficial epidermal layer of skin is underlined by a layer of
epithelial cells known as keratinocytes. Keratinocytes are important innate immune
cells in the skin and may function as 'non-professional' APCs and keratinocyte-
derived cytokine mediated cellular communication leads to the recruitment of other
cell types during pathogen challenge or cutaneous insult. Keratinocytes are known to
express TLRs (Kollisch et al., 2005) and ligation may lead to (3-defensin release via
TLR signalling (Sumikawa et al., 2006). Other cells reside in the skin and include
vascular derived leucocytes, dermal fibroblasts, Langerhans cells (LC), dermal
dendritic cells, mast cells. Typically, blood monocytes may be recruited in a steady
state or at an accelerated rate (during antigenic challenge) to replenish dermal DCs.
A newly described CD la CD207"ve non-Langerhans dermal APC population in the
human skin (Angel et al., 2006) is also involved in cutaneous mediated immune
response.
1.7.2 Immunity at Mucosal Surfaces
Mucosae make up the innermost layer of the organs that they line and come in direct
contact with lumen contents. The mucosa is structurally divided into three layers;
epithelium, lamina propria and muscularis mucosae. Unlike the skin that has a dead
keratinous outer layer, all layers of the mucosal surfaces are made up of live cells
and epithelial cells express PRRs and may initiate immune responses in response to
pathogens. However, once mucosal epithelial integrity has been breached, more
concereted inflammatory immune responses are initiated to prevent systemic
infection.
The immune system at the mucosal surface is divided into two structurally and
functionally distinct sites. The first are those that take part in antigen recognition,
uptake and processing. These sites tend to be rich in lymphoid tissue, usually
organized as mucosae associated lymphoreticular tissue (MALT), and APCs, T and
B cells. Peyer's patches in the terminal ileum are an example of MALT and are
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usually specifically called gut-associated lymphoreticular tissues (GALT). The
second sites are those that take part in the effector functions of the immune system.
1.7.2.1 Immune mechanisms in the Gastrointestinal Tract (GIT)
The gastrointestinal tract possesses the largest reservoir of macrophages and
lymphocytes in the body and also makes up the largest mucosal surface interfaced to
the environment.
Gut contents are a heterogeneous population of micro organisms made up of
symbiotic commensals and potentially pathogenic ones and also ingested food. The
mucosal epithelia have the challenging task of deciphering the vast amount of
antigentic information derived from gut contents and translating this into appropriate
immune clearance or tolerance. The exact mechanisms by which the GIT immune
system achieves this daunting task are yet still unknown. However, dysregulation in
the immune balance leads to auto immune diseases such as inflammatory bowel
disease (Crohn's disease, ulcerative colitis), and allergic gastroenteropathy. Peyer's
patches make up the most specialized and organized gut-associated lymphoid tissue
(GALT) where antigen recognition and processing take place.
At least four mechanisms are available by which immune sampling takes place and
antigen may be delivered from the gut lumen to the sub-epithelial immune cells via
three mechanisms (summarised schematically in Figure 1.9);
dendritic cells - specialized DCs sample the lumen contents by passing their
dendrites between epithelial cells, whilst maintaining tight junction integrity. These
specialized trans-epithelial dendrites carry out 'steady state' sampling and their
activity increases in bacterial infections of the GIT. DCs bearing trans-epithelial
dendrites are limited to the terminal ileum.
enterocytes - Intestinal epithelial cells may become infected and die by apoptosis.
Sub-epithelial DCs will be able to take up such apoptotic cells and acquire antigen.
Intestinal epithelial cells are also able to transport antigen from the lumen to the sub¬
epithelial space via a process known as transcytosis.
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Direct access - Antigen may be delivered to sub-epithelial immune cells via
disruptions in GIT surface mucus lining and the integrity of the epithelium. The tight
junctions between intestinal epithelial cells (IEC) may be disrupted and allow
leakage of intestinal contents into the sub-epithelial cells and access the immune
system there.
Multi-fenestrated (or microfold) epithelial cells (M cells) - These are found on the
epithelium of Peyer's patches, organised lymphoid follicles and scattered
independently in the rest of the GIT epithelium. M cells engulf antigen by
endocytosis and transport the antigen across the epithelium by transcytosis to be
presented to APCs in the sub-epithelial space for downstream immune response. M
cells are adapted for this function by lacking surface glycocalyx and not secreting
mucus. Unlike intestinal epithelial cells, they are thus in direct contact/close
proximity with lumen contents.
The main effector site for GIT immune mechanisms is thus, the lamina propria. It
normally has a high number of DCs, macrophages, T cells, B cells, plasma cells,
mast cells (see Figure 1.9). The non-ciliated simple columnar epithelium of the lower
GIT is made up of a single layer of IECs with an underlying lamina propria. The
lamina propria contains most of the immune cells. This anatomical arrangement has
minimal resistance to injury and healing tends to be difficult when substantial
portions of the epithelial lining have been eroded.
The GIT also discharges other innate immune function by virtue of a) the low pH in
the stomach is anti-microbial b) secreted mucus (containing IgA) as well as other
secreted components such as enzymes and bile have anti-bacterial effects and c)
commensal microbes preclude the overgrowth of potentially pathogenic microbes in
the GIT.
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Figure 1.9 Mechanisms of Immune sampling and immune mechanisms in the gastrointestinal
tract
Mechanisms of immune sampling in the GIT and components of the local immune system. The GIT
lumen is separated from the lamina propria by a single layer of intestinal epithelial cells (IEC). The
lamina propria contains B cells. T cells, APCs such as DCs, and macrophages. Antigen can be
delivered to the immune system in the lamina propria by specialized DCs with long dendrites, via M
cells, directly via IEC cell tight junction disruption and by transcytosis. Plasma cells release IgA in the
subepithelial space and into the GIT lumen.
Abbreviations: DC dendritic cell: iDC immature DC; mDC mature DC; Mo macrophage
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1.7.3 Oral Tolerance - immunity towards GIT commensals
The intestinal mucosa must strike a balance between rapidly recognizing pathogenic
organisms and rapidly eliminating them via regulated immune responses and
maintain hypo-responsiveness to normal gut flora/commensals (Cario, 2005; Rakoff-
Nahoum et al., 2004). The intestinal immune system is exposed to antigens derived
from food as well as those from commensal. It is however, in a state of
immunological balance with these 'normal' antigens. Unlike pathogens, commensal
microbiota cannot be effectively eliminated from the GIT by the immune system,
thus persistent immune responses to these organisms may cause chronic
inflammatory disorders. A point worth noting is that these commensal organisms that
are in a state of immunological balance in the GIT, would lead to severe or even fatal
disease when introduced to mucosae of other organs such as the lung. Like
pathogens, commensal organisms also possess PAMPs but do not normally elicit
severe immune reactions. The reason for this is not understood but several theories
have been advanced. Intestinal epithelial cells have been shown to express LPS
related PRRs such as CD14, TLR4 and MD-2, in very low levels. This would
therefore make them non-responsive (or hypo-responsive) to the LPS derived from
gut micro flora. Responses triggered by LPS receptors tend to be inflammatory - but
inflammatory reactions are contra-indicated at mucosal surfaces as they are tissue
damaging and such damage tends to be difficult to resolve and results in erosive
lesions. Macrophages in the gut also do not express significant amounts of certain
PRRs such as CD14 (Abreu et al., 2001; Smith et al., 2001; Smythies et al., 2005).
Receptor complexes are also located away from potential sites of interaction with gut
microflora. They may be located intracellularly instead of on the plasma membrane,
a strategy thought to further protect against continuous inflammation or may be
located on the basolateral aspect of epithelia whereby the epithelium has to be
breached in order for them to have any contact with gut flora. The above strategies
may be used for essential co-receptors, where the PRRs may have contact with the
microflora, but the co-receptors such as CD14, MD-2 that are required for sensing
are either absent, lowly expressed or present in a different physical location. The GIT
mucosae are also known to have tolerogenic DCs (Weiner, 2001).
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Gut microflora reside in the lumen of the gut and not directly on the epithelial cells.
The physical separation of gut epithelial cells from lumen contents by the secreted
mucus layer also limits epithelial reactivity. The mucus layer also contains anti¬
microbial peptides such as a and P-defensins. In contrast, pathogenic bacteria have
developed virulence factors that confer them the ability to actively disrupt and
penetrate the mucus lining to gain access and attach to the intestinal epithelial cells.
This brings these organisms into direct contact with PRRs expressing lECs,
macrophages, monocytes and dendritic cells and other immune system components.
This results in appropriate immune responses aimed at eliminating or containing
these microbes.
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1.8 Ovine Paratuberculosis (Ovine Johne's Disease - OJD)
Paratuberculosis, an intestinal mycobacteriosis, also known as Johne's disease (JD),
is a chronic, progressive granulomatous enteritis predominantly of ruminants caused
by the bacteria Mycobacterium avium subsp. paratuberculosis (M a.
paratuberculosis) (basonym M. paratuberculosis). M. a. paratuberculosis (Map)
causes granulomatous inflammation in the intestine (predominantly ileum) and
associated draining mesenteric lymph nodes in ruminants. It usually gains entry into
the body after oral ingestion and passage through the intestinal mucosa. Animals
usually get infected as less-than-six-month-old neonates (kids, lambs, calves) but do
not develop clinical signs until they become adults (average - cattle; 2-5 years, sheep
and goats ca 2 years) and is usually ultimately fatal. The progression of the disease
has four stages; silent infection, a protracted sub-clinical infection, clinical and
advanced terminal clinical disease. During the protracted sub-clinical phase, the Map
infection seems to be under control, but soon progresses to severe clinical disease
with clinical signs related to a protein losing enteropathy.
Two discrete microscopical forms of pathology are described, related to a high or a
low degree of mycobacterial colonization (termed as "multibacillary" or
"paucibacillary"). Each of these forms has a characteristic type of cellular infiltrate in
the terminal ileal mucosa and submucosa.
Paucibacillary (tuberculoid) - granuloma formation, high lymphoid cell, low
macrophages, low bacterial counts
Multibacillary (lepromatous) - high bacterial counts, diffuse lesions, high
macrophages
Sheep disease will have both pauci and multi, whilst cattle tend to be mostly
lepromatous. Sheep will have chronic weight loss but rarely diarrhoea. Map strains
of sheep and cattle disease have been shown to be different and can be distinguished
by PGR (Collins et ah, 2002) but this has not been shown to be an influencing factor
in the subtle differences in clinical manifestation between sheep and cattle.
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JD is not a disease exclusively of ruminants, many other species including dogs,
pigs, horses, chickens and primates may be affected. Map has a well-defined tissue
tropism for the intestine (Sweeney et al, 2006) and corresponding mesenteric lymph
nodes, even if administered parenterally. Even when given subcutaneously or
intravenously, it preferentially goes to the terminal ileum and colon where it causes
chronic inflammation.
1.8.1 Pathogenesis of OJD
Map preferentially invades macrophages that are found in the ileal Peyers patches,
where the macrophages play a conflicting function of being the primary site ofMap
replication and also an important cell type involved in the development of immunity
to eliminate the Map. As a consequence, the pathogenesis ofMap at the intracellular
level (in macrophages) is very poorly understood. Further, most of the information in
literature on Map is deduced from M. tuberculosis and other Mycobacterial species
in human and murine infections/experiments. Similarities between the immuno-
pathogenesis of leprosy and OJD exist and there are striking similarities between the
granulomatous lesions of ruminant Johne's disease and those in human leprosy
(Modlin et al., 1988). Both diseases have clinical forms that are highly polarized and
the Thl/Th2 balance has an important role in determining disease progression and
outcome. Granulomata formation is associated with the paucibacillary (tuberculoid)
form that is characterized by a Thl-type response. Granulomata are formed as
organized immune barriers that limit infection and control disease progression. Chiu
and co-workers (Chiu et al., 2004) proposed that granulomata are likely sites where
innate and adaptive immune responses merge, regulated by dendritic cells. On the
other end of the immune spectrum is the lepromatous (multibacillary) form that is
characterized by a Th2-type response. This Th2-type response has a weak cell-
mediated immunity and is thus unable to limit the mycobacterial proliferation and
tissue damage. In humans, tuberculoid granulomatous lesions have a better clinical
outcome than lepromatous lesions. Thus, the control of mycobacterial infections in
humans is directly correlated to the granuloma type. Mechanisms that mediate the
decision to mount either a Thl-type or Th-2 type immune response, and the resulting
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clinical form are not well understood. However, TLR signalling seems to skew naive
T cells towards Thl-type response polarization (Trinchieri, 2003a) and has also been
proposed to actually censor Th2 cell development (Sun et al., 2005). Paradoxically,
TLR signalling has also been shown to drive Th2 responses in certain instances (Re
and Strominger, 2001). This is achieved by DCs via subtle differences in PRR
signalling and temporal factors leading to pathogen specific cytokine milieu that will
determine the Thl/Th2 balance (Jankovic et al., 2001; Langenkamp et al, 2000).
During the progression of OJD, it is known that the initial control of the early sub¬
clinical Map infection, 'reactive paratuberculosis' is due to the limitation of the
infection by Thl type (tuberculoid) granuloma formation. The effective immune
response is characterized by a strong cytotoxic and proinflammatory action, but this
gives way to a Th2-type response characterized by humoral immunity. The dynamics
of the change from Thl to Th2 immune response and overt clinical disease are
poorly understood. It is however, known that the decision to differentiate into Thl
and Th2 CD4+ T cells is made early following infection and antigen recognition and
processing for presentation. Koets and co-workers (Koets et al., 2002) working with
Map, hypothesized that the reduction in the number of protective CD4+ T cells leads
to a lack of control of mycobacterial replication. This consequently, leads to the
fulminating granulomatous enteritis that is typical of ruminant paratuberculosis.
Zhang and co-workers (Zhang et al., 1995) proposed that the progression in the
mycobacterial infection is due to a diminished Thl response per se and not an
increase in the Th2 response. However, numerous authors report and increase in the
number of infdtrating CD4+ cells (Bassey and Collins, 1997; Weiss et al., 2006) in
paratuberculosis lesions
The exact mechanisms involved in the shifting immune response to Map are
unknown but are most likely multifaceted, involving antigen processing, antigen
presentation, and tolerance induction.
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Adapted from (Hostetter et al., 2005)
1.8.2 Mycobacterium and pattern recognition receptors
To date there has been no comprehensive and mechanistic dissection and
understanding of how Mycobacterial infections proceed and how host defenses are
marshalled against Mycobacterium. The comprehensive understanding of both
successful and unsuccessful host defense mechanisms is a very important goal but it
remains elusive. Quesniaux and co-workers (Quesniaux et al., 2004) postulated that
mycobacterial factors and released products such as lipoarabinomannan (LaM)
contribute towards continued macrophage and DC stimulation via TLRs and other
PRRs in cases of mycobacterial infections. Disparate findings exist on the role of
PRRs in mycobacterial disease pathogenesis. For example, Sugawara and co¬
workers, (Sugawara et al., 2003) using TLR2 and TLR6 knock-out mice, concluded
that these TLRs are necessary for the recognition of mycobacteria but do not
determine the outcome of pathology. It would also concur with Nicolle and co¬
workers (Nicolle et al., 2004) who, working with knock-out mice concluded that
TLR2, TLR4 and TLR6 are not necessary for long-term control of BCG
mycobacteria. This is in contrast to other workers who concluded that TLR2
expression correlates with a better out come of disease in leprosy (Krutzik et al.,
2003).
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1.8.3 Immunity development to Mycobacterium species and Immune evasion
strategies by mycobacteria
The induction of a strong and appropriate innate immune response to invading
mycobacteria is essential for the control of infection. Mycobacterium tuberculosis
has however, been shown to survive the innate immune responses by suppression of
inflammation. It has been postulated to use the tolerogenic effects of PRR signalling
to facilitate its long term persistence (Pai et al., 2003). M. tuberculosis uses
numerous other mechanisms to evade host immune responses including the down
regulation ofMHC classll (Noss et al., 2001) leading to poor antigen processing and
manipulating phagosome maturation, reviewed by Flynn and Chan (Flynn and Chan,
2003). M. tuberculosis inhibits phagosome maturation into phago-lysosome and also
prevents the acidification of the phagosome, thus maintaining a milieu that ensures
their continuing survival in the engulfing macrophage or APC (Harding et al., 2003).
Mycobacteria may use PRR signalling to evade the immune system. The C-type
lectin DC-SIGN has been postulated to be used by many viral organisms and
Mycobacterium to evade immune recognition (van Kooyk and Geijtenbeek, 2003).
In mice, immunity to M. avium has been shown to be regulated by a host of other
unknown MyD88 dependent factors in addition to the well-known TLR2 and TLR4
(Feng et al., 2003). M. tuberculosis also causes immuno suppression in host's cells
by secreting large quantities of glycosylated antigen.
Manca and colleagues (Manca et al., 2001) show that different strains of M.
tuberculosis strains have different capacities to induce Thl responses and this has an
impact on disease outcome. Strains of Map derived from different spps. may have
different pathogenic effect on macrophages under in vitro conditions (Janagama et
al., 2006). This may have a bearing on the manifestation of clinical disease in sheep
although no work has conclusively shown this.
The strong association between the incidence of Crohn's disease in humans and the
culture of Map in these individuals (Grant, 2005; Naser et al., 2004; Sartor, 2005),
has led to speculation that Map may be zoonotic and pathogenic in humans under
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certain conditions. This is a developing and still very controversial association with
some authors finding no correlation (Ellingson et al., 2003). Modern wildlife
management practices of farming wild animals for profit or preservation, have now
led to the increase of diseases that are by and large scarce in wild herds, including
such diseases such as Johne's disease (Motiwala et al., 2004). This changing
epidemiological perspective of Johne's disease will inevitably bring new challenges
to the control and attempts towards eradication of this economically and
immunologically challenging disease.
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1.9 Aims and Objectives
1.9.1 Background and Hypotheses
In order to understand the role that PRRs have in the immune system in sheep, the
expression pattern of these PRRs in normal tissues and cells must be well defined.
This would provide a baseline, from which deviations would indicate a shift into a
diseased state or immune activation. The critical task was therefore to first identify
PRR homologues in sheep as have been described in humans and other species and
characterize their expression in different tissues, cells and disease situations. 1
hypothesized that all PRRs described in humans would all be present in sheep and
also have similar functions and expression profiles in 'steady state' tissues and cells
and in similar diseases as in humans and the mouse.
It is well documented that mammalian neonates are more susceptible to infectious
challenge than adults and this is because they have an underdeveloped immune
system. Most of the work on the underdevelopment of the immune system has been
focused on the adaptive immune system development from birth (term or premature)
compared with adults. It is however known that foetuses are able to respond to
vaccinations. With the knowledge that the innate immune system drives adaptive
immune responses, I undertook to investigate if this underdevelopment may be
primarily due to an underdeveloped innate immune system and particularly due to a
naive pattern recognition receptor system. In order to unravel the potential to
recognize antigens by the developing foetus, I undertook to comparatively quantify
the PRRs mRNA expression in the skin and spleen of pre-term ovine foetuses and
adult sheep. The premise being that since neonates are known to have under¬
developed immune systems, the PRRs mRNA expression in developing foetuses
could be either very low or absent at birth and increases with age.
PRRs have been shown to be altered in disease states. PRRs are recognized to be
pivotal in innate immunity development and innate immune mechanisms are known
to be important for the control of Mycobacterium infections. I hypothesized that
PRRs may be critical in determining outcome of Map infections and the resultant
clinical forms of JD.
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1.9.2 Specific Aims and Objectives of the Study
To identify sheep homologues of selected PRRs described in humans and
mice
To elucidate the in vivo gene expression patterns of PRRs in 'steady state'
ovine dendritic cell subset populations
To characterize the existence and distribution of ovine PRRs in selected
different cell types and tissue types in clinically healthy subjects.
To characterize the expression of PRRs in ovine paratuberculosis. The
hypothesis being that altered PRR expression during antigen recognition
and processing (particularly TLR2 with its hetero dimers and associated
accessory molecules) may account for the development of any of the three
clinical manifestations of the disease in sheep.
To characterize the expression of PRRs in LaM (a M. paratuberculosis
associated ligand) stimulated skin in sheep.
To characterize the expression of PRRs in the preterm foetal spleen and
skin.
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2 Chapter Two - Materials and Methods
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Figure 2.1 Schematic overview of the experimental procedures carried out during the PhD study
Schematic overview of the experimental procedures carried out in this study
Abbreviations: DC. dendritic cells: FACS, flourescense activated cell sorting: PVI. post-mortem:
qPCR quantitative real time PCR:
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2.1 Chemical and Reagents
All reagents used were molecular biology grade quality and obtained from reputable
suppliers listed in Appendix I. The name of the manufacturer of each reagent is noted
against the particular reagent. All oligonucleotide primers were synthesized by
Sigma-Genosys, UK. The recipes for all commonly used buffers and solutions are in
the appendix.
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2.2 Sample collection and processing
2.2.1 Ethical approval ■ study animals
All animal experiments were approved by the University of Edinburgh's Ethical
Review Committee and conformed to the standards and practices of the Animals
(Scientific Procedures) Act 1986. All the experiments were carried out under Home
Office project licence and personal licence PPL/60-3072 and 60/9994 respectively.
2.2.2 Normal ovine tissues
Samples were collected from clinically healthy adult ewes kept predominantly
indoors. The ewes had previously been treated with the anthelmintic moxidexin
(Cydectin®) eight weeks prior to euthanasia. All animals were euthanized humanely
using intravenous pentobarbitone sodium and exsanguination. The anaesthetic was
administered to effect terminal anaesthesia and once unconsciousness was achieved,
the animals were exsanguinated via carotid artery bleeding. Tissues were collected
immediately afterwards.
Approximately one cm of each of the tissues; mesenteric lymph node, pre-scapular
lymph node, skin, kidney, lung, spleen and urinary bladder was collected and cut into
four equal sized pieces and immediately placed in 5ml of RNA stabilizing agent,
KNAlater™ (Ambion®). RNA later™ is a stabilizing solution that permeates tissues
and cells and protects contained mRNA from degradation. The tissues were then
stored at 4°C overnight, removed from the RNAlater™ and stored at minus 80°C until
RNA extraction.
2.2.3 Pre-term ovine foetal skin and spleen
Spleens and thoracic-flank-skin strips were collected from foetuses carried by date-
mated experimental ewes. Access to foetal tissues was courtesy of Allan McNeilly,
University of Edinburgh. The ewes were euthanised with intravenous pentobarbitone
sodium and the intact gravid uterus removed to sample foetal tissues. The foetuses
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were estimated gestational age (EGA) 60 («=5), 70(«=5), 80(«=5) and 90(n=2) days
(All EGAs being of second trimester pregnancy - ovine normal gestation 145-150
days). All collected samples were immediately placed in five times their volume of
KNAlater™ and stored overnight at 4°C. After overnight storage, the RNA/afer™ was
removed and the treated tissue samples stored at minus 80°C until RNA extraction.
2.2.4 Steady state dendritic cells and PBMCs
2.2.4.1 Lymph fluid collection via canulation
Lymph fluid was collected from healthy sheep via surgically implanted canulae
placed into a pseudo afferent lymph duct of the pre-femoral lymph node (Hopkins et
al., 1986). Pseudo afferent ducts were formed by surgically removing the pre-
femoral lymph node several months prior to canula implantation for lymph
collection. One week post-operatively, lymph was collected daily in previously
autoclaved plastic bottles containing canulation fluid (containing actinomycin D
((Sigma) lpg/ml), heparin (400U), penicillin (1000U)/streptomycin(lmg)). Dendritic
cells were purified (Section 2.2.4.3.1) within twenty four hours of lymph collection.
This system allows for the in vivo manipulation of DCs for ex vivo examination and
the actinomycin D added to the collection fluid prevents de novo RNA synthesis.
2.2.4.2 Blood collection
Blood (40ml) was collected into heparinized tubes from healthy sheep donors via
jugular venipuncture. PBMCs were extracted within four hours of blood collection.
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2.2.4.3 Cell enrichment/extraction
2.2.4.3.1 Dendritic cells
Afferent Lymphatic DCs were extracted from lymph by centrifugation on a Ficoll-
Metrizoate density gradient (density = 1.320; OptiPrep®; Axis-Shield); using the
OptiPrep* at room temperature. Afferent Lymphatic cells were pelleted by
centrifugation at 4°C, 300xg for 5 minutes. The cell pellet was washed once with ice-
cold buffer B (see appendix II) and re-suspended in buffer B up to a maximum
concentration of 2 x 107 cells/ml. 2.5ml of cell suspension was transferred into 20ml
sterile universal containers and 1ml of OptiPrep* added and mixed gently. To this
mixture, 4ml of freshly prepared OptiPrep* solution 1 (See appendix II for
constituents; OptiPrep® solutionl densisty: 1,078g/ml - lymphocyte specific density
layer) was carefully overlaid, followed by 10ml of OptiPrep* solution 2 (See
appendix II for constituents; OptiPrep* soluition2 density: 1.068g/ml) and finally
overlaid with 1ml sPBS.
Gradient separation of DCs was achieved by centrifugation of this mixture at 600 x g
for 25 minutes at room temperature, with the brake de-activated during deceleration
at the end of the spin. Dendritic cells, in the gradient fraction above the OptiPrep®
solution 1, were collected and transferred into a new 20ml sterile universal container,
washed with sPBS and cells pelleted by centrifugation at room temperature, 300 x g,
5 minutes. The cells were re-suspended in ice-cold FACS buffer and centrifuged at
4°C, 300 x g, for 5 minutes. The supernatant was carefully decanted and the DCs re-
suspended in 10 ml ice-cold FACS buffer, then counted and assessed for viability.
2.2.4.3.2 PBMCs
For PBMC extraction, 9ml histopaque® was pipetted into a standard 20ml sterile
. . (r)
universal container. Onto this histopaque , 10ml of an equal mixture of
anticoagulant treated blood and PBS was carefully overlaid using an automatic
pipettor set at the slowest speed (see Figure 2.2). The layered
histopaque®/blood&PBS was centrifuged at 800 x g, 20 minutes at room
temperature, with the brake at the end of the spin switched off. The PBMCs in the
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interface were carefully removed using a Pasteur pipette and washed once with ice-
cold sPBS; 300 xg, 5 minutes at 4°C. The cells were then counted and assessed for
viability (see Appendix III for detailed protocol).
Figure 2.2 Schematic overview of the Histopaquc" protocol for extraction of PBIVICs.
Schematic overview of the histopaque' PBMC extraction protocol. Anti-coagulated blood is mixed
with and equivalent volume of sPBS and mixed gently but thoroughly. 10ml of this mixture is
carefully overlaid over 9ml histopaque^ and the resultant mixture spun at 800 x g for 20 minutes at
room temperature. PBMCs are aspirated with a Pasteur pipette at the interface.
2.2.4.4 Counting cells
Cells resulting from the cell enrichments were checked for viability using trypan blue
exclusion. A lOpl volume of cell suspension was added to 10pl of 0.5% (w/v) trypan
blue in PBS and mixed by gentle pipetting. A lOgl aliquot of the mixture was placed
on a previously assembled Improved Neubauer haemocytometer. Cells were counted
using a light microscope and x 200 magnification. The percentage viable cells was
determined by counting cells that excluded the dye (viable cells) and those that took
on the blue dye. The cells were then re-suspended to an appropriate cell
concentration in FACS buffer for immunostaining.
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2.2.4.5 Immunostaining and cell sorting
2.2.4.5.1 Flow cytometry
Isolated dendritic cells were double-stained with IL-A24 (anti CD 172a) and
biotinylated SW73.2 primary monoclonal antibodies conjugated to the following
fluorochromes; anti-mouse Ig fluorescein isothiocyanate (FlTC(Sigma)), and
streptavidin phycoerythrin (SA-PE (Sigma)) respectively. PBMCs were incubated
with the following antibodies, biotinylated STU-4 (conjugated to SA-PE), STU-T8,
VPM30, andVPM65 (conjugated to F1TC) (see Table 2.1).These cells were then
subjected to fluorescence activated cell sorter (FACS) analysis using a FACS
Calibur® or FACS Scan® cytometer (Becton-Dickson). FACS data were obtained by
collecting a total of 10,000 cells (events) from each sample. Cells were acquired and
gated based on the cells' expected characteristic forward scatter (FSC) and side
scatter (SSC) profile. Different cell types have different profiles with dendritic cells
having a high FSC and SSC representing a large cell size and complexity
respectively (Figure 2.3). Appropriate compensation settings were determined for
two-colour dendritic cell FACS analysis to overcome the overlap between the FITC
and SA-PE fluorochrome spectrum. The analysis of the cell populations was done
using the Cell Quest® software (Becton-Dickson). Post-acquisition screening data
analysis and data presentation was also done using WinMDI software
(http://facs.scripps.edu/software.html).
(r) .
DC populations were purified using FACS (FACSvantage , (Becton Dickinson)) at
the University of Edinburgh Medical School, Inflammation Research Unit by Shonna
(R)
Johnston. PBMCs populations were purified using FACS (FACS Aria , (Becton
Dickinson)) at University of Edinburgh, Ashworth Building by Andrew Sanderson.
Chapter Two - Materials and Methods 71
Characterization of Ovine Pattern Recognition Receptors Expression
Figure 2.3 Dotplot of Unstained PBMCs and dendritic cells
Dotplot of a) Unstained Histopaque extracted PBMCs and b) unstained Optiprep® separated dendritic
cells. Data displayed using WinMDl software. The PBMC dotplot (a) shows cells of relative
homogeneity in terms of size and granularity as reflected by the tight distribution of the FSC and SSC
profiles. Dendritic cells on the other hand have a greater heterogeneity in terms of size and granularity
as reflected by their diverse FSC and SCC profiles from the dotplot (b). DCs are large and extremely
granular cells.
2.2.4.5.2 Monoclonal antibodies
Monoclonal antibodies (mAb) used in this study are listed in Table 2.1. These mAb
were obtained from stocks currently held within our Lab. Biotinylation of the
SW73.2 was also performed in order to facilitate double immuno staining of
dendritic cells.
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CD4 T cells PBMCs (Maddox et al,
1985)
VPM30 28 kD B-cells PBMCs (Naessens and
Howard, 1991)
VPM65 CD 14 Monocytes/ Monocytes/ (Gupta et al.,
macrophages macrophages 1996)
Table 2.1 Monoclonal antibodies (mAb) used for immunostaining and FACS analysis
Monoclonal antibodies (mAb) used for immunostaining cells for FACS analysis. Target cell type and
original references listed. 1LA-24 and SW73.2 were used for double staining dendritic cells and the
rest of the antibody panel was used for single staining peripheral blood mononuclear cells.
2.2.4.6 Immunostaining
2.2.4.6.1 One colour immunostaining
Single colour immunostaining was carried out to allow FACS sorting of PBMC
populations. During immunostaining, all procedures were done on ice, and working
. . (r)
as quickly as possible. Following histopaque extraction, PBMCs were counted and
re-suspended in ice-cold FACS buffer to a concentration of 2 x 108cells/ml and 50p.l
dispensed into FACS tubes (Falcon). The cells were first incubated with an equal
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volume of 1:500 diluted Normal Mouse Serum (NMS) for 15 minutes at 4°C. To
remove unbound NMS, the cells were washed twice with 2.5ml FACS buffer/FACS
tube and centrifugated at 4°C, 300 x g, for 5 minutes. The cells were then incubated
for 15 minutes at 4°C with an appropriate amount of monoclonal antibody (Table
2.1) based on concentrations derived from individual mAb titration (Section
2.2.4.6.3). To remove unbound mAb, the cells were washed twice with 2.5ml FACS
buffer/FACS tube and centrifugation at 4°C, 300 x g, for 5 minutes. For the
biotinylated STU-T4, the cells were incubated with streptavidin phycoerythrin (SA-
PE (Sigma)) 5pl/l x 106 cells and incubated for 15 minutes at 4°C. The non-
biotinylated mAb were detected following similar incubation but using 50pl anti
mouse Ig FITC (Sigma)) diluted 1:80. The cells were again washed twice. Cells for
sorting were then re-suspended in ice-cold FACS buffer at a concentration of not
more than 5 x 106 cells/ml and sorting carried out immediately. Cells that were to be
used for FACS analysis were re-suspended in 2% (w/v) paraformaldehyde in PBS
and stored at 4°C, covered in aluminium foil until use. FACS analysis of
paraformaldehyde stored cells was normally done within 48 hours (see Appendix
III).
2.2.4.6.2 Two colour immunostaining
Two colour immunostaining was carried out to facilitate FACS sorting of CD172a7
CD 172a* DCs populations. The cells were incubated with the ILA-24 and SW73.2
mAb for 15 minutes at 4°C. NMS blocking and washing were as for the single colour
immunostaining above.
2.2.4.6.3 Titration ofmonoclonal antibodies
Prior to being used for immunostaining for FACS cell sorting, respective mAb used
in these experiments were titrated on extracted PBMCs and DCs to establish
optimum working concentrations. An optimum volume of supernatant (or dilution for
concentrated biotinylated mAb) of the primary antibody, i.e. that which gave
strongest fluorescence signal and lowest background staining, was determined for
each mAb. Where appropriate the anti mouse Ig FITC dilution was adjusted from the
standard 1:40 dilution by titration.
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2.2.5 Ovine paratuberculosis tissue collection
A retrospective study of ovine ileum tissues was carried out from sheep flocks
naturally infected with paratuberculosis. Archival distal ileum samples, stored in
RNA/ater™ (Ambion), were from 24 cases of Johne's disease diagnosed at Moredun
Research Institute's veterinary postmortem service. All cases had clinical histories,
typical of Johne's disease and all cases were confirmed by gross pathological
changes at necropsy, culture and histopathology. There were 8 cases each of;
paucibacillary, mutlibacillary and 'asymptomatic' designation (Appendix V). Access
to these tissues was courtesy of Dr. Craig Watkins (Mycobacterial Research Group,
Mordeun Research Institute, Edinburgh) and RNA was extracted by Jennifer Smeed.
'Normal' ileum tissue was also collected from sheep at the Marshall building, Roslin;
a facility that has had a low incidence of Johne's disease (Docherty, personal
communication).
2.2.6 PRR expression in ligand stimulated ovine skin
2.2.6.1 Preliminary study (dosage test)
An initial pilot experiment was undertaken to determine an appropriate concentration
ofMycobacterium avium paratuberculosis strain V lipoarabinomannan (LaM) to use
for carrying out a cutaneous LaM stimulation experiment to determine resulting
innate immune responses via PRRs. Three concentration of the LaM were used for
this pilot study namely, 100pg/ml, 200pg/ml, 400pg/ml. lOOpl of each concentration
of the ligand were administered to one animal as outlined in Section 2.2.6.3. The
LaM was administered in duplicates and at time points 8hr, 4hr, 2hr and 1 hour prior
to euthanasia.
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2.2.6.2 Study animals
For the experiment, four, one-year old Boorola male sheep were administered with
50pl (50pg/ml) LaM as outlined in Section 2.2.6.3.
2.2.6.3 Ligand administration
The flank of the study sheep was shaved with electric clippers covering the area from
the tuber coxae to the 10th rib caudo-cranially and a distance of approximately 30 cm
from the level of the transverse processes ventrally. The clipped area was washed
with warm water and de-fatted with 100% ethanol followed by an iodine scrub and
wash. The flank was marked with grids using an indelible marker representing the
intradermal injection sites and time points (Figure 2.4).
In order to ease the discomfort to the study subjects, the ligand solutions were
warmed to approximately body temperature by holding the vials in a clasped hand
for about a minute prior to intradermal injections. 50pl LaM or sPBS were
administered in triplicates 24hr, 8hr, 4hr 2hr and 1 hr prior to euthanasia and skin
biopsy collection. Euthanasia was carried out using 200mg/ml intravenous
pentobarbitone sodium. Biopsies were collected using 6mm disposable biopsy
punches and excessive fat and connective tissue were trimmed off. Half of one
biopsy was placed into 5m 1 zinc sulphate fixative solution (Gonzalez et al., 2001)
(Appendix VI) for histopathology. All other collected biopsies were immediately
TM TM
placed in RNA/afcr and stored at 4°C overnight, then removed from the KNAlater
and stored at minus 80°C until RNA extraction. The skin biopsy in the fixative was
also stored at 4°C overnight, and the fixative replenished with double the volume
fresh fixative. Within 48 hours post-mortem, the biopsy samples were sent to Easter
Bush Veterinary Centre (University of Edinburgh (EBVC), Midlothian) for
automated processing paraffin wax embedding, sectioning and Haematoxylin and
eosin staining.
Chapter Two - Materials and Methods 76
Characterization ofOvine Pattern Recognition Receptors expression
Figure 2.4 Sheep prepared for cutaneous ligand administration.
Figure showing the shaved area of the right flank of a study sheep and a permanently marked grid
representing the location for intradermal injections. Each box was at least 4cm x 2cm in dimension
and boxes were at least 2cm apart. Two intradermal injections were administered into each box at the
polar ends of the rectangles and the middle of the intradermal bleb marked with a marker pen tip to
facilitate accurate biopsy punching (post mortem).
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2.3 Nucleic acid extraction
2.3.1 Good molecular biology practices
Most methods used in this study for DNA or RNA manipulation were based on
methods in 'Molecular Cloning: A Laboratory manual" (Sambrook et ah, 1989) and
the Laboratory kits' manufacturer's guidelines. Prior to use, all bench-top surfaces,
equipment and pipettors were decontaminated using 10% Decon®, followed by 70%
ethanol and finally with RNAseJway® and MicrosoL® to avoid contamination.
Nuclease free-sterile plastic ware and aerosol resistant filter tips were utilized and
disposable gloves were changed frequently whilst carrying out all the molecular
biological procedures.
2.3.2 RNA extraction
2.3.2.1 Cells and normal tissues
RNA was extracted from tissues and cell types collected from healthy sheep
populations. The RNA extraction process from sorted PBMCs and DCs was begun
on the same day of cell isolation. Cells purified as in section 2.2.4.3 were re-
suspended in RLT buffer with 1% |3-mercaptoethanol, vortexed briefly and the cell
lysate stored at -80 °C until completion of the RNA extraction process. RNA was
extracted using commercial RNA extraction kits - RNeasy® Midi Kit and Mini Kit
(Qiagen) following the manufacturer's protocol.
2.3.2.2 Ligand stimulated skin
An approximately 25mg piece of RNA/ur/er™ preserved biopsy sample was placed
onto an individual, sterile, disposable Petri dish and cut up into small pieces. The
pieces were then carefully placed into a clean RNAse free, 1.5ml microcentrifuge
tube tube into which 200pl of lysis buffer (RLT with (3-mercaptoethanol) was added.
In order to get a uniformly homogenized sample, skin was homogenized using a
motorized pestle. Freshly autoclaved individually packed pestles were used for each
sample. Half way through the homogenization process, another 150pl of the lysis
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buffer was added. After obtaining a homogenate of uniform consistency with no
tissue clumps. 550pl of nuclease free water was added and mixed well. To the
mixture, 10p.l of proteinase K (Sigma; 20mg/ml) was added and mixed well by light
vortexing. The suspension was incubated in a water-filled hot block at 55°C for
fifteen minutes. After incubation, genomic DNA was sheared using an RNAse free
syringe and 20G needle and passing the lysate through the needle at least five times.
The homogenate was subsequently centrifuged at 10,000 x g for 3 minutes and the
supernatant collected and placed into a clean 1.5ml microcentrifuge tube. An equal
volume of 70% ethanol was added to the supernatant and mixed well prior to
dispensing onto the Qiagen RNeasy mini spin columns. All subsequent steps were
according to the manufacturer's protocol and final elution was carried out in 30pl of
RNAse free water.
2.3.2.3 Removal of trace DNA contamination - DNAse I treatment
In order to remove trace quantities of contaminating DNA, DNAsel treatment of
eluted RNA was carried out. Briefly, 1/19th of the eluate volume of 20x DNAse
buffer was added to the RNA followed by lpl of the DNAsel enzyme (8 units/pl).
After gentle mixing, the mixture was incubated at 37°C for thirty minutes. This was
followed by a DNAse deactivation stage at room temperature. One fifth of the total
eluate volume of DNasel inactivation slurry was added to the mixture and stored at
room temperature for two minutes. After the two minute incubation, during which
the slurry mixture was mixed gently and constantly, the mixture was centrifuged at
10,000 x g for 1 minute to pellet the deactivation agent. The DNA free RNA
containing supernatant was collected by pipetting and placed into an appropriately
labelled, clean 1.5ml microcentrifuge tube. From the total sample, one 5jul aliquot of
RNA was removed for spectrophotometry and a 2pl aliquot for RNA integrity
. (r)
analysis with the Agilent 2100 bioanalyzer. All RNA samples and aliquots were
stored at minus 80°C until use.
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2.3.2.4 Sample integrity confirmation.
Total RNA was quantified using spectrophotometry - using the formula that OD260 nm
(absorbance at wavelength OD260 nm) of 1.0 = 40pg/ml RNA. As a measure of purity
the ratio of the absorbance at 260nm/absorbance 280nm was determined, with pure
RNA free of protein contamination having a ratio of 2.0. The RNA quality and
integrity was further confirmed using the Agilent® 2100 bioanalyzer. Ideal RNA has
an electropherogram showing rRNA Ratio [28s/18s] approaching 2.0 and an RNA
integrity number (R1N) close to 10.0 as shown in Figure 2.5. RNA samples with
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Figure 2.5 Agilent 2100 Bioanalyzer Electropherogram and gel view
A) Segment of an electropherogram showing the 18s rRNA peak (left shorter peak) and the 28s rRNA
peak (right higher peak) with minimal peaks in the fast region and inter region. The 28s peak is higher
with a larger area under it than the 18s region indicating good quality RNA with a high 28s/18s. B) A
sample Agilent 2100 bioanalyzer gel view of good quality RNA showing two distinct bands
representing 18s and 28s rRNA peaks.
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2.3.3 DNA extraction
Genomic DNA (gDNA) was extracted using a commercial kit, DNeasy® (Qiagen).
Briefly, 20mg of tissue was placed on a sterile clean Petri dish and chopped up into
small pieces. The pieces were transferred into a clean 1.5ml microcentrifuge tube
tube into which 20pl proteinase K was added and mixed. The mixture was incubated
at 55°C until the tissue was completely lysed. The mixture was vortexed for 15s,
200pl buffer AL added, mixed and incubated at 70°C for 10 minutes. The mixture
was vortexed again prior to, and after the addition of 200pl pure ethanol. This
mixture was transferred into a DNeasy® spin column and washing with the
manufacturer's buffer AW1 and AW2 carried out according to the manufacturer's
protocol followed by an elution with 150pl buffer AE. The DNA was quantified
using a spectrophotometer and stored at minus 20°C until use.
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2.4 Reverse Transcriptase - Polymerase Chain Reaction (RT-
PCR)
2.4.1 First strand cDNA synthesis - Reverse transcription
RNA was reverse transcribed using Oligo(dT)is primers and using either Moloney
murine leukaemia virus (MMLV) reverse transcriptase (Promega) for the tissues or
Omniscript® (Qiagen) for the cells. The cDNA was used for all subsequent
conventional PCRs and quantitative real time PCRs.
2.4.1.1 cDNA synthesis-tissues
For each RNA sample, cDNA was synthesized using M-MLV reverse transcriptase
kit (Promega). For the conversion of RNA into cDNA, reverse transcription (RT)
was done using 0.5pg OHgo(dT)i5 primers and reactions were carried out in a final
volume of 25 pi. For the first strand cDNA synthesis, 2.5pg of total RNA, together
with the 0.5pg Oligo(dT)i5 primers was heated in a thin-walled PCR tube at 70 °C
for 5 minutes and cooled quickly on ice for a further 5 minutes. To the annealed
primer template mixture 5pl of M-MLV RT 5X reaction buffer, lpl of dNTPs mix
(lOmM), lpl RT enzyme and nuclease free water up to 25pl were added. After
gentle mixing, the reaction was incubated at 40°C for 10 minutes, 42°C for 50
minutes and the reaction inactivated at 70°C for 15 minutes. The cDNA was diluted
four-fold in nuclease free water and stored at -20°C until use. For the initial PRRs
identification experiments the cDNA was used neat.
In order to avoid discrepancy arising during cDNA synthesis, sufficient cDNA
synthesis from each tissue set was carried out in a single batch to avoid any likely
variability caused by differences in the reverse transcription efficiency of target and
reference gene. A second batch of cDNA synthesis was performed and the two
batches mixed.
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2.4.1.2 cDNA synthesis - FACS sorted cells
Reverse transcription of RNA derived from cell subsets was carried out using
Omniscript® Kit (Qiagen). This kit is designed for optimal cDNA synthesis from low
quantities of RNA template (50ng - 2pg). RT was carried out using 200ng RNA and
a final volume of 20pi. All pre-incubation steps in this protocol were carried out on
ice. A master mix was prepared using the supplied reagents comprising; 2pl lOx
buffer, 2pi 5mM dNTPs, 2pl Oligo(dT)i5, lpl (10 units/pl) RNase inhibitor and lpl
Omniscript". Reverse transcriptase for each RT reaction. Into each labelled, thin-
walled PCR tube 8pl of the master mix was added, followed by template RNA and
made up to 20pl with ice-cold nuclease free water. The tubes were mixed by light
vortexing and the contents collected by pulse centrifugation. The mixtures were
incubated at 37°C for lhour. The cDNA was diluted two-fold in nuclease free water
and stored at -20°C until use.
2.4.2 Primers
Primers used in this work are shown in Table 2.2. The sequences of sheep PRRs
were not available at the commencement of the study; therefore primers were
designed using bovine PRR sequences deposited in Genbank or The Institute of
Genomic Research (T1GR). Human mouse consensus GAP sequences were used for
the design of TLR5 and TLR7 primers. The partial bovine sequence for TLR8 was
kindly provided by Dr. EJ Glass, Roslin Institute, Edinburgh.
The primers were selected and designed using the Primer3
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) software, a web based
program. Where intron-exon structures of the genes were known, primers were
designed to span an intron(s) or intron/exon splice junction to obviate the possibility
of amplification of genomic DNA. All selected primer sequences were then checked
for possible cross-hybridization by subjecting them to a BLAST
(http://www.ncbi.nlm.nih.gov/BLAST/index.shtml) database similarity search
program (Altschul et al, 1990). The primers were then subjected to quality check
using Premier Biosoft (http://www.premierbiosoft.com/netprimer/index.html). All
primers were obtained from Sigma-Genosys Ltd, UK.
Chapter Two - Materials and Methods 83
Characterization ofOvine Pattern Recognition Receptors expression
Table 2.2 Primers used in the Study







TLR1 For 5'- GAATTTCTGGGGTTGAGTGC
TLR1 Rev 5"-CTGGAGGATCGTGAAGAAGG
58 375 bp AY634628
Toll-like receptor 2
TLR2 For 5'- TGCCTGAAACTTGTCAGTGG
TLR2 Rev 5'-AATGGCCTTCTTGTGTCAATGG
58 953 bp AY634629
Toll-like receptor 3 ***
TLR3 For 5'- GGGTCTGGAAGCACTTCTCC
TLR3 Rev 5 - GCTGAATTTCTGGACCCAAG




58 945 bp AF310952
Toll-like receptor 5
TLR5 For 5'- CCAGAGTCTGCTGTTCAAGG
TLR5 Rev 5'-ACCCTCTGATGGACTGATGC
57 404 bp AB060695 &
AF186107
Toll-like receptor 6
TLR6 For 5'- TTTGTCCTCAGGAACCAAGC
TLR6 Rev 5' - TGGGCTAAAGAATTGGAAGC
58 421 bp AJ618974
Toll-like receptor 7
TLR7 For 5'- ATGCTGTGTGGTTTGTCTGG
TLR7 Rev 5'- GGTCACGTGATTGTCTGTGG
58 752 bp AF245702 &
AY035889
Toll-like receptor 8
TLR8 For 5~- GGTTTTACTGGGATGCTTGG
TLR8-Rev 5'-TCTCCTCCATTAGCCTCTGC
57 358 bp
N.B. Table of primers used continued on the following page.
?
V -
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Table 2.2 Primers used in the Study (continued)







TLR9 For 5-- GACCTGTCACGGAACAACCT
TLR9 Rev 5 - GGAGGGATCCACTGTCTTCA
58 798 bp AJ509825
Toll-like receptor 10
TLR10 For 5'- ATACTTGGAGTGGCCCAAGG
TLR10 Rev 5'- ACACATGGGAAACCAACTGC
58 648 bp DQ058827
Beta actin
P-actin For 5'- ACTGGGACGACATGGAGAG
P-actin Rev5'- AGGAAGGAAGGCTGGAAGAG
58 538 bp U39357
MyD88
MyD88 For 5'- CCTGTCGCTCTTCCTAAACG
MyD88 Rev 5'- CAATGAGTTCACTGGCGATG
58 542 bp AJ853453
CD/4
CD14 For 5'- CGGGTACTCTCGTCTCAAGG
CD 14 Rev 5'- AGATCATCGGGTCATTTTGG
56 695 bp D84509
CARD15 (NOD2)***
CARD 15 For 5' - ACTCTGCCTGGAGGAGAACC
CARD1 5 Rev 5'- AGTGGACGAACCACTCAACC
58 621 bp AY518748
Dectin-I*** a- isoform
Dectin-1 For 5' - CTCATTGGCGTCTGATTGC
Dectin-1 Rev 5' - CCATGGTTCTTCTGTCTGACG
61 455 bp AY937383
Dectin-2***a- isoform
Dectin-2 For 5' - CCTCCTCAGTGCATGTTTCA
Dectin-2 Rev 5' - GGAATATCCCCATGACCTGA
61 658 bp DQ176046
Succinate dehydrogenase (SDHA) **
SDHA For 5" - ACCTGATGCTTTGTGCTCTGC
SDHA Rev 5' - CCTGGATGGGCTTGGAGTAA
59 126 bp NM174178
GAPDH**
GAPDH For 5' - AAGGCAGAGAACGGGAAG
GAPDH Rev 5' - AGT GAT GGC GTG GAC AGT
55 865 bp AF022183
*** These primers span an intron(s) based on BLAST results of the bovine genome.
** These primers were kindly provided by other members of our Lab group.
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2.4.3 Polymerase Chain Reaction (PCR)
(R) •
PCR was carried out using a standard protocol described by Promega , with
modifications in reaction conditions to suit each primer pair. For each PCR run,
positive and negative controls were included. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) RT-PCR was performed on all reaction sets as a positive
control to confirm the presence of cDNA. Nuclease free water was used (in the place
of the cDNA template) as a negative control.
For the PCR amplification 2pl of cDNA synthesized from 1 pg of total RNA from
the RT reaction (section 2.4.1) was utilized and carried out in a final volume of 50pl.
Primers used for each PRR are shown in Table 2.2 above. For multiple reactions, all
reactants (except for the Thermus aquaticus (Taq) and template) were mixed together
as a master mix (Table 2.3). For a Z reaction master mix (where Z is the total number
of PCR reactions required), Z+l of each reagent were aliquoted to take care of
aliquoting variations. The master mix was prepared in a nuclease free
microcentrifuge tube as outlined below and after thorough mixing; 47.75pl was
aliquoted into each thin-walled PCR tube: The cDNA template was added to each
tube prior to the 'hot start' denaturation stage and the Taq added after this stage.
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Table 2.3 Preparation of a PCR 'master mix'
Reagent Each Mix (Z+l)
reactions
10 x PCR buffer with 1,5mM MgCE (Promega) 5p,l (Z+ 1) x 5pl
dNTPs mix 1 p.1 (Z+ l)x lpl
Primers (20pmol) Forward 0.2pl (Z+ l)x0.2pl
Primers (20pmol) Reverse 0.2pl (Z+ 1) x 0.2pil
Template (cDNA or Nuclease free water) 2pl
Taq polymerase (Thermus aqnauicus enzyme) 0.25pl
Nuclease free water (up to 50pl) 41.35pl (Z+ l)x41.35pl
Total vol. 50pl (Z + 1) x 47.75pl
PCR amplification was carried out in a Px2 thermocycler (Thermo Electron
Corporation) using the 'hot start' principle and a temperature gradient. Reaction
conditions i.e. annealing temperature, Mg" concentration and cycle conditions for
each primer set were optimized. Manual 'hot start' was employed to reduce the
chances of mispriming and non-specific amplification products. The PCR mixture
(without the Taq polymerase) was initially denatured at 95 C for 2 minutes prior to
the addition of the Taq polymerase enzyme. The now complete reaction mixture was
then cycled under the following general conditions: Thirty cycles of denaturing at
°
. . °
95 C, 60s; annealing at a temperature gradient 60s; and extension at 72 C, 60s. This
was followed by a final extension at 72 C for 10 minutes. Amplicons were visualised
by gel electrophoresis and ethidium bromide staining (section 2.5.1) to determine the
optimum candidate annealing temperatures and if there was need to adjust Mg"
concentration.
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2.5 PCR Product identification
2.5.1 Agarose Gel Electrophoresis
Resulting PCR products were size fractionated and analysed using ethidium bromide
agarose gel electrophoresis to determine the quality and size of the amplicons. The
percentage of the agarose in the gels used in this study varied from 0.7% to 2.5%
(w/v) in TAE buffer depending on the expected size of the PCR product - a lower
percentage for expected larger amplicons and a higher percentage for expected
smaller amplicons, see appendix VII. Gels were made in 70ml TAE buffer (20mM
Tris, ImM EDTA, 0.1% (v/v) glacial acetic acid). The agarose in TAE buffer was
mixed well and heated in a microwave oven for 90 seconds until the agarose was
completely dissolved. The agarose was allowed to cool to about 60°C and 0.5pl
ethidium bromide (lOpg/ml) added and mixed well. The melted agarose was poured
into a tray with an appropriate comb and the gel was allowed to set for at least 30
minutes prior to loading.
Five to ten microliters of sample was mixed with 2pl of blue/orange DNA loading
dye (Promega8') and added to each well. The first and last well contained lOObp
ladder (Promega®) to allow for size determination. All gels undergoing
electrophoresis were subjected to 80 - 100V steady voltage for 45 to 80 minutes
depending on speed of dye migration.
After electrophoresis, the gel was placed on a UV light trans-illuminator for
visualization, and the fluorescent ethidium bromide stained DNA pattern captured
with a camera for image storage and printing. Fragment size was determined by
comparing with a 100 base pair and 1 kilo base pair DNA ladder (Promega®).
Once the expected size of amplicons was confirmed, remaining PCR product in the
PCR tube was purified for restriction mapping and eventual cloning and sequencing.
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2.5.2 PCR Product Purification
PCR products were purified using the QIAquick® kit (Qiagen). Briefly, five volumes
of binding buffer (PB) were added to the PCR reaction and mixed well by pipetting.
The mixture was then added onto the QIAquick® spin columns and centrifuged in a
desktop centrifuge at 13,000 rpm for one minute. The flow through was discarded
and the column washed by placing 750pl of the manufacturer's wash buffer PE onto
the column and centrifuging for one minute at 13,000 rpm. After discarding the flow
through, the spin column was placed in a new 1.5ml microcentrifuge tube and
centrifuged again for one minute at 13,000 rpm to remove any excess ethanol. The
column was placed into a fresh nuclease free 1.5ml microcentrifuge tube and cDNA
was eluted by placing 50pl of the manufacturer's elution buffer (EB) on the centre of
the column, incubating at RT for at 1 minute and centrifuging at 13,000 rpm for one
minute.
2.5.3 Gel extraction PCR amplicon
Where multiple bands of PCR products were present, the amplicon of interest was
(r)
purified using a QIAquick gel extraction kit (Qiagen). Briefly, working as quickly
as possible, under the UV transilluminator and taking all safety precautions; the
DNA band of interest from the agarose gel was excised with a new sterile scalpel.
The gel slice was placed into a previously weighed colourless 1.5ml microcentrifuge
tube and the weight of the gel determined. Three volumes of the manufacturer's
buffer QG were added to one volume of gel (lmg ~ 1 pi, no more than 400mg of
gel). The mixture was incubated at 50°C and vortexed often until the gel was
completely dissolved. One gel volume of isopropanol was added and mixed by
inverting several times. The mixture was transferred into a QIAquick® spin column
and centrifuged at room temperature, 13,000 rpm for one minute. The flow-through
was discarded and the column washed with 750 pi of the manufacturer's buffer PE
and centrifuged twice at 13,000 rpm. The column was transferred into a clean 1.5ml
microcentrifuge tube and DNA eluted with 50 pi of the manufacturer's buffer EB.
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2.5.4 Restriction mapping ■ Restriction enzyme digestion
Once the expected size of product was obtained, the initial verification of sequence
of the PCR product was achieved using restriction digests of purified PCR product.
Restriction maps were generated, to determine appropriate restriction endonucleases,
using the bovine sequence of amplicon and the web-based HGMP Jemboss® remap®
program (http://www.hgmp.mrc.ac.uk/Software/EMBOSS/Jemboss/) and another
web based software, NEBcutter® V2.0 (http://tools.neb.com/NEBcutter2/index.php).
Single cutting enzymes resulting in markedly differing fragment sizes were
preferred. Each of the enzymes chosen was specific to a particular restriction site
contained within the expected amplicon. 0.5-2 units of enzyme were used for 0.2 -
2.0pg of cDNA per reaction and incubation times of 1 hour to 3 hours at 37°C. The
list of restriction enzymes used for the different PRRs is shown in Table 2.4.
After restriction digests, the digest was subjected to ethidium bromide gel
electrophoresis for verification of restriction fragments sizes. In cases where the first
digests failed alternative enzymes, cutting elsewhere on the amplicon sequence, were
utilized, to take care of the possibility of slight differences in the actual ovine and
source bovine sequences used to generate the restriction map.
Restriction map verified PCR products were cloned using a commercial kit from
pGEM-T Easy® vector (Promega).
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Table 2.4 Restriction enzymes used and resultant expected restriction map fragment sizes






TLR 1 Hinfl 5' GVNTC 3'
3' CTNAnG 5'
1 219,156
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Key: N= Any nucleotide
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2.5.5 PCR-Genomic DNA
For those primers designed to span introns (Primers for TLR3, CARD 15, qTLR3 and
qCARD15), PCR was performed on ovine genomic DNA to ascertain the absence of
PCR product identical to cDNA derived amplicons.
2.6 Cloning and Sequencing of PRR Amplicons
Each of the PRR PCR amplicons were individually inserted into pGEM T-Easy®
(Promega), and the recombinant vectors transformed into JM109 (Promega) high
efficiency competent cells. The pGEM T-Easy vector system has a great ease of
inserting PCR amplicons into the vector and this can be further confirmed by colour
screening of bacterial clones grown on LB/ampicillin/IPTg/X-gal agar plates.
2.6.1 Ligation Reactions
The volume of PCR amplicon required to achieve 1:3 1:1 and 3:1 (vector: insert)
(r)
molar ratios was calculated. Approximately 50ng of the pGEM-T Easy vector
(Promega) was ligated to QIAquick® (Promega) purified (Section 2.5.2) PRR
amplicon at the appropriate molar ratio. Reactions were carried out in a total volume
of lOp.1, containing lpl vector, 5pl 2X ligation buffer, lpl T4 DNA ligase and made
up to lOpl with water and insert. The reaction was mixed gently and incubated
overnight at 4°C. Positive and negative controls were included to assess ligation
efficiency according to manufacturer's recommendations.
2.6.2 Transformation of High Efficiency Competent Cells
• (r)
All pipette tips and 15ml Falcon tubes used during the transformation were stored at
-20°C overnight prior to use and kept on ice whilst carrying out the transformation.
Following overnight incubation, the ligation reaction was pulse centrifuged and 2pl
added to 25pl of JM109 (Promega) FTigh efficiency competent cells, mixed gently
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and incubated on ice for 20 minutes. The cells were then heat-shocked for 50 seconds
in a water bath at 42°C and then returned on ice again for 2 minutes. To these
transformed cells, 975pl of SOC medium (Invitrogen) at room temperature was
added and incubated at 37°C, with constant shaking, for 1.5 hours. Following this
incubation, lOOpl of transformed cells were plated onto an LB/ampicillin/IPTG/X-
gal (1.5 % agar in Luria Bertani media supplemented with 50pg/ml ampicillin,
200mM IPTG (isopropyl thiogalactoside) and 0.04% X-gal (5-Bromo-4-Chloro-3-
Idoly-P-D-Galactopyranoside)) agar plate and labelled LOW. The remaining cells
were centrifuged at 2400 rpm and 500pl of supernatant removed. The remaining
amount was flicked gently to re-suspend the cells and then 100pl of that was plated
onto an LB/ampicillin/IPTG/X-gal agar plate as before and labelled HIGH.
These plates were incubated at 37°C overnight and then placed at 4°C to facilitate
blue colour development of the colonies. Two single, isolated white colonies from
each plate (high and low) were picked and inoculated into 10ml LB medium and
incubated overnight at 37°C with constant shaking. These fresh overnight cultures
were then used for plasmid DNA isolation.
Figure 2.6 pGEM-T Easy® Vector map and sequences with restriction sites
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Figure 2.7 pGEM -T Easy' multiple cloning sites
T7 Transcription Start
5'. . . TGTAA TACGA CTCAC TATAG GGCGA ATTGG GCCCG ACGTC GCATG CTCCC GGCCG CCATG
3' . . . ACATT ATGCT GAGTG ATATC CCGCT TAACC CGGGC TGCAG CGTAC GAGGG CCGGC GGTAC
T7 Promoter
Apa I Aafll Sph I BstZ I A/col
GCGGC CGCGG GAATT CGATT37 , , . \ ATCAC TAGTG AATTC GCGGC CGCCT GCAGG TCGAC
CGCCG GCGCC CTTAA GCTA V 73'TTAGTG ATCAC TTAAG CGCCG GCGGA CGTCC AGCTG
'1U ]' II 1 I Jl—II l.^pr II FrnR I .^np I FrnR I 'JSac\\ Eco I Spel EcoR I 1 1 Pst i Sal I
BstZ I BstZ I
SP6 Transcription Start
1
CATAT GGGA GAGCT CCCAA CGCGT TGGAT GCATA GCTTG AGTAT TCTAT AGTGT CACCT AAAT ... 3'
GTATA CCCT CTCGA GGGTT GCGCA ACCTA CGTAT CGAAC TCATA AGATA TCACA GTGGATTTA ... 5'
Nde I Sac I SsfX I Nsi I
SP6 Promoter
Figure 2.6 and Figure 2.7. Restriction map, multiple cloning sites and the SP6 and T7 transcription
sites for the pGEM -T Easy® vector. Figure 2.6 also shows the location of the ampicillin resistance
gene and the LacZ gene necessary for the blue/white colony discrimination.
2.6.3 Isolation of Plasmid DNA
Plasmid DNA was isolated from fresh overnight cultures using a commercially
(R)
available kit, Miniprep (Qiagen), according to the manufacturer's protocol. Briefly,
1.5ml of culture was pelleted in a 1.5ml microcentrifuge tube. The supernatant was
decanted and a further 1.5ml of culture pelleted. The cell pellet was re-suspended in
250pl buffer PI until a uniform suspension with no clumps was obtained. Lysis
buffer P2 (250pl) was added to this and mixed by gentle inversion and the reaction
allowed to proceed for three minutes. The reaction was inactivated by adding 350pl
of buffer N3 and mixing well. The suspension was centrifuged in a desktop
centrifuge at 13,000 rpm for 5 minutes and the supernatant transferred onto a
(K)
Miniprep spin column. The silica bound plasmid DNA was washed with 350pl RPE
buffer and the DNA was eluted in 50pl elution buffer solution. Eluted plasmid DNA
was stored at minus 20°C until use.
Successful ligation and transformation of the Plasmid with the correct DNA fragment
was confirmed by restriction digest using the EcoRl or NotI endonuclease to check
for the DNA insert fragment size. Agarose gel separation and visualization was used
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to confirm expected restriction digest products. The extracted plasmid DNA was then
submitted for sequencing. Sequencing for TLR1-10 was done by Ian Bennet. MPU,
Royal (Dick) School of Veterinary Studies (RDSVS), Edinburgh. For MyD88 and
the other PRRs. the sequencing reaction was done 'in house' followed by submission
to the Oxford zoology department for automated sequencing.
Resultant sequences were then subjected to a BLAST
(http://www.ncbi.nlm.nih.gov/BLAST/index.shtml) database similarity search
program (Altschul et al., 1990) in order to check for closest available sequence
matches found in the database. These sequences were used for developing real-time
quantitative PCR assays and also used to generate nucleotide and amino acid identity
alignments.
2.7 Quantitative Real Time Assay Development
Two-step, quantitative real-time RT-PCR (qPCR) was carried out using a Rotor-
Gene™ 3000 Sequence Detection System employing the SYBR Green I technology.
Two-step qPCR was preferred because it is technically more practical and reliable
and the same batch of cDNA can be used to assess the relative expression of several
genes. Each real-time PCR reaction was done in a total reaction volume of 20jil.
2.7.1 Internal PCR primers for real time PCR
Primers were designed using the sequences obtained from the cloned DNA fragments
and the web-based Primer 3 design program. The primers for the real time PCRs
were 20/21 mers with resultant amplicons between 100 to 170 base pairs. All
selected primer sequences were then checked for possible cross-hybridization by
subjecting them to a BLAST database similarity search program (Altschul et al.,
1990). Prior to being used for the real time PCR, the primers were subjected to
normal RT-PCR using full-length cDNA and initial source PCR product as template.
Each primer pair resulted in a single distinct band of the expected size upon
amplification. Plasmids carrying the outer PRR sequenced fragment were used for
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standard curve generation for each PRR gene of interest. All real time PCR primers
used in the study are shown in Table 2.5.
Table 2.5 Quantitative RT-PCR Primers Used







TLR1 For 5"- GCACCACAGTGAGTCTGGAA 62.5 164 bp AM231298
TLR1 Rev 5'- CTGGAGGATCGTGAAGAAGG
Toll-like receptor 2
TLR2 For 5'- GCACTTCAACCCTCCCTTTTA 62.5 125 bp AM183218
TLR2 Rev 5'- TCTCCGAAAGCACAAAGATG
Toll-like receptor 3***
TLR3 For 5'- AAAGGGACTTTGAGGCAGGT 62.5 150 bp AM231299
TLR3 Rev 5'- TAGCTTGCTGAACTGCATGG
Toll-like receptor 4
TLR4 For 5'- TGCTGGCTGCAAAAAGTATG 62.5 149 bp AM231300
TLR4 Rev 5'- CCCTGTAGTGAAGGCAGAGC
Toll-like receptor 5
TLR5 For 5~-CCTCGAAGCCTTCAGTTACG 62.5 121 bp AM231301
TLR5 Rev 5'-ACCCTCTGATGGACTGATGC
Toll-like receptor 6
TLR6 For 5"- GCTTTCTTTGGAAACACTGGA 62.5 123 bp AM231302
TLR6 Rev5'- GAGTCAGTGAGGGCATTTGA
Toll-like receptor 7
TLR7 For 5-- TGGAAAATCTTTCCCAGAGC 62.5 133 bp AM231303
TLR7 Rev 5'- TCCACTTTTTCATCCATGAGC
Toll-like receptor 8
TLR8 For 5'- CACCAAAGACGCTTCTGTCA 62.5 132 bp AM231304
TLR8 Rev 5'-GCATGAGGTTGTCGATGATG
Toll-like receptor 9
TLR9 For 5-- AGATGTTTACCCGCCTCTCC 62.5 144 bp AM231305
TLR9 Rev 5"- CCATGGTACAGGTCCAGCTT
N.B. Table of primers used for qPCR continued on the following page.
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Table 2.5 Quantitative RT-PCR Primers Used (continued)







TLR10 For 5'- CAAGGATAGGCGTAAATGTGG
TLR10 Rev 5'- TGATCAGAGAGACTGCAGAACC
62.5 146 bp AM231306
Beta actin
P-actin For 5-- CTGGCACCACACCTTCTACA
(3-actin Rev5'- CCACATACATGGCAGGAGTG
62.5 149 bp U39357
MyD88
MyD88 For 5'- CCCTCGGATAAATGACATGG
MyD88 Rev 5'- CAGACACGCACAACTTCAGC
62.5 170 bp AMI 17196
CD14
CD14 For 5'- ATGTGTCTGGCCCAGTGC
CD 14 Rev 5'- CTCCCTGCTTAGCTTGTTGC
62.5 124 bp AMI 17197
CARD15 (NOD2)***
CARD15 For 5' - CCACGTCCAGGATGAAGG
CARD15 Rev 5'- GAGCCAGACTTCCAGAATGG
62.5 159 bp AMI 17125
Dectin-I***
Dectin-1 For 5" - CCTACCAAGGCTCTCACGAC
Dectin-1 Rev 5' - CCCAGTTGAAAGCATCGTCT
62.5 139 bp AM 167930
Dectin-2*** a- isoform
Dectin-2 For 5- - GAAGGGACAAGGGTGACAGA
Dectin-2 Rev 5' - TTGATCACCACCAAGTGAGC
62.5 154 bp AM 167931
SDHA**
SDHA For 5' - ACCTGATGCTTTGTGCTCTGC
SDHA Rev 5' - CCTGGATGGGCTTGGAGTAA
62.5 126 bp NM174178
*** These primers span an intron(s) based on BLAST results of the bovine genome
** These primers were kindly provided by other members of the Lab group.
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2.7.2 Standard curve generation for PRR assays
2.7.2.1 Linearization of the plasmid DNA
Stocks of PRR plasmid clone standards were generated by linearizing plasmid DNA
constructed from outer primers' amplicons (Section 2.6) with the enzyme Ndel
(Except for (3-actin where Xmnl was used). Linearized stock plasmid was used for
producing templates for qPCR standards by ten-fold serial dilution and qPCR
amplification. Each 1 jag of plasmid DNA was cut with 2 units of Ndel incubated for
two hours at 37°C. The PGEM T-Easy vector has one restriction site for Ndel (Figure
2.6 and Figure 2.7) and all PRR amplicons contained no restriction site for the Ndel.
Linearization was verified by agarose gel electrophoresis of 5pl of plasmid DNA to
show a single band of the expected size (amplicon size plus 3.015Kb vector). Bulk
• (R)
linearized plasmids were purified using a commercially available kit QIAquick
(Qiagen) and stored at minus 20 °C until use.
2.7.2.2 Quantification of Plasmid DNA ■ Calculation of Copy Numbers
Plasmid DNA concentration was measured by spectrophotometric determination of
nucleic acid content. Molecular weights calculated were calculated based on the total
size of the vector plus the PRR amplicon insert. These values were changed into the
copy numbers of plasmid based on Avogadro's number (1 mol=6.022xl02j
molecules) and a consensus between two related formulae;
A formulae according to (Whelan et al., 2003)
Weight in daltons (g/mol)
= (bp size of ds product) (330 Da x 2nt/bp)
Hence: (g/mol)/Avogardro's number
= g/molecule = copy number
(where: bp= base pairs, ds= double-stranded, nt=nucleotides)
and,
according to (Giulietti et al., 2001) and (Overbergh et al, 2003) where;
lpg of lOOObp DNA = 9.1 x 10" molecules
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2.7.2.3 Standard Curve Generation
In order to determine the detection limit of the SYBR green assay and to establish a
standard curve used for quantification, serial 10-fold dilutions of Plasmid DNA
templates from each PRR (containing the partial sequence of the PRR gene of
interest) at a final concentration from 4 x 109 copies to 4 x 10° per 20|o.l of PCR
reaction were analyzed using the real-time PCR. The standard curves demonstrated a
linear relationship across a range of at least 8 logs of plasmid DNA concentrations.
The correlation coefficient was between 0.9 to 0.99 with a slope value of the
standard curves in the range of -3.33 +/- 0.3 and the PCR efficiency calculated from
slope of> 0.9 (Figure 2.8).
2.7.2.4 Quantitative real-time PCR SYBR Green master mix
Quantitative real-time PCRs were carried out in a final volume of 20p.l containing
2)0.1 of template cDNA. A master mix containing the gene specific primer pair,
dNTPS, Magnesium chloride, nuclease free water, SYBR green and Fastart® Taq
was made up as outlined in Table 2.6 below. The master mix was made up on ice and
kept on ice until dispensing into the Rotor-Gene™ tubes. Rotor-Gene™ tubes were
placed into a pre-chilled aluminium Rotor-Gene block rack and 18|il of master mix
placed into each tube. This was then followed by the addition of 2jol of template
(PRR plasmid standards dilution series, sample cDNA, nuclease free water as a
negative control) in each respective tube and thermocycling on the Rotor-Gene™
3000.
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Table 2.6 SYBR green Quantitative real time PCR 'Master mix'
Reagent Each Mix (Z+l)
reactions
Taq 0.15pl (Z+ l)x0.15|ol
Primers (**pmol) Forward 0.2|ol (Z+ l)x0.2pl
Primers (**pmol) Reverse 0.2pl (Z+ l)x0.2pl
dNTPs 0.4pl (Z+ 1) x 0.4pl
MgCE 2.8pl (Z+ 1) x 2.8jlx1
Buffer 2.0pl (Z+ 1) x 2.0pl
Nuclease free water (up to 50pl) 11.55pl (Z+ l)x 11.55p.l
SYBR Green 0.7pl (Z+ 1) x 0.7pl
Template (cDNA or Nuclease free water) 2.0pl
Total vol. 20pl (Z+ l)x 18(0.1
** Optimized working concentration of the primers - See appendix VIII. (Where Z is
the total number of PCR reactions required).
All assays were optimized to an identical annealing temperature of 62.5°C and forty
cycles. Cycling conditions were; 94°C for ten minutes to achieve activation of the
Taq, followed by forty cycles of 62.5°C 20s, 72°C 20s and fluorescence acquisition,
followed by 94°C 20s. Optimal performance was achieved by selecting the primer
concentrations, and magnesium concentrations, that resulted both in a lower
threshold cycle value (Ct), for a fixed amount of target template, acceptable
amplification efficiency and minimum primer-dimer formation.
Copy numbers were determined from the Ct values of each sample in comparison to
the copy number values assigned from the plasmid DNA standard. This was done by
the Rotor-Gene analysis software. Melt analysis was performed after each qPCR run
to assess the specificity of amplification. The specificity of each qPCR assay was
further verified by carrying out ethidium bromide gel electrophoresis of the
amplification products. qPCRs with copy numbers less than 1000/qPCR reaction
were run twice.
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Figure 2.8 Rotor-Gene0, quantitative SYBR green Real time PC'R melt curves
Examples of quantitative SYBR green dye real time PGR melt curves form an experimental run. A)
Showing a single peak on the melt curve with vers minimal primer-dimer from the no template
negative control. B) qPCR amplification plot of cycle number versus fluorescence intensity C)
Standard curve depicted as a plot of log concentration versus CT value. The curve has an ideal slope
of 3.324. and efficiency of 1 and a CT intercept of >35.
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2.7.2.5 Determination of Intra ■ assay variation
To determine the accuracy and reproducibility of each qPCR assay, the intra-assay
accuracy was determined using triplicates of ten-fold diluted cDNA within one run.
The variability was determined by making three ten-fold dilutions the same cDNA
and running these cDNAs against the plasmid DNA standards. All comparisons of
gene expression in this study were made between samples on the same run and never
between runs.
2.7.2.6 Data Analysis - Normalization
To take into account variations in the percentage of messenger RNA present in the
starting amount of total RNA, copy numbers from each PRR qPCR run were
normalized using P-actin and succinate dehydrogenase (SDHA) housekeeping genes.
A gene expression normalization factor taking into account the geometric means of
both housekeeping genes was calculated using the geNORM® software
(Vandesompele et al., 2002).
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2.8 PRR mutation analysis
Forty ileum tissue samples were obtained from Dr. Craig Watkins, (Moredun
Institute, Edinburgh) to carry out a pilot search for PRR mutations that may be
associated with the various clinical forms of paratuberculosis. The distribution of the
samples was 12 paucibacillary, 16 multibacillary and 12 asymptomatic. TLR2 Exon2
and CARD15 exon 11 were chosen based on published literature associating
mutations in these genes' exons to the related mycobacterial diseases leprosy
(Bochud et al., 2003;Kang and Chae, 2001) and tuberculosis (Ogus et al., 2004) and
the granulomatous inflammatory bowel disease (Ogura et al., 2001). These
granulomatous conditions in humans have similar immuno-pathological
manifestations to ruminant Johne's disease.
Table 2.7 Primers used in the analysis of CARD15 Exonll and TLR Exon2 for mutations





CARD 15 - For 5'- TCATTGGGAATCTCAGACAGG 57 378
CARD 15 - Rev 5'- GAACCAGATTCATCCCATGC
Ovine TLR2 Exon 2 (Partial)
DNA1TLR2 - For 5' - TTTCTCATCTCCCAAATCTGC 59 1801
DNA1TLR2 - Rev 5' - AATGGCCTTCTTGTCAATGG
DNA2TLR2 - For 5' - TGTGGAGACGTTAACAATACGG 59 1256
DNA2TLR2 - Rev 5'- TCATCAAAGAGACGGAAATGG
DNA4TLR2 - For 5'- TGCCTGAAACTTGTCAGTGG Unidir'
DNA4TLR2 753 5'- ACGCCTTTGTGTCCTACAGC Unidir'
Unidir' - Unidirectional sequencing primer only




1. DNA1TLR2 For 5. DNA4TLR2 For





Figure 2.9 Approach to sequencing Ovine TLR2 Exon2 (Accession AMI 17123).
Each blue box represents an exon as described for bovine T1.R2. The arrows associated with a number
represent primers that are named. The sequences of these primers are outlined in Table 2.7. The green
line represents the fragment of the exon DNA that has been confirmed by PGR amplification from
mRNA (cDNA) and sequencing (Accession AM1832I 8).
2.8.1 PCR analysis of genomic DNA
PCR amplification of the forty gDNA samples were performed with each of the
primers pairs; CARD 15 For/Rev, DNA1TLR2 For/Rev and DNA2TLR For/Rev as
outlined previously (Section 2.4.3) with the annealing temperatures shown in Table
2.7 and prolonged extension times of 2 minutes. Primers were designed to result in
mutually overlapping fragments (see Figure 2.9) within the TLR2 gene primer set to
facilitate sequence assembly. PCR amplification was verified by ethidium bromide
gel electrophoresis to ensure the presence of a single distinct amplicon band. The
resulting amplicons were purified using the QIAquick'" (Qiagen) kit as outlined
before (Section 2.5.2) and used as templates for sequencing.
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2.8.2 Amplicon Sequencing
PCR amplicons were genotyped by direct sequencing using BigDye® Terminator
Cycle Sequencing Kit using both the forward primer and reverse primer. Each
sequencing reaction was set up in a thin-walled PCR tube as outlined in Table 2.8.




1/100 diluted primer8 3.2
Template cDNA (10-40rjg) 1.0
Water 3.55
Total 10
The reaction was then run in the thermocycler with thirty cycles of the following
cycle: 96°C, 10 sec; 50°C, 5 sec; 60°C, 2 min. After thermocycling, the reaction
underwent precipitation and clean up prior to submission for sequencing. Briefly, the
reaction was transferred into a clean 0.5ml microcentrifuge tube containing 15pl
nuclease free water. To this 50pl 100% ethanol and 2pl 3M sodium acetate (pH 5.2)
were added and mixed gently. The mix was incubated at room temperature for 45min
followed by precipitation through centrifugation at 13,000 rpm for 30 min in a
desktop centrifuge.
The supernatant was removed carefully, 300pl 70% (v/v) ethanol added and the
pellet re-suspended by vortexing. Precipitation was then achieved by spinning at
13,000 rpm for 10 min. The supernatant was removed carefully and the pellet dried
by vacuum centrifugation. Sequencing reactions were stored at -20°C until they were
sent off to the University of Oxford, Department ofZoology for sequencing.
8
Amplicon specific primer (reverse or forward) or SP6 or T7 for P-GEM T Easy inserted amplicons
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2.8.3 Sequencing data processing
Raw data coming directly from automated sequencing machine often have base-
calling errors and require processing for subsequent genomic data analysis. DNA
(r)
sequence chromatograms were analysed using the Staden sequence assembly
package to distinguish poor quality data from good and to minimize base calling
errors. The package was utilised to distinguish regions with trace artifacts due to
sequencing chemistry and background noise.
Contiguous regions (contigs) were assembled for each genomic DNA sample and the
resultant sequences aligned for comparison and determining possible SNPs. Each of
the SNPs determined from sequence comparison were confirmed by manual
inspection of the chromatographs. Below is the flow chart representing the various
processing stages:
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2.8.4 Tetra primer Amplification Refractory Mutation System (tetra-ARMS).
For those amino acid-changing SNPs of interest determined by direct sequencing
further verification was sought using another methodology. A multiplex PCR assay
was designed to simultaneously amplify the two different alleles in a single PCR
reaction. Tetra-ARMS was set up as described by Ye and colleagues (Ye et al., 2001)
and primers were designed using the web-based tetra-ARMS primer design software
located at http://cedar.genetics.soton.ac.uk/public_html/primerl.html. The primers
used are outlined in Table 2.9 and the process is schematically presented in Figure
2.10.
SNP Primer Allele Product size





5'-GCAAATTAGTATCTCTCAGTTCTAAATGAT A allele 143 bp
5'- ATTCTTATAGATATTGTAAGTTCCTTGGC C allele 110 bp





5'- GGAGCTGGAGCACTTCAACCCTCACT T allele 214 bp
5' - AAGTCTCGCTTATGAAGACACAGCTTCAG C allele 192 bp
Table 2.9 Primers used for tetra-ARMS for TLR2 exon 2 SNPs and expected allele specific
products
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Figure 2.10 Schematic overview of the tetra primer ARMS experimental process
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2.9 Data Analysis and Statistical Analyses
Statistical analysis and data graphing was done using MINITAB® Release 14
software for Windows®.
Where data were not normally distributed, Log transformation was carried out to
correct the skewed data. Individual values of copy numbers per gene were Logio
transformed for data presentation and statistical analysis. Group means for the three
clinical types of paratuberculosis were compared using the one way analysis of
variance (ANOVA). Tukey's multiple comparison test was used for the pair-wise
comparison between the clinical types. Significant differences were defined as those
withp < 0.05.
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3 Identification of ovine Pattern Recognition Receptors
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3.1 Introduction
The important role played by PRRs in host-pathogen interactions is well known and
it is also known that expression levels change during infection and disease (Akira
and Hemmi, 2003; Berrebi et al., 2003). PRR engagement alerts the innate immune
system to the presence of 'danger' or microbial infections and eventually culminates
in the initiation of adaptive immune responses. Detailed studies of the contribution
made by these receptors in disease require accurate quantification of their expression.
Few monoclonal antibodies to ovine PRRs exist; therefore, expression of PRRs
requires the measurement of PRR messenger RNA (mRNA) transcripts. Although
mRNA expression does not always indicate the presence of protein, RNA expression
directly correlates to protein production as without mRNA there would be no protein.
The aim of this work was to identify ovine PRR homologues to those described in
humans and mice and to use the resultant sequences to develop qPCR assays for
accurate quantification of ovine PRR gene expression.
Reverse transcription - real time polymerase chain reaction (RT-qPCR) is the most
sensitive and accurate technique for mRNA detection, comparison and quantitation
currently available. RT-qPCR uses fluorescent reporter molecules that bind to double
stranded DNA to monitor the amount of PCR product at the end of each cycle. In
comparison to other frequently used research techniques for quantifying mRNA,
such as Northern blot analysis, RT-qPCR can be used for the quantification of
nominal amounts of mRNA derived from much smaller samples, and with a shorter
turn-around time. It is a single homogenous assay that detects fluorescent signal
formed proportionally during amplification of a PCR product and obviates the need
for laborious post-PCR processing such as gel electrophoresis. There is however, a
need for a fully homologous sequence in order to develop reliable, highly
reproducible, sensitive qPCR assays.
Since no sheep PRR (of the PRRs studied, other than ovine CD 14) sequences were
known at the start of this study, the first task embarked on was to obtain these
sequences. This was achieved by RT-PCR, designing primers based on the available
bovine sequences or where bovine sequences were unavailable, based on consensus
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human/mouse sequences. Using these sequences, primers were selected using Primer
3 software (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). RT-PCR was
used for amplification, and assay optimization was carried out for each primer pair,
and amplicon size identification carried out using agarose gel electrophoresis.
Further verification of the PRR sequences was achieved by restriction digests and via
cloning and sequencing. The sequences obtained were finally subjected to BLAST
(http://www.ncbi.nlm.nih.gov/BLAST/index.shtml) database comparison. The
resulting sequences were used to design primers to be used for the development of
quantitative real time RT-PCR assays for PRRs. These assays formed the basis for
studying the mRNA expression of PRRs in normal tissues, a Thl/Th2 polarizing
disease and in blood & DCs subsets.
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3.2 RT-PCR Ovine Pattern Recognition Receptors
As a first step towards determining the gene expression of the different PRRs,
qualitative PCR assays were developed for the PRRs using primers designed in
Section 2.4.2 and shown in Table 2.2. The results show ethidium bromide stained
agarose gels showing separations of PCR product after qualitative RT-PCR using
PBMC, spleen and lung derived RNA, with respective PRR primers sets. Amplicon
size is estimated by comparison with a lOObp and/or 1,000 bp (1 kb) DNA ladder.
The expected product size as calculated from bovine and human/mouse consensus
sequences are tabulated in Table 3.1.
Table 3.1 Expected PRR amplicon sizes based on bovine and human/mouse consensus sequences
PRR Expected amplicon PRR Expected amplicon
Toll-like Receptors and adaptor molecule MyD88
TLR 1 375 bp TLR 6 421 bp
TLR 2 953 bp TLR 7 752 bp
TLR 3 403 bp TLR 8 358 bp
TLR 4 945 bp TLR 9 798 bp
TLR 5 404 bp TLR 10 648 bp
MyD88 542 bp
Other PRRs
Dectin-1 455 bp Dectin-2 658 bp
CD14 695 bp CARD 15 621 bp
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3.2.1 PRRs RT-PCR Agarose Gel Electrophoresis
PRR PCR amplicons were visualized using ethidium bromide agarose gel
electrophoresis to ensure the amplification of a specific, single product of the
expected size. The gels were visualized on a UV light trans-illuminator and the
fluorescent ethidium bromide stained DNA pattern captured with a camera.
500







Figure 3.1. 1.5% Ethidium bromide Agarose gel showing all TLR PCR amplicons
Ethidium bromide agarose gel of TLR amplification products. The first and last two lanes represent
the molecular size markers (lOObp, 1 kilo base pair and lOObp respectively). Lanes labelled 1-10
represent each TLR1 - TLR10 respectively. The DNA fragments for all the PCR products are of the
expected sizes as estimated from the bovine TLR sequences (Table 3.1).
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Figure 3.2 Agarose gel of ovine CD14 and MyD88
Ethidium bromide agarose gels showing the PCR amplicons of CD 14 (A) and MyD88 (B) on a
temperature gradient. A) Agarose gel showing the circa 700bp PCR amplicon of CD 14 at 55°C and
56°C with lung and spleen derived cDNA. B) Agarose gel showing the circa 550bp PCR amplicon of
MyD88 at 57°C and 58°C with lung and spleen derived cDNA.
Abbreviation: Lnn, lymph node.
DNA ladder
Figure 3.3 Agarose gel of ovine dectin-1 and dectin-2 a and P-isoforms
Ethidium bromide agarose gels showing the PCR amplicons of dectin-1 (A) and dectin-2 (B) on a
temperature gradient. A) Agarose gel of dectin-1 isoforms with two different primer pairs and on a
temperature gradient. B) Agarose gel of dectin-2 showing possible isoforms.
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Figure 3.1 shows distinct bands representing ovine TLR1-10 amplicons. All the
amplicons are of the expected size as calculated from the source sequences and
shown in Table 3.1. The TLR 7 amplicon is of the expected size of circa 752 base
pairs as compared to the DNA ladders. The gel also shows distinct bands
representing the amplicons of TLR2 and 5 which are of the expected size of circa
953 and 404 base pairs respectively. The amplicons of TLR1, TLR 6 and TLR8 are
circa 375, 421 and 358 base pairs respectively which are within the approximate
expected product sizes expected.
Figure 3.2A shows distinct bands that represent CD 14 amplicons on two annealing
temperatures (55°C and 56°C) and using cDNA derived from lung, spleen and lymph
node (Inn). The bands are of the expected size of circa 695bp and the bands for the
lung and lymph node derived cDNA are stronger than those for the spleen perhaps
indicating higher transcript content. Figure 3.2B shows distinct bands that represent
MyD88 amplicons at two annealing temperatures (57°C and 58°C) and using cDNA
derived from lung and spleen. The bands are of the expected size circa 542bp. Figure
3.3A shows the two distinct bands represent the long and short forms of dectin-1.
The short form is an equivalent of the bovine splice variant that has 138 nucleotide
bases (representing exon3) missing (Accession AY937382) as compared to the long
form (Accession AY937383). The primer pair on the right, dectin-1 For Rev, (Figure
3.3A) was used and the long-isoform amplicons were gel-extracted and used for
cloning and sequencing. Figure 3.3B shows an agarose gel of dectin-2 amplicon also
showing possible isoforms product with annealing temperatures of 60°C and 61°C.
Similar to the dectin-1 the possible isoforms have a >100bp difference in size and
would be equivalent to the bovine dectin-2 alpha(long) form (Accession DQ176046 )
and the beta(short) form (Accession DQ 176047). One of the obvious disadvantages
of gel electrophoresis for analyzing PCR DNA products is that it provides little more
than relative benchmarks of the size of the DNA fragments on the gel. The gels do
not provide much information regarding the specific characteristics of the sequence
amplified. For further verification restriction digests were performed.
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3.2.2 Restriction mapping of ovine PRR PCR amplicons
All amplicons so far obtained were of the approximate expected size. However, prior
to cloning and sequencing, further confirmation of the identity by restriction
mapping were performed. Restriction endonucleases were selected using the source
bovine sequence, selecting those enzymes that cut the sequence into dissimilar
fragments and fragments greater than lOObp each. Table 3.2 lists the endonucleases
that were used for those PRRs that were subjected to restriction mapping, showing
the expected fragments (based on source sequences (Table 2.2)) and the product on
ovine sequences. Figure 3.4 to Figure 3.7 show the restriction maps for the PCR
products of TLR 1, 2, 6, 7,10, dectin-2, CD14 and MyD88.
Table 3.2 Expected DNA fragments from endonuclease digest of PRR amplicons




TLR 1 Hinfl 156/219 As expected
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Figure 3.4 Agarose gels of endonuclease digests of ovine TLRs 1 and TLR2
Agarose gel electrophoresis showing restriction maps of ovine TLR 1 and TLR2 amplicons visualized
with ethidium bromide staining on 1.5% TAE agarose gels with lOObp DNA ladder A) TLR1
endonuclease digestion with Hinfl. B) TLR2 restriction digestion with Pst 1 and Sal I.
DNA ladder EcoRI Hinfl DNA ladder
Figure 3.5 Agarose gels of endonuelease digests of ovine TLR6 and TLR7
Agarose gel electrophoresis showing restriction maps of ovine TLR6 and TLR7 amplicons visualized
with ethidium bromide staining on 1.5% TAE agarose gels with lOObp DNA ladder. A) TLR6
restriction digestion with EcoRI and Hinfl endonuclease. B) TLR7 restriction digestion with EcoRV
and Rsal endonucleases.
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Figure 3.6 Agarose gels of endonuclease digests of TLR10 and dectin-2
Agarose gel electrophoresis showing restriction maps of ovine TLR10 and dectin-2 amplicons
visualized with ethidium bromide staining on 1.5% TAE agarose gels. A) TLR10 restriction digestion
with Pst I and Xmn 1 visualized with lOObp DNA ladder and B) dectin-2 restriction digestion with Dra
111 and Hinf I visualized with both lkb and lOObp DNA ladder.
Pstl Xmnl Aval Hinfl Xhol Aval
0014 MyD88
Figure 3.7 Agarose gel of endonuclease digests of CD14 and MyD88
Agarose gel electrophoresis showing restriction maps of CD 14 and MyD88 amplicons visualized with
ethidium bromide staining on 1.5% TAE agarose gels with lkb and lOObp DNA ladders. CD14
restriction digestion with Pst I, Xmn I. and Ava I and the MyD88 restriction digestion with Hinf I,
Xho 1 and Ava I.
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Following endonuclease digests, the resulting fragment size was determined by
agarose gel electrophoresis, it was sometimes not possible to make a distinction
between two expected fragments that were within 30bp of each other. This is clearly
demonstrated in the TLR6 EcoRl digest (Figure 3.5A) where it was difficult to tell
between the 197 and the 224 bp digest product. Some restriction digests that were set
up did not cleave the DNA sequences at all and resulted in only the original TLR
amplicon being visualized on the gel (Figure 3.4B). Other digests generated maps
that were different from what was expected (see Table 3.2) sometimes with more
fragments. This was ascribed to differences in the sequences between the bovine
(source of the restriction maps) and the ovine sequences (actual DNA being
digested). However, the restriction digests provide a useful tool in assisting in
verification of DNA sequences. Figure 3.4A shows TLR1 endonuclease digest with
0.2 p.1 (left) and 0.5 jil (right) HinfT The left side shows partial digest of the
amplicon whilst the right has a complete digestion of the amplicon into the expected
product size of 219 and 146/156 bp. TLR2 restriction digest were performed with Pst
I and Sal 1 (Figure 3.4B). The PstI was not able to digest the TLR2 amplicon, even
after overnight incubation. Having obtained the ovine TLR2 sequence, it showed that
a PstI recognition site is absent in the ovine sequence and that explains why it was
not able to digest the amplicon. The Sal I digest shows a faint band of undigested
amplicon and distinct bands of the expected digest products sizes of circa 384 and
569 bp. Restriction mapping for TLR6 with EcoRl and Hinfl endonuclease and
demonstrated the expected product sizes of 197/224 and 285/136 respectively.
However, the band for the EcoRl does not distinguish between the 197 and 224 bp
fragments due to their proximity but the band is wider than the one for the Hinfl
which has distinct bands. TLR7 Restriction digest (Figure 3.5B) was performed with
EcoRV endonuclease and showed a faint band of undigested amplicon and two
distinct bands of the expected digest products sizes of circa 286 and 466 bp. The
endonuclease Rsa I was also used to digest the TLR7 amplicon and it shows two
distinct bands one representing the circa 512 bp fragment and another wider one
representing 191 bp digest product. There was however, no fragment representing the
239bp fragment that was expected from Rsa I digestion of bovine TLR7 (Table 3.2).
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PstI digest of TLR10 gave the expected products of circa 150bp and 500bp (Figure
3.6A). The gel also shows some undigested product of the original amplicon still
visible. The Xmnl digest of TLR10 was expected to generate two fragments but 1 got
three.
Aval digest of CD 14 and MyD88 gave two restriction digestion products instead of
the three that were expected based on the bovine sequence (Table 3.2). The other
restriction digestions for the CD 14 (with PstI and Xmnl) and MyD88 (with Hinfl and
Xhol) were as expected.
Having putative confirmation of the PRRs' identity using different endonuclease
(Table 3.2) it was decided to proceed with cloning and further verification would be
achieved post sequencing.
3.2.3 Plasmid Endonuclease Restriction digests
In order to facilitate sequencing, PCR amplicons were purified and cloned into the
pGEM-T Easy'8' vector system (Section 2.6). Following successful ligation and
transformation of the PRR inserts into the vector, the structure of the constructs was
confirmed by restriction enzyme mapping and DNA sequence analysis. Initial
verification of the correct PRR amplicon insertion was done using restriction digest
on the circular plasmid using EcoRI and/or NotI endonuclease to excise the insert.
After the digestion, ethidium bromide agarose gel electrophoresis was performed to
determine the size of the released insert. The endonucleases EcoRI and NotI cut the
plasmid DNA in two places thus releasing the insert (Figure 2.6 and Figure 2.7).
EcoRI cuts 9bp and 15bp from either side of the vector and similarly NotI cuts 15bp
and 21 bp on either side and these fragments added to the insert DNA following
restriction digestion. This results in restriction maps showing plasmid DNA of circa
3.0 kbp and the tagged insert (original size plus 24bp or 36bp (EcoRI, NotI
respectively)).
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DNA ladders
Figure 3.8 Agarose gels plasmid restriction digests TLR2 and TLR4
Agarose gel electrophoresis showing plasmid endonuclease digests of TLR2 and TLR4 visualized
with ethidium bromide staining on 1% TAE agarose gels A) Ovine TLR2 plasmid digestion with
EcoRI B) Ovine TLR4 digestion with EcoRI.











Plasmid DNA ladder B
Figure 3.9 Agarose gels plasmid restriction digests p-actin, CARD15 and CDI4
Agarose gel electrophoresis showing plasmid endonuclease digestion of p-actin, CARD15 and CD14
visualized with ethidium bromide staining on 1% TAE agarose gels (A) Plasmid DNA with P-actin,
CARD 15 and CD 14 amplicon inserts digested with EcoRI. (B) CARD 15 plasmid DNA repeat digest
with Notl.
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Figure 3.10 Agarose gels Plasmid Restriction digests TLR8, TLR10, CD14, MyD88, PABP,
dectin-1 and dectin-2
Agarose gel electrophoresis showing plasmid endonuclease digestion of TLR8, TLR10, CD14,
MyD88. PABP, dectin-1 and dectin-2 visualized with ethidium bromide staining on 1% TAE agarose
gels (A) Lane 1 to 6 representing plasmid DNA digested with EcoRl containing TLR8, TLR10,
TLR6, CD14, MyD88 and GAPDH amplicon inserts respectively. (B) Plasmid DNA of dectin-1 and
dectin-2 digested with EcoRi.
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Figure 3.8 to Figure 3.10 show representative restriction maps of ovine PRR and
MyD88 plasmid restriction digests with EcoRI and Notl. The maps clearly show the
plasmid DNA with the different expected sizes of inserts released, other than for the
CARD 15. The TLR 2 and TLR4 digestion in Figure 3.8 shows some plasmid DNA
that has had only one cut, thus linearizing it but without releasing the insert. This
would tend to leave a band with an overall size larger than the pGEM-T Easy vector
alone as it would have the amplicon insert still attached. Lane 5 of the TLR2 digest
(Figure 3.8A) shows a plasmid DNA fragment of circa 4.0kb which would represent
plasmid that still has the TLR2 insert attached. The same applied to Figure 3.8B lane
1 and 2.
Figure 3.9A shows the EcoRI restriction maps of (3-actin, CARD15 and CD 14
plasmid DNA. The released inserts for the P-actin and CD14 were of the expected
size but that of CARD 15 showed two bands neither being of the correct size. Their
cumulative total seemed to be about the expected size of the CARD 15 insert. In view
of this discrepancy, the CARD15 plasmid DNA digest was repeated with Notl. The
Notl digestion ofCARD 15 revealed the release of the expected size for the CARD15
amplicon and thus was able to confirm that the CARD 15 amplicon was inserted
(Figure 3.9B). Subsequent sequence analysis demonstrated that the ovine CARD 15
has a recognition site for EcoRI and this explains the double bands seen in Figure
3.9A. Figure 3.10 shows the EcoRI digestions release of the inserts of TLR8, TLR10,
CD14, MyD88, GAPDH, dectin-1 and dectin-2. The inserts were all of the correct
expected size.
Having putative proof that the correct insert was in the vector, plasmid DNA was
submitted for sequencing.
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3.2.4 Sequences for the cloned PRR amplicons.
The resultant ovine PRR sequences were then subjected to BLAST
(http://www.ncbi.nlrn.nih.gov/BLAST/index.shtrnl) database similarity search
program (Altschul et al., 1990) in order to check for closest available sequence
matches found in the database. The obtained ovine PRR and MyD88 sequences were
then used to design primers for the quantitative real time PCR assays for quantifying
PRR gene expression. The identity between the ovine nucleotide sequences and the
other species' sequences ranged from 57 % to 98% and amino acid identity between
56% to 99%.
3.3 Sequence Analyses of Ovine PRR Sequences
The homologies of ovine PRRs with those of the bovine, human and murine
orthologs were compared at the nucleotide and amino acid levels. Sequence
comparisons were carried out using the web-based program Emboss: pair wise
alignment (http://www.ebi.ac.uk/emboss/align/). For the nucleotide and amino acid
sequence identity comparisons, the following criteria were used:
Nucleotide Amino Acid
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3.3.1 Sequence comparison analyses for ovine PRRs and MyD88
Multiple sequence comparisons were carried out using the web-based EMBL
program ClustalW with default settings and the data was graphically presented and
edited using Genedoc® program. Appendix IX shows the graphically presented
sequence comparison between the ovine PRR sequences and bovine, human and
murine sequences. The human, mouse and bovine sequences were obtained from the
public databases at NCBI and compared with the ovine sequences obtained from the
present study. Table 3.3 to Table 3.17 summarizes the sequence identities. In the
tables the source accession number of the sequences used in the comparison is
included and indicated with an asterisk. For the identity values in the table, the
figures in italics text represent the nucleotide level sequence identity and those in
bold indicate the amino acid sequence identity.
Appendix IX, shows each nucleotide sequence comparison is followed by the
respective amino acid identity comparison for each PRR and MyD88. The numbers
on the right represent the nucleotide/amino acid positions and on the left of each
sequence the species. Identical nucleotide residues for all four sequences are shaded
black, three sequences dark grey and two sequences light grey. On the consensus
sequence upper case letters further represent agreement of all four sequences and
lower case letter represents agreement of three sequences. For the amino acid
sequences comparison, Genedoc® graphical presentation is based on
similarity/conservation (conserved mode) where black (100%), dark grey (80%) and
light grey (60%) amino acid conservation.
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Ovine 100 96 89 85
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No murine TLR10 sequence has been published
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3.4 Results and Discussion
In the last decade, PRRs have generated a lot of interest in immunology research due
to their ability to recognize PAMPs and their ability to drive and modulate adaptive
immune responses. The existence of PRRs has been established in plants,
invertebrates and several vertebrate species. The aim of this study was to determine
if selected PRR homologues described in other mammalian species exist in the
sheep. Using PCR amplification and cDNA cloning, this study has been able to
identify a number of ovine PRRs and MyD88. The data obtained from this study
confirms the presence of the ten TLRs hitherto described in humans, mice and cattle
and also MyD88, CARD 15, CD 14, dectin-1 and dectin-2. Bovine and ovine
homologues of these PRRs and MyD88 share greater than 95% nucleotide sequence
identity and greater than 91% amino acid sequence identity. Sequences identities
between the ovine and the murine generally tended to be the lowest in comparison
with that of the ovine and other species. The lowest identities with the murine
sequences were 57% (nucleotide) and 56% (amino acid) identity.
Sequence comparison allows us to determine the relatedness and evolutionary
differences of these genes. PRRs being evolutionary conserved, should have a high
percentage of similarity across species boundaries. Recently, Menzies and Ingham
(Menzies and Ingham, 2006) have published the identification and partial sequences
of the ten ovine TLRs and their sequence comparisons are generally similar with the
findings of this study.
As a general observation, the leucine residues locations of the TLRs and CARD 15
seem to be more or less conserved within most of the sequences between species.
Ovine dectin-1 and dectin-2 also form a and P-isoforms (long and short forms) as
described in cattle (Bonkobara et al., 2006; Willcocks et al., 2006) and humans
(Brown and Gordon, 2001; Yokota et al., 2001) as shown by the specific
amplification double bands shown RT-PCR (Figure 3.3 A and B). Ovine dectin-2
could possibly also have the y isoform described in the mouse as evidenced by the
multiple bands on the gel. This would need to be verified by cloning and sequencing
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the other bands not sequenced for this study. The cloned dectin-1 sequence included
the full stalk (a isoform) and partially included the equivalent to the murine CRD
domain (part of exon 4, (CRD incorporates exon 4-6)) as predicted by (Adachi et al.,
2004) and also the bovine sequence (Willcocks et al., 2006) see Figure 3.11.
Similarly, only the long form of the ovine dectin-2 was cloned and sequenced and its
amino acid sequence comparison with the bovine long and short forms is shown in
Figure 3.12.
Figure 3.11 Bovine dectin-1 a and P-isoforms compared with ovine a-isoform
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Figure 3.11 and Figure 3.12 Comparison of the amino acid sequences of ovine dectin-1 and dectin-2
with the bovine a and (3-iso forms of dectin-1 and dectin-2 respectively.
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The ovine PRR sequences that were cloned and sequenced were used to design
primers for qPCR assays. Those sequences that included more than one exon (as
determined by comparison with the bovine genomic sequence) enabled the design of
primers for the qPCR assays that across introns and thus eliminated the possibility of
qPCR signal from genomic DNA. The plasmid DNA was used as a template for the
generation of qPCR standard curves for 'absolute' copy numbers qPCR
quantification.
All the PRR nucleotide sequences that were cloned and sequenced for this study have
been deposited in the National Centre for Biotechnology Information (NCBI) public
databank. Genbank with the following accession numbers TLR1 (AM231298), TLR2
(AM 183218), TLR3 (AM231299) TLR4 (AM231300) TLR5 (AM231301) TLR6
(AM231302) TLR7 (AM231303) TLR8 (AM231304) TLR9 (AM231305) TLR10
(AM231306), MyD88 (AMI 17196), CD14 (AMI 17197), CARD15 (AMI 17125),
dectin-1 (AM 167930), dectin-2 (AM 167931). From the sequences' identity
comparison, I therefore conclude that the cloned sequences for ovine TLR1 - TLR10,
MyD88, CD14, CARD15, dectin-1 and dectin-2 are the ovine homologues to the
human, murine and bovine counterparts. It would be interesting, whenever full
sequences of these ovine PRRs become available, to carry out predicted structural
analysis and also phylogeny studies.
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PRRs mRNA expression in normal tissues
Chapter Four - PRRs expression in normal adult and foetal tissues
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4.1 Introduction
The ability of a multi-cellular organism to detect and eliminate pathogens is the most
critical task of the immune system. Initial host defence mechanisms are initiated by
the innate immune system and this step drives the adaptive immune response.
Accurate recognition is essential for tailoring an appropriate immune response to
eliminate a pathogen and it is now well-established that the detection of pathogens is
done via innate immune receptors called pattern recognition receptors (PRRs). PRRs
have evolved to recognize PAMPs and mediate immune responses to microbes in
insects and mammals via the induction of protective, pro-inflammatory mechanisms
(Janeway and Medzhitov, 2002; Martin et al., 2003). PRRs are also reported to be
involved in the maintenance of homeostasis and tolerance development (Rakoff-
Nahoum et al., 2004). In order to perform the above functions, PRRs are able to
discriminate between, 'non-self, 'self, and 'altered self. Microbial infection of a
mammalian host can have potentially harmful sequela and different tissues and
mucosal sites have different immune challenges with some being inhabited by
commensal micobes. These differences in level of commensals, and potential
microbial exposure would suggest that each tissue would have different innate
immune mechanisms to sense and mount an immune response, or induce tolerance.
Having identified selected PRRs and MyD88 in sheep in Chapter 3, this chapter
looks at the expression of these different PRRs and MyD88 in selected foetal (skin
and spleen) and adult (skin, spleen, kidney, lung, prescapular lymph node,
mesenteric lymph node and urinary bladder) sheep tissues. The spleen is a secondary
lymphoid organ that has the function of facilitating the interaction between APCs
and lymphocytes. The spleen is a major focus for APC/Ag interaction with T cells
and also a major centre for B cell congregation. The spleen also has a second and
vital function of removing infected, defective and old erythrocytes. Lymph nodes
have a similar function and structure to the spleen, but lack red pulp and do not have
the function of erythrocyte removal. Lymph nodes and the spleen are extremely
dynamic organs and their cellular constitution rapidly changes with immune status.
During systemic infection, APC and lymphocyte cell trafficking and cell content in
the spleen increases and a similar situation occurs during infection of regions drained
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by specific lymph nodes. Mucosal epithelia have innate immune functions by acting
as physical barriers and also as the first line of defence by innate immune responses
of epithelial cells and sub-epithelial leucocytes. The mucosa of the lung is in constant
contact with inspired air that may contain microbes and allergens. Unlike the lung,
the mucosa of the urinary bladder is not directly in contact with the externum, though
it is in perpetual contact with the urine produced by the kidney and urine contents
may be immunostimulatory. Skin and mucosae represent dynamic tissues that must
respond effectively and appropriately to constantly changing endogenous and
exogenous stimuli. These tissues are able to do this by possessing an array of PRRs
of sufficient quantity and quality to recognise and respond to all potential pathogens
while maintaining tolerance to commensal organisms.
I postulated that the PRR expression in different tissues would be different to reflect
their different immuno-physiological functions and anatomical properties. Innate
immune mechanisms initiated by PRRs in different tissues may elucidate each tissues
unique immune potential and ability to respond to particular pathogenic challenge. A
tissue's PRR expression profile/repertoire would thus represent its ability to
accurately recognize pathogens and mount an appropriate immune response. It would
indirectly translate into a host tissues' pathogen susceptibility and capacity to
eliminate named pathogen classes. The potential risk of pathogen challenge is higher
on mucosae thus PRR expression would be expected to be high especially in those
mucosae that have a rich commensal flora. Thus, I postulated that the urinary bladder
would have lower PRR expression compared to the skin and the lung that have
constant contact with the externum, and the skin has a resident commensal flora. I
further hypothesized that secondary lymphoid organs like lymph nodes would also be
expected to have high PRR expression to reflect the high immunological activity
taking place there and the cellular composition of cells known to highly express
PRRs such as DCs, macrophages and B cells. The kidney has a very low
APC/immune cell infiltrate and I postulated that it would have low PRR expression.
The renal epitheliae also does not communicate directly with the externum and
would thus have a reduced risk of direct pathogen challenge.
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Ligation of most TLRs (other than TLR3) leads to the recruitment of an adaptor
molecule, MyD88, and this leads to a signal transduction cascade that, via NF-kB,
culminates in immune gene expression. A lack of MyD88 has been associated with
severe immunopathologies in mice (Schnare et al., 2001). Thus, taking into account
the importance of this adaptor molecule in TLR signalling, the expression ofMyD88
in tissues was also analysed. 1 postulated that tissues with high potential risk of
pathogen infection, high PRR expression and high commensal microbiota would also
have a high MyD88 expression.
Mammalian neonates are known to have a reduced response to specific antigens and
an increased susceptibility to bacterial infections and sepsis. This increased
susceptibility is more pronounced in premature babies where it causes significant
morbidity and mortality although species differences exist in the level of immune
development at birth (A1 Salami et al., 1985; Durandy, 2003; Schultz et al., 1973).
This has been partly ascribed to neonates having reduced complement factors, poor
phagocytic capabilities (Strunk et al., 2004) and an overall underdeveloped innate
immune system and nai've adaptive immune system. However, it is evident that other
mechanisms might be important in this immune status and are continuingly being
investigated. PRRs are a critical aspect of innate immunity and their expression
levels could therefore represent a mechanism explaining the underdeveloped immune
response of neonates. Literature on mammalian PRRs ontogeny is scanty and
disparate findings have been reported on mRNA levels in prenatal tissues compared
to neonatal and adult levels with some workers reporting lower neonatal levels and
others reporting comparable levels. To ascertain the possible contribution of the
foetal innate immune system's pattern recognition receptors to the initiation of
antigen specific immune reactivity, a comparative age-related PRR expression was
investigated in second trimester spleen (a secondary lymphoid organ) tissue and skin
(an organ that is in contact with the external environment in the amnion) in
comparison to similar tissue from healthy adult sheep. I hypothesized that PRR
expression in the foetus is either absent or very low and expression increases with
progressing gestation, with neonatal levels still being significantly lower than adult
PRR levels.
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4.2 PRRs mRNA expression in normal adult ovine tissues
In order to assess the biological tissue diversity of PRRs, quantitative mRNA
expression in seven different normal ovine tissues was analyzed. The tissues were
taken from clinically healthy adult sheep and represented secondary lymphoid tissues
(spleen, mesenteric and prescapular lymph node), mucosae (lung and urinary
bladder), skin and an internal organ (kidney) (Section 2.2.2). The PRR mRNA
expression in the ovine tissues was analyzed by SYBR green, reverse transcriptase,
real time quantitative PCR technique, a sensitive technique for the detection and
quantitative enumeration of mRNA transcripts (Section 2.7). Figure 4.1 shows the
PRR expression in the different ovine tissues and Table 4.1 shows the linear means
of the tissues compared to spleen PRR expression whilst Table 4.2 contains a more
detailed tabulation of the statistical relationships between all the tissues.
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Boxplot of Log TLR5 vs Tissue Boxplot of Log TLR6 vs Tissue
Figure 4.1 PRR mRNA expression in selected normal adult ovine tissues
Graphical representation of the TLRlfrtj. TLR2f/>). TLR3(cl. TLR4(d), TLRSfe) and TLR6(/) mRNA
expression in selected normal adult ovine tissues (n=4). Data are expressed as box plots of
Log10(normalized copy number/qPCR reaction) of each PRR. The box representing the 25 and 75%
percentile, and the circle represents the median and the whiskers representing data range. Where
present, the asterix (*) represents an outlier value.
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Figure 4.1 PRR mRNA expression in selected normal adult tissues (continued)
Graphical representation of TLR7 (g), TLR8 (It), TLR9 (i), TLR10 (j). MyD88 (k) and CARD 15 (I)
mRNA expression in selected tissues (n=4). Data are expressed as box plots of Logl0(normalized copy
number/qPCR reaction) of each PRR. The box representing the 25 and 75% percentile, and the circle
represents the median and the whiskers representing data range.
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Figure 4.1 PRR mRNA expression in selected normal adult ovine tissues (continued)
Graphical representation of CD 14 (m). dectin-1 (n) and dectin-2 (o) mRNA expression in selected
tissues (n=4). Data are expressed as box plots of Log]0(normalized copy number/qPCR reaction) of
each PRR. The box representing the 25 and 75% percentile, and the circle represents the median and
the whiskers representing data range. Where present, the asterix (*) represents an outlier value.
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TLR1 is the main receptor for microbial lipoproteins and it is also known to form
functional heterodimers with TLR2 which widens the receptor's ligand range
(Ozinsky et al., 2000; Takeuchi et al., 2001; Takeuchi et al., 2002). Real time
quantitative PCR showed that TLR1 was highly expressed in the lymph nodes, lung
and spleen. Expression in the kidney and urinary bladder was moderate and only
weakly expressed in the skin with the skin having almost twenty fold lower
expression than the spleen (Figure 4.1a) and (Table 4.1). There was a greater than
five-fold difference in expression level between the kidney and the lung and about
ten-fold difference between the kidney and the lymph nodes and the difference in
mRNA expression was statistically significant between the two groups. Disparity in
mRNA expression between the kidney and urinary bladder were not statistically
different. Differences in mRNA expression between the skin and the kidney and
bladder were also statistically significant. TLR2 recognises the broadest range of
ligands that include peptidoglycan from Gram positive bacteria, bacterial
lipopeptides, lipoarabinomannans from Mycobacteria, and yeast zymosan. TLR2 has
a similar tissue expression profile to TLR1 with the lymph nodes, lung and spleen
having an approximately five-fold higher expression of TLR2 than the expression of
the kidney and urinary bladder. Unlike TLR1, the skin expresses more TLR2
transcripts than the kidney and urinary bladder (Figure 4.1 b). The skin's mean
expression level of TLR2 is statistically higher than that of the kidney and urinary
bladder. Flowever, the difference in the mean TLR2 mRNA expression between the
kidney and urinary bladder were not statistically different.
The natural ligand for TLR3 is pathogen derived ds RNA and host nucleic acids
(Aksoy et al., 2005; Alexopoulou et al., 2001; Kariko et al., 2004). TLR3 was highly
expressed in the kidney, spleen, lung and urinary bladder and only moderately
expressed in the mesenteric and prescapular lymph nodes and skin (Figure 4.1c).
There was a four fold difference in expression between with the kidney and the
moderately expressed tissues such as the mesenteric and prescapular lymph nodes
and skin. The spleen and urinary bladder had about two-fold and three-fold higher
expression than the moderate tissues respectively (see also Table 4.1 and Table 4.2).
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TLR4 recognises bacterial LPS in conjunction with the accessory molecules, CD 14
and MD-2. TLR4 also recognises host derived fibrinogen, Hsp and p-defensins. All
tissues examined expressed TLR4 transcripts in considerable quantities with the
spleen expressing the highest amounts followed by the kidney and lung (Figure
4.1 d). The spleen had a greater than two fold higher expression of TLR4 than the
lymph nodes, skin and urinary bladder and the difference was statistically significant.
The mesenteric lymph node revealed the lowest amount of TLR4 transcripts
followed by the skin, prescapular lymph node and urinary bladder, but the
differences between these tissues were not statistically significant.
Bacterial flagellin is the described natural ligand for TLR5. The lung expresses the
highest amount of TLR5 transcripts, followed by the urinary bladder. TLR5
expression in both these tissues is significantly higher than the other tissues studied
but TLR5 expression in the lung is significantly higher than the urinary bladder.
Ovine mesenteric lymph nodes and spleen expressed the lowest TLR5 transcripts,
being approximately 9 fold lower that the expression in the lung. Prescapular lymph
nodes, kidney and skin have expression levels that are approximately two fold higher
that that of the mesenteric lymph node and spleen (Figure 4.\e).
TLR6 participates in the recognition of diacylated lipopeptides, usually in
conjunction with TLR2 (Nakao et al., 2005; Ozinsky et al., 2000) and is expressed in
appreciable quantities in all the tissues examined though the skin has a significantly
lower expression (Figure 4.1/). The difference between the highest expressed tissues
(kidney, prescapular lymph node, and urinary bladder) and the skin is approximately
two - fold. TLR6 expression levels of the lung, mesenteric lymph nodes and spleen is
statistically comparable and about 1.5 fold higher than the skin.
TLR7 and 8 are reported to have viral single stranded nucleic acids as the natural
ligands (Heil et al., 2004; Lund et al., 2004). TLR7 transcripts in the skin were just
barely perceptible being five-fold less than that in the kidney and urinary bladder
(Figure 4.1gj. The spleen had the highest TLR7 expression, being about 30-fold
higher than in the skin, followed by expression in the lung and prescapular lymph
nodes that was about 1.5 fold lower than the lung. The mesenteric lymph nodes had
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TLR7 expression approximately three fold lower than that of lung but about nine¬
fold more than the skin and both of these differences were statistically significant
(see also Table 4.1 and Table 4.2). Secondary lymphoid tissues and the lung express
the highest levels of TLR8 of the tissues examined (Figure 4.1 h). The mesenteric
lymph nodes have the highest TLR8 expression, being about five-fold higher than the
lung and about 2.5 fold higher than the spleen and the TLR8 expression in the
mesenteric lymph nodes is significantly higher than all the other tissues examined.
The kidney and the skin have comparable TLR8 expression but express statistically
lower TLR8 transcript levels than all the other tissues, being approximately fifty fold
less that that of the mesenteric lymph nodes and three fold less than the urinary
bladder.
The kidney had imperceptible expression of TLR9, the receptor for bacterial DNA
and host chromatin Tg-complexes. The secondary lymphoid tissues had the highest
expression that was more than fifteen-fold greater than that of the kidney. The skin
and urinary bladder had comparable, but low levels of TLR9 expression that was
about two fold more than the expression in the kidney (Figure 4.1/). The lung had six
fold more than the expression in the kidney (Figure 4.1/) and this difference was
statistically significant.
TLR10 has no known natural or synthetic ligand (Chuang and Ulevitch, 2001; Hasan
et al., 2005). Similar to TLR9, TLR10 was highly expressed in the secondary
lymphoid tissues and also in the lung. The spleen had the highest expression being
approximately 1.5 fold higher than lung and mesenteric lymph node and 1.3 fold
higher than the prescapular lymph node. TLR10 expression differences between the
lung, prescapular lymph node and mesenteric lymph nodes were not statistically
significant. The skin had imperceptible expression of TLR10. The urinary bladder
and kidney had low expression of TLR10, being about ten fold and fifty fold lower
than that in the spleen respectively (Figure 4.1/).
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MyD88 is an adaptor molecule required for TLR signalling (other than TLR3), as
well as interleukin-1 and interleukin-18 signalling (Medzhitov et al., 1998; Wesche
et al., 1997). The prescapular lymph node had the highest expression of MyD88,
having about 1.5 fold higher mRNA expression than the lung, mesenteric lymph
nodes and spleen. The prescapular lymph node had approximately three-fold higher
MyD88 transcripts than the skin, kidney and two-fold higher expression than the
urinary bladder (Figure 4.1 A). The MyD88 expression in the skin, kidney and urinary
bladder is statistically comparable, but statistically significantly lower than the other
tissues.
CARD 15 is a PRR that is reported to recognize muramyl dipeptide (MDP) a PGN
derivative but is also reported to have a negative regulatory function on TLR2
signalling (Girardin et al., 2003; Watanabe et al., 2004). The skin had the highest
expression of CARD15, having transcript levels about twenty fold higher than the
lowest expressed tissue, the kidney and a 1.5 fold higher expression than its next
ranked tissue, the lung (Figure 4.1/). There is no statistical difference in CARD 15
expression between the lung and the skin but the skin has a significantly higher
CARD15 expression than the other tissues. The lymphoid tissues and the urinary
bladder had comparable expression levels that were approximately five to six-fold
higher than the kidney.
CD14 is a co-receptor for LPS recognition by TLR4 and is highly expressed on cells
of myeloid derivation such as macrophages and monocytes. The prescapular lymph
node had the highest expression of CD14 with the kidney having the lowest tissue
expression (Figure 4Am). CD 14 expression in the prescapular lymph nodes is
significantly higher than all the other tissues examined. The kidney had a greater
than five-fold lower expression of CD 14 than the prescapular lymph node and the
lung and mesenteric lymph nodes had an approximately four fold greater expression
than the kidney. Skin, spleen and urinary bladder had statistically comparable CD 14
expression and an approximately two-fold higher expression than the kidney. The
spleen had significantly higher CD 14 expression than the kidney, but the skin,
urinary bladder and kidney are statistically comparable.
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Dectin-1 and dectin-2 are C-type lectins involved in the recognition of sugar
moieties. The secondary lymphoid tissues, skin and urinary bladder express similar
levels of dectin-1 (Figure 4.1 n). The lung has a statistically significantly higher
expression of dectin-1 than all other tissues. The lung expresses approximately
fourteen fold higher dectin-1 than the kidney and about five-fold higher expression
of dectin-1 than the lymphoid tissues. The lung similarly expresses, approximately
five fold higher expression of dectin-2 than all the other tissues studied and this
difference is significant. The mesenteric lymph node had the lowest expression of
dectin-2 and the expression was statistically significantly lower than the lung, skin
and spleen (Figure 4.1o).
Table 4.1 shows data with the all relative fold changes of the mean of the linear
absolute mRNA expression of the different PRRs and MyD88, normalized to spleen
transcript levels. Table 4.2 shows the detailed statistical relationships between each
of the seven different tissues for each PRR and MyD88. Statistical relationships were
generated using one-way ANOVA and Tukey's multiple comparison test with
statistical significance being ap value <0.05.
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Relative PRR
Expression TLR1 TLR2 TLR3 TLR4 TLR5 TLR6
Kidney 0.15 0.25 0.76 0.66 1.54 1.29
Lung 0.77 0.96 1.34 0.61 8.67 0.93
Mesenteric Lnn 1.57 0.94 0.49 0.30 0.75 0.90
Prescapular Lnn 1.51 1.24 0.56 0.43 1.54 1.27
Skin 0.05 0.35 0.25 0.39 1.60 0.67
Spleen 1.00 1.00 1.00 1.00 1.00 1.00
Urinary Bladder 0.21 0.22 1.56 0.50 6.02 1.23
Relative PRR
Expression TLR7 TLR8 TLR9 TLR10 MyD88 CARD15
Kidney 0.09 0.05 0.04 0.02 0.54 0.17
Lung 0.58 0.58 0.23 0.60 0.89 1.92
Mesenteric Lnn 0.28 2.41 0.90 0.69 1.04 0.73
Prescapular Lnn 0.65 1.29 1.24 0.75 1.53 1.08
Skin 0.03 0.05 0.10 0.00 0.54 3.87
Spleen 1.00 1.00 1.00 1.00 1.00 1.00
Urinary Bladder 0.10 0.19 0.10 0.08 0.75 1.16
Relative PRR
Expression CD14 Dectinl Dectin2
Kidney 0.66 0.36 1.03
Lung 2.08 5.30 4.69
Mesenteric Lnn 2.34 1.36 0.50
Prescapular Lnn 4.42 0.93 0.79
Skin 0.93 1.12 0.97
Spleen 1.00 1.00 1.00
Urinary Bladder 0.97 1.25 0.62
Table 4.1 PRR tissues expression relative to the spleen PRR expression.
Mean PRR expression of different tissues normalized to the spleen mean expression. To facilitate
comparison, the spleen mean PRR expression is allocated an arbitrary value of 1 and mean PRR
expression of all other tissues are compared to this arbitrary value.
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Table 4.2 Statistical relationships between tissue groups.
TLR1
TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 + + + _ + 0
Lung 0 + + _ 0 _
M. Inn 0 0 _ _ _
P. Inn 0 _ 0 _




TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 + + + 0 + 0
Lung 0 0 0 _ 0 _
M. Inn 0 0 _ 0 _
P. Inn 0 _ 0 _




TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 + _ 0 _ 0 +
Lung 0 _ _ _ 0 0
M. Inn 0 0 _ + +
P. Inn 0 _ + +
Skin 0 + +
Spleen 0 0
Ur. Bl. 0
Key: 0 : no significant difference - p>0.05
+ : column tissue significantly higher than the row tissue -p<0.05
- : column tissue significantly lower than the row tissue - p<0.05
M. Inn (mesenteric lymph node), P .Inn (prescapular lymph node) Ur. Bl. (urinary bladder).
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Table 4.2 Statistical relationships between tissue groups (continued).
TLR4
TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 0 _ 0 0 0 0
Lung 0 _ 0 0 + 0
M. Inn 0 0 0 + 0
P. Inn 0 0 + 0




TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 + 0 0 0 0 +
Lung 0 _ _ _ _
M. Inn 0 0 + 0 +
P. Inn 0 0 0 +




TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 _ _ 0 _ 0 0
Lung 0 0 0 0 0 0
M. Inn 0 0 0 0 0
P. Inn 0 _ 0 0
Skin 0 + +
Spleen 0 0
Ur. Bl. 0
Key: 0 : no significant difference - p>0.05
+ : column tissue significantly higher than the row tissue - p<0.05
- : column tissue significantly lower than the row tissue - p<0.05
M. Inn (mesenteric lymph node), P .Inn (prescapular lymph node) Ur. Bl. (urinary bladder).
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Table 4.2 Statistical relationships between tissue groups (continued).
TLR7
TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 + + + _ + 0
Lung 0 _ 0 _ 0 _
M. Inn 0 0 _ + _
P. Inn 0 _ 0 _




TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 + + + 0 + +
Lung 0 + + _ 0 _
M. Inn 0 _ _ _ _
P. Inn 0 _ 0 _




TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 + + + + + +
Lung 0 + + 0 + 0
M. Inn 0 0 _ 0 _
P. Inn 0 _ 0 _
Skin 0 + 0
Spleen 0 _
Ur. Bl. 0
Key: 0 : no significant difference - p>0.05
+ : column tissue significantly higher than the row tissue -p<0.05
- : column tissue significantly lower than the row tissue -p<0.05
M. Inn (mesenteric lymph node), P .Inn (prescapular lymph node) Ur. Bl. (urinary bladder).
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Table 4.2 Statistical relationships between tissue groups (continued).
TLR10
TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 + + + _ + +
Lung 0 0 0 _ 0 _
M. Inn 0 0 _ 0 _
P. Inn 0 _ 0 _




TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 + + + 0 + 0
Lung 0 0 0 0 0 0
M. Inn 0 0 _ 0 0
P. Inn 0 _ 0 _




TISSUE Kidney Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidney 0 + + + + + +
Lung 0 _ 0 0 _ _
M. Inn 0 0 + 0 0
P. Inn 0 + 0 0
Skin 0 _ _
Spleen 0 0
Ur. Bl. 0
Key: 0 : no significant difference - p>0.05
+ : column tissue significantly higher than the row tissue - p<0.05
- : column tissue significantly lower than the row tissue - p<0.05
M. Inn (mesenteric lymph node), P .Inn (prescapular lymph node) Ur. Bl. (urinary bladder).
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Table 4.2 Statistical relationships between tissue groups (continued).
CD14
TISSUE Kidnev Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidnev 0 + + + 0 + 0
Lung 0 0 + . .
M. Inn 0 + . . .
P. Inn 0 . . .




TISSUE Kidnev Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidnev 0 + + + + + +
Lung 0
M. Inn 0 0 0 0 0
P. Inn 0 0 0 0




TISSUE Kidnev Lung M. Inn P. Inn Skin Spleen Ur. Bl.
Kidnev 0 + 0 0 0 0
Lung 0 . . .
M. Inn 0 0 + + 0
P. Inn 0 0 0 0
Skin 0 0 0
Spleen 0 0
Ur. Bl. 0
Key: 0 : no significant difference - p>0.05
+ : column tissue significantly higher than the row tissue - p<0.05
- : column tissue significantly lower than the row tissue - p<0.05
M. Inn (mesenteric lymph node), P .Inn (prescapular lymph node) Ur. Bl. (urinary bladder).
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4.3 Comparative PRR mRNA expression in ovine foetal skin and
spleen
The aim of this part of this study was to determine the relative PRR mRNA
expression in foetal skin and spleen compared to adult tissues. PRR mRNA
expression was compared between second trimester skin and spleen with adult
equivalents using two-step RT-qPCR. Foetal tissues were taken from foetuses of
estimated gestational ages 60, 70, 80 and 90 and PRR expression was compared with
tissues derived from healthy adult sheep.
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4.3.1 Foetal Skin PRR mRNA expression
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Interval Plot of TLR4 vs Age
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Age
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Figure 4.2 PRR mRNA expression in foetal skin
Graphical representation of TLR1 (a). TLR2 (b), TLR3 (c). TLR4 (d), TLR5 (e) and TLR6 (J) mRNA
expression in foetal skin and adult skin tissue (n=5, EGA60; n=5. EGA70; n=5. EGA 80; n=2. EGA
90 and n=6. Adult). Data are expressed as bar graphs of normalized copy number per qPCR reaction
of each PRR. The bars represent the mean and the whiskers representing 95% confidence interval of
the mean.
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Figuic 4.2 PRR iiiRNA expression it) foetal skin (continued)
Graphical representation of TLR7 (g). TLR8 (It), TLR9 (i). TLRI0 (j), MyD88 (k) and CARD 15 (I)
mRNA expression in foetal skin and adult skin tissue (n=5. EGA60: n=5, EGA70: n=5. EGA 80: n=2,
EGA 90 and n=6. Adult). Data are expressed as bar graphs of normalized copy number per qPCR
reaction of each PRR. The bars represent the mean and the whiskers representing 95% confidence
interval of the mean.
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Figure 4.2 PRR mRNA expression in foetal skin (continued)
Graphical representation of CD14 (m). dectin-I (n) and dectin-2 (o) mRNA expression in foetal skin
and adult skin tissue (n=5, EGA60; n=5, EGA70: n—5, EGA 80: n=2, EGA 90 and n=6. Adult). Data
are expressed as bar graphs of normalized copy number per qPCR reaction of each PRR. The bars
represent the mean and the w hiskers representing 95% confidence interval of the mean.
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PRR expression in foetal skin
Second trimester foetal skin expresses all PRRs that are expressed in adult skin. The
levels of TLR2 (Figure 4.2/?), TLR3 (Figure 4.2c), TLR8 (Figure 4.2/?), and MyD88
(Figure 4.2k) were not statistically significantly different between the second
trimester foetal skin and the adult skin tissues. TLR9 (Figure 4.2/) and TLR10
(Figure 4.2/) were both below the lower limit of detection of the assay since only 1 pg
of RNA was used for the foetal tissue experiment per reverse transcription reaction.
TLR1 expression in the foetal skin is similar from EGA day 60 to EGA day 90
(Figure 4.2r/). TLR1 expression in adult skin is approximately 3.5 fold lower than the
expression in foetal skin and the difference is statistically significant. TLR5
expression increases from EGA day 60 to EGA day 90 and there is a two fold
increase during this gestation interval. TLR5 foetal expression is significantly
different between EGA day 60 and EGA day 70 and 90 (Figure 4.2c). but there is no
significant difference between EGA day 70 and EGA day 80. Adult TLR5 expression
level is significantly lower than foetal expression during the entire second trimester
period studied. TLR7 expression in foetal gestational stages is comparable. Adult
TLR7 expression is approximately two fold lower than foetal expression and the
difference is significant (Figure 4.2g),
TLR4 foetal skin expression increases steadily from EGA day 60 to EGA day 90.
Adult TLR4 transcript levels are greater than three fold higher than EGA day 90
levels, and the difference is statistically significant (Figure 4.2d). TLR6 expression in
adult skin is approximately 1.5 fold higher than second trimester foetal skin. The
difference in TLR6 transcripts between adult skin and foetal skin is statistically
significant but there is no significant difference in TLR6 between the gestational
stages (Figure 4.2/). CARD 15 expression in adult skin is greater than three-fold
higher than foetal skin. The differences in foetal and adult skin CARD 15 expression
are statistically significant (Figure 4.2/). CD 14 expression is approximately three
fold higher in adult skin than foetal skin and this difference is significant (Figure
4.2/??). There are no significant differences in CD14 expression during the gestational
period EGA 60 days to EGA 90 days.
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Dectin-I expression in foetal skin ranges from imperceptible to no expression at all.
Adult dectin-1 expression is also low, but is significantly higher than foetal levels
(Figure 4.2n). Similarly, dectin-2 expression levels (Figure 4.2o) were significantly
higher in adult skin than in foetal skin.
Figure 4.3 shows haematoxylin and eosin stained paraffin histological sections
comparing EGA day 70 foetal skin and adult skin. Like the adult skin (Figure 4.3 A
and C), the foetal skin shows hair follicles and a distinct epidermal layer (Figure 4.3
B, D and E). Whereas the adult skin has a more tight and dense connective tissue, the
foetal skin has a looser lattice like arrangement with a moderately high cellular
infiltrate. The high eel 1 ularity of the foetal skin may partially explain the comparable
levels of PRRs expressed by foetal skin. The foetal skin also shows developing hair
follicles.
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Figure 4.3 Skin architecture in adult skin and foetal skin
Haematoxylin and eosin stained paraffin section of adult and foetal skin from second trimester foetus
(EGA 70) and adult ewe. Tissues fixed with zinc sulphate fixative. Figure 4.3A and Figure 4.3B 40 x
magnification of adult and foetal upper skin respectively. Figure 4.3C and Figure 4.3D 100 x
magnification of the epidermis of adult a foetal skin respectively. Figure 4.3E showing a 400 x
magnification of loose lattice tissue and cellular infiltrate.
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4.3.2 Foetal Spleen PRR mRNA expression
Interval Plot of TLR1 vs Age
95% CI for the Mean
EGA 60 days EGA 70 days EGA 80 days EGA 90 days Adult
Age
Interval Plot of TLR2 vs Age







EGA 60 days EGA 70 days EGA 80 days EGA 90 days
Interval Plot of TLR3 vs Age
95% CI for the Mean





Interval Plot of TLR4 vs Age
95% CI for the Mean
in
EGA 60 days EGA 70 days EGA 80 days EGA 90 days Adult
Age
Interval Plot of TLR5 vs Age
95% CI for the Mean





Interval Plot of TLR6 vs Age
95% CI for the Mean
X
T
EGA 60 days EGA 70 days EGA 80 days EGA 90 days
Figure 4.4 PRR mRNA expression in foetal spleen
Graphical representation of TLR1 (a), TLR2 (h). TLR3 (c). TLR4 (<l). TLR5 (e) and TLR6 (J) mRNA
expression in foetal spleen and adult spleen tissue («=5. EGA60; n=5. EGA70: n-5. EGA 80: n=2.
EGA 90 and n=6. Adult). Data are expressed as bar graphs of normalized copy number per qPCR
reaction of each PRR. The bars represent the mean and the whiskers representing 95% confidence
interval of the mean.
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Figure 4.4 PRR mRNA expression in foetal spleen (eontinued)
Graphical representation of TLR7 fe). TLR8 (It). TLR9 (i). TLR10 (j), MyD88 (k) and CARD 15 (I)
mRNA expression in foetal spleen and adult spleen tissue (n=5. EGA60; n=5. EGA70: n=5. EGA 80:
n=2. EGA 90 and n=6. Adult). Data are expressed as bar graphs of normalized copy number per qPCR
reaction of each PRR. The bars represent the mean and the whiskers representing 95% confidence
interval of the mean.
Chapter Four - PRRs expression in normal adult and foetal tissues 167
Interval Plot of CD14 vs Age
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Figure 4.4 PRR mRNA expression in foetal spleen (continued)
Graphical representation of CD 14 (m). dectin-1 (n) and dectin-2 (o) mRNA expression in foetal
spleen and adult spleen tissue (n=5. EGA60; n=5. EGA70: n=5, EGA 80: n=2. EGA 90 and n=6.
Adult). Data are expressed as bar graphs of normalized copy number per qPCR reaction of each PRR.
The bars represent the mean and the w hiskers representing 95% confidence interval of the mean.
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PRR expression in foetal spleen
Similar to foetal skin, foetal second trimester spleen expressed all PRRs that are
expressed in adult spleen.
TLR1 expression in the foetal spleen increases from EGA day 60 to EGA day 90.
There is a significant difference in TLR1 expression between EGA day 60 and EGA
day 80. Adult spleen TLR1 expression is lower than foetal EGA day 70 to EGA day
90, but the difference is not significant (Figure 4.4a). TLR2 expression in the foetal
spleen is similar from EGA day 60 to EGA day 80 and these levels are comparable to
adult TLR2 transcript levels. EGA day 90 spleen has a lower TLR2 expression than
the other foetal stages (Figure 4.46). TLR3 expression in the foetal spleen is similar
from EGA day 70 to EGA day 90 and these levels are comparable to adult TLR3
transcript levels (Figure 4.4c). EGA day 60 spleen has a higher TLR3 expression
than the other foetal stages but the differences are not significant. Adult spleen has a
slightly higher expression of TLR4 than foetal second trimester spleens, but these
differences are not statistically significant (Figure 4.4(7). TLR5 expression increases
in foetal spleen from EGA day 60 to EGA day 80 and there is a slight drop in
expression levels at EGA day 90 (Figure 4.4c). Adult levels of TLR5 are similar to
EGA day 90 levels. The differences in TLR5 expression during the second trimester
and adult levels are not significant. Adult TLR6 expression is slightly higher than
foetal expression and this difference is statistically significant. EGA day 60 spleen
has an approximately two-fold lower expression than the other gestational stages and
this difference is statistically significant (Figure 4.4/).
Adult spleen had an approximately two fold higher expression of TLR 7 than foetal
spleen (Figure 4.4g) and this difference is significant. There was no significant
difference in spleen TLR7 expression within the second trimester gestational stages.
Similarly, adult spleen had a greater than two fold higher expression of TLR 8 than
foetal spleen (Figure 4.4/?) and this difference is significant. There was also no
significant difference in spleen TLR8 expression within the second trimester
gestational stages.
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TLR9 expression increases in foetai spleen from EGA day 60 to EGA day 80 and
there is a drop in expression levels at EGA day 90 (Figure 4.4/). There is a
significant difference in TLR9 transcripts between EGA day 60 and EGA day 80.
The differences in TLR9 expression during the second trimester spleen and adult
levels are however not significant.
TLR10 shows a steady increase from EGA day 60 to adult levels. EGA day 60 has
significantly lower expression of TER10 than EGA day 70, EGA day 80 and adult
spleen levels (Figure 4.4/). Adult spleen TLR10 expression is however, not
significantly different with EGA day 70, EGA day 80 and EGA day 90 spleen.
MyD88 expression is comparable between foetal spleen and adult spleen (Figure
4.4*).
CARD15 shows a steady increase from EGA day 60 to adult levels. EGA day 60 has
significantly lower expression of CARD 15 than EGA day 90 and adult spleen levels.
Adult spleen CARD 15 expression is also significantly higher than EGA day 70
spleen, but there is no significant difference with EGA day 80 and EGA day 90
spleen (Figure 4.41).
CD 14 had an approximately 5 fold greater expression in adult spleen than foetal
spleen (Figure 4.4m) and this difference is statistically significant. There is no
significant difference in CD14 expression between the gestational stages spleens.
Dectin-1 and dectin-2 do not show any statistically significant differences in
expression between adult spleen and foetal second trimester spleen (Figure 4.4/7 and
Figure 4.4o).
Figure 4.5 shows haematoxylin and eosin stained paraffin histological sections
comparing EGA 70 foetal spleen and adult spleen. The sections show the normal
lymphoid aggregations of adult spleen and in comparison shows the commencement
of such aggregations and in some instance taking up adult splenic architecture where
the aggregations are around a central arteriole.
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Figure 4.5 Splenic architecture in adult nnd foetal spleen
I laematoxylin and eosin stained paraffin section of spleen front adult ewe and second trimester foetus.
Tissues fixed with zinc sulphate fixative. Figure 4.5 A and IT 40 x magnification of adult and foetal
spleen respectively. Figure 4.5 C and I) 100 x magnification of adult and foetal spleen respectively. In
Figure 4.5 (' the adult spleen showing the development of organised lymphoid aggregations. These
aggregations are organized around a central arteriole and similarly the foetal spleen shows the
commencement of such an organizational pattern.
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Figure 4.5 Splenic architecture in adult and foetal spleen (continued)
Haematoxylin and eosin stained paraffin section of spleen from adult ewe and second trimester foetus.
Tissues fixed with zinc sulphate fixative. Figure 4.5 E and F. 200 x magnification of adult spleen
follicle and foetal follicular aggregation respectively. Figure 4.5 (f 200 x magnification of foetal
spleen follicle cell aggregation. Figure 4.5 H 400 x magnification of foetal spleen follicle cell
aggregation show ing the composition of the cellular infiltrate.
Chapter I our - PRRs expression in normal adult and foetal tissues 173
Uhnritclcri/alion nj'Owite Pattern Recognition Receptor expression
4.4 Discussion
The innate immune system recognizes phylogenetically conserved motifs on
pathogens referred to as PAMPs and also endogenous products (referred to as
'danger signals') released during tissue injury via PRRs. During the last decade,
much progress has been made in unravelling the complex role that PRRs play in
PAMP recognition and immune modulation but many questions still remain to be
answered.
The aim of this part of this study was to determine the expression and distribution of
particular PRRs and MyD88 in foetal tissues (skin and spleen) and selected adult
tissues (skin, spleen, kidney, lung, mesenteric lymph node, prescapular lymph node
and urinary bladder) from normal healthy subjects. Quantitative real time PCR
assays were developed and optimized for the PRR panel and MyD88 and normalized
to the housekeeping genes P-actin, and SDHA. The quantitative real time PCR
assays revealed reliable and consistent amplification of target genes within the
tissues examined. The preceding data shows the PRR mRNA expression diversity in
the adult ovine tissues and also a comparison between PRR mRNA expression in
second trimester spleen and skin and the respective adult tissues.
The kidney had a low to moderate PRR expression compared to other tissues studied
except for TLR4 and TLR6 where the kidney expression was on the higher end. PRR
expression levels of the kidney were generally slightly lower or comparable to the
expression levels of the urinary bladder (which together form the major parts of the
urinary system). This may reflect the fact that the kidney has a lower contact with
antigens/pathogens due to its anatomical location and lack of direct contact with the
external environment. The kidney is an internal organ that is uncommonly infected in
the sheep and it does not normally harbour resident commensal microflora. This
could explain the low PRR expression observed in the kidney by this study. The
urinary bladder contains urine, a waste product of the body, and the urine may
contain iiiiiiiunosLimulatory factors. Uric acid has been shown to be an endogenous
ligand of TLR2. This study showed that the urinary bladder had a very low
expression of TLR2, and I speculate that this may be a homeostatic mechanism to
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prevent a hyper-inflammatory state that would arise if there were a raised TLR2
mediated immune responses to urates in the urine. This would be a mechanism
similar to the one observed in the gastrointestinal tract mucosae with LPS sensing
PRRs, TLR4 and CD 14, which have very low expression to prevent
hyperinflammatory responses of the gut to commensal organisms that also possess
LPS (Abreu et al., 2001; Smith et al., 2001; Smythies et al., 2005).
The lung generally had very high PRR expression levels. This may reflect the high
pathogen/antigen stimulation it receives at its mucosal surfaces due to its anatomical
location and intrinsic physiological function of air exchange. Air often contains low
levels of microbes and particulate material that would inevitably keep the lungs
constantly stimulated. The lung had a high expression of TLR2, a PRR necessary for
the detection of Gram positive bacteria and mycobacteria. High TLR2 expression has
been specifically demonstrated in human alveolar macrophages and lung epithelial
cells (Droemann et al., 2003), cells that are important in initial pathogen contact and
sensing in the lung. The TLR2 expression from these cell types could contribute to
the high TLR2 expression seen in the ovine lung in this study. The lung also had the
highest expression of dectin-1 and dectin-2; findings which are consistent with
findings reported by Brown and Gordon (Brown and Gordon, 2001) for dectin-1 in
humans but different from the findings reported by Bonkobara and colleagues
(Bonkobara et al., 2006) who found that the lymph nodes had the highest expression
of dectin-2 in cattle. Willcocks and colleagues (Willcocks et al., 2006) showed a
consistent dectin-1 expression in alveolar macrophages and the high number of these
cells in the lung could contribute to the high expression observed. Gavino and co¬
workers (Gavino et al., 2005) also found a high expression of human dectin-2 in the
lung (amongst the non-lymphoid tissues) and and unlike this study found no
expression in the kidney. Amongst lymphoid tissues, Gavino and co-workers (2005)
found that the spleen had a higher dectin-2 expression than lymph nodes. This study
showed comparable expression of dectin-2 between all the other tissues except the
lung that showed a seven to ten-fold higher difference in expression as compared to
the other tissues. In contrast to findings by Ariizumi and colleagues (Ariizumi et al.,
2000), who found highest expression of dectin-2 in mouse spleen and very low
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expression in skin, urinary bladder and kidney. The lung also had a high expression
of TLR5, and this finding agrees with the data of Sebastiani and co-workers
(Sebastiani et al., 2000) and Zarember and Godowski (Zarember and Godowski,
2002). Similar to the findings of Nishimura and Naito (Nishimura and Naito, 2005)
this study showed that the lung and urinary bladder had comparable expression of
TLR5 and similarly, that expression was higher than the expression in the spleen.
TLR5 expression is hypothesized to play an important role in the innate immune
defence mechanisms of the lung against inhaled flagellated bacteria since a mutation
in TLR5 has been associated with increased susceptibility to Legionnaires disease
(Hawn et al., 2003).
A rather surprising finding from this study is the low relative mRNA expression of
most PRRs by the skin (except for TLR4, TLR5, CD 14, dectin-1, and dectin-2 where
levels were comparably moderate). One would expect that being constantly exposed
to the environment, the skin would have significantly higher amounts of PRRs
compared to other tissues reflecting that constant contact with a pathogen filled
environment. Using semi-quantitative PCR, Ishii and co-workers (Ishii et al., 2006)
showed a lower expression of TLR2 in canine skin and urinary bladder compared to
the lung and spleen. This is in concordance with the findings of this study. This may
reflect the fact that the immune system in the skin is effectively separated from the
externum by the impervious keratinized squamous cell layer. Thus, the low PRR
expression may indicate the resulting low immunological activation of the steady
state cellular constituents of skin and also its capability to recruit inflammatory cells
from the bloodstream during times of need. Liu and co-workers (Liu et al., 2003)
also found a low/absent expression of TLR9 in mouse skin but a capacity to increase
expression during physical trauma attributed to the recruitment of TLR9 expressing
blood leucocytes. Another possible way of looking at the low expression of PRRs in
the skin is that it could be an immune tolerance mechanism (similar to that found in
the gut), since the skin is also quite well endowed with commensal organisms and
would then otherwise be in a constant state of inflammation. It may thus represent a
specialized mechanism for retaining the capacity for selectively responding to
pathogens while maintaining homeostatic tolerance to resident commensal
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organisms. Other groups working with innate immune mechanisms have
demonstrated the low level expression of certain PRRs and hyporesponsiveness of
these epithelial surfaces to PAMPs (Abreu et al., 2001). Similar immune
mechanisms may not be suitable for other tissues that may need to mount a robust
immune response to any microorganism that may invade it, including microbes that
may reside as commensals elsewhere. This fact is aptly demonstrated by the fact that
commensal/symbiotic organisms that are beneficial in one tissue may be harmful and
cause disease in another tissue of the same host. The fact that these specimens were
collected from indoor sheep could also reflect the low level of pathogenic challenge
on the skin as compared to outdoor reared or feral sheep. CARD 15 however, was
consistently highly expressed in skin than any other tissue. I speculate that the high
CARD 15 expression in the skin could arise from the Langerhans cells (LC) and other
dermal APCs. This is based my extrapolation from work by Ginhoux and co-workers
(Ginhoux et al., 2006) who show that LCs are derived from blood monocytes, and
cells of the macrophage/monocyte lineage are known to highly express CARD 15
(Gutierrez et al., 2002).
This study demonstrated that the lymph nodes and spleen generally had higher
expression of most PRRs compared to the other tissues examined. Lymphoid tissues
are regions of high infiltrate of immune cells that are activated from the periphery
and resident immune cells. This may have a bearing on their high PRR expression
observed in the lymphoid tissues studied. Ochoa and colleagues (Ochoa et al., 2003)
were able to demonstrate the co-localization of TLR2 expression with DCs and
macrophages in human secondary lymphoid tissues. Ochoa and colleagues (Ochoa et
al., 2003) were however not able to detect TLR1 or TLR2 on B cells and T cells in
these secondary lymphoid organs although the TLR1 and TLR2 expressing APCs
were closely apposed to these cells.
Lung and all lymphoid tissues had a very high expression of TLR7 compared to skin
and urinary bladder. These findings are similar to those by Philbin and co-workers
(Philbin et al., 2005) who also speculates that the high immune cell content could
explain the high TLR7 in these tissues. These findings on TLR7 expression in lung
and spleen also concur with the findings of Nishimura and Naito (2005). This study
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demonstrated higher levels of TLR10 in the lung, mesenteric and prescapular lymph
nodes and imperceptible levels in the skin and kidney. This is in agreement with the
findings of Chuang and Ulevitch (Chuang and Ulevitch, 2001) who found high
expression levels in human lymphoid tissues and the findings of Nishimura and
Naito (2005) who found high TLR10 expression in the spleen and lung. The high
expression of TLR10 in the lymph nodes and spleen may reflect the abundance of
APCs cells such as B cells and DCs that are reported to express high quantities of
TLR10 (Hasan et al., 2005). Similar to the findings of Nishimura and Naito (2005)
the spleen expressed the highest amount of TLR4 compared to other tissues. The
relative proportions of TLR8 in the spleen and the mesenteric lymph nodes is similar
to those recorded by Ignacio and co-workers (Ignacio et al., 2005) in cats.
Mesenteric and prescapular lymph nodes expression of PRR was statistically
comparable for all PRRs studied except for TLR8 and CD 14, where mesenteric
lymph nodes had a significantly higher TLR8 expression than prescapular lymph
nodes but a significantly lower CD 14 expression. Expression of the TLR adaptor
molecule, MyD88, between these two lymph nodes was comparable. Similar to this
study, Hashimoto and co-workers (Hashimoto et al., 2005) also found the expression
of TLR9 in canine spleen and lymph nodes, but unlike this study did not detect any
TLR9 in the skin, bladder and kidney. This study found lower expression in skin,
bladder and kidney and the difference could be ascribed to the lower sensitivity of
the qualitative RT-PCR assay they used compared to the quantitative real time PCR
used in this study. The CARD 15 expression from this study is similar to that found
by Iwanaga and colleagues (Iwanaga et al., 2003) in mice with regards the relative
expression of CARD15 in the spleen, lung and kidney. Iwanaga and colleagues
(2003) found that the lung had a two-fold higher CARD 15 expression than the spleen
and about eight-fold higher than the kidney.
TLR4, TLR6 and MyD88 were the only genes that did not have substantial tissues
variation greater that five fold between the different adult tissues and from this study
1 conclude that TLR4, TLR6 and MyD88 are expressed ubiquitously in the tissues
studied.
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Recently, Menzies and Ingham (Menzies and Ingham, 2006) published findings on
TLR expression in sheep. Some of my findings are in contrast to their findings
although in that study only three ovine tissues were looked at, namely Peyers patch,
jejenum, mesenteric lymph node, and the bovine skin. In the bovine skin they found
that TLR7 was the most abundant transcript, I found that TLR7 was mostly
expressed in very low levels and the expression was similarly low in foetal skin. The
presence of low levels of TLR7 in skin is similar to that found by Philbin and co¬
workers (Philbin et al., 2005) in chickens. In concordance with the findings of
Menzies and Ingham (2006) I also found TLR 9 and 10 being very lowly expressed
in skin but unlike their finding, where they found an absence of TLR6 this study
revealed moderate amounts of TLR6 in adult skin and also in foetal skin. The
findings on low cutaneous TLR9 expression in the present study also agree with the
findings of Hashimoto and co-workers (Hashimoto et al., 2005) who were unable to
detect TLR9 in canine skin using qualitative RT-PCR. The differences with the skin
PRR expression could be a species difference considering that their study looked at
TLR expression in bovine skin and did not examine TLR expression in ovine skin.
They also found a higher expression of TLR2 in bovine skin which is different from
the findings of this study and that of other studies looking at TLR2 in human skin
and canine skin (Ishii et al., 2006).
The tissues' specific physiological mRNA expression profiles of the different PRRs
may reflect the most likely pathogens (or PAMPs) each tissue is likely to encounter
and its relative preparedness for the challenge. On the other hand it may also
represent the actual steady state 'PAMP load' of each tissue since PRRs are known
to sense endogenous PAMPs such as heat shock proteins that may reflect the normal
physiological tissue destruction and re-modelling. Mucosal surfaces are colonised by
commensals and have a higher likelihood of encountering pathogens compared to
internal organs that are considered 'sterile'. They thus need to be able to distinguish
between commensal and pathogens and thus generate homeostatic or protective
immune responses respectively.
Different tissues also seem to have a predisposition towards a particular class of
effector immune response that are often quite polarized. Delayed type
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hypersensitivity characterized by the hallmarks of inflammation, as described by
Cornelius Celsus (30BC to 38AD), redness, heat, pain, swelling, is more likely to
occur in the skin on exposure to antigen. The obverse is true with tissues such as the
gut, eye and brain where such an immune response would be catastrophic. In such
tissues antigenic stimulation thus tends to favour Th2 responses predominated by
antibody production to protect the tissues from self damage. For example, if the gut
were to have such an excessive inflammatory response, it would expose the sub¬
epithelial tissues to the dense gut microbiota and this would have severe
consequences.
In conclusion, the study of PRR expression in healthy adult tissues shows that,
consistent with their ability to mount immune responses, all tissues expressed the
studied PRRs, though individual tissues had different PRR expression
profiles/patterns. Secondary lymphoid tissues and lung mucosae generally have
higher PRR expression, compared to the other tissues studied. Some PRRs showed
great variations in expression in the same tissue and this is most likely due to the
inherent variability that is to be found between these outbred sheep compared to
experimental inbred mouse strains. Larger population studies would elucidate such
potential expression differences.
Ascribing rigid functional limitations on the capacity of a tissue to respond to a
particular class of pathogens based on tissue PRR expression must be done with
caution as it may be erroneous in the absence of more extensive studies on PRR
expression of a tissue's constituent cells in relation to cellular composition. This is
particularly so, because it is known that the cellular composition of a tissue has a
direct translation to its PRR expression and immune capabilities. Further, tissues are
also able to recruit immune cells such as monocytes from blood that may rapidly
alter overall tissue PRR expression by modifying tissue cellular proportions. This is
characteristically evident during healing, infection and inflammation. Studies in the
dynamics of tissues recruiting such cells in physiological and pathological situations
in relation of PRR expression may be quite revealing and provide useful insights of
the real time immune capacity of tissues. Functional studies in tissue PRR expression
would be further strengthened by concurrent proteomic analysis and
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immunohistological analysis of tissues to identify immune cell populations. These
options are however currently not possible due to the absence of specific monoclonal
antibodies to most of these PRRs. A single ligand may also stimulate multiple PRRs
and each PRR may be able to compensate for the other. This is typically exemplified
by viral RNA recognition by TLR3 but also by R1G-1 and MDA5 where either or all
PRRs may be engaged during viral infection. Although possibly of minor
importance, the presence of spliced variants that have now been described for
numerous PRRs (Ariizumi et al., 2000; Leung et al., 2007; Philbin et al., 2005) may
account for some differences that may be seen in quantified mRNA expression.
Spliced variants have been shown to be tissue specific although the functional
implication on immune function has not been elucidated. Where spliced variants
have been described, comparative quantification of the expression of the variants in a
tissue would be of value in future experiments.
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PRR expression in preterm skin and spleen
Very few data are currently available on the molecular immune mechanisms in
foetuses of higher mammals such as ruminants or humans. Ethical considerations
have hampered this research in humans and ethical - economical considerations in
veterinary species. The lack of absolute differences in most of the second trimester
PRR expression in spleen and skin as compared to adult equivalents shown in this
study was rather surprising. Since it is a documented fact that neonates are more
susceptible to bacterial infections especially, one would assume that PRRs being
placed so central in innate immunity would have some correlation to this increased
susceptibility.
The skin generally has low levels of TLR1 and surprisingly adult skin expressed
significantly lower TLR1 compared to second trimester foetal skin. This may be due
to some stimulation of the foetal skin that may arise from its constant contact with
amniotic fluid. Similarly, TLR5 and TLR7 levels were lower in adult skin than foetal
skin. Foetal skin has imperceptible levels of TLR9 and TLR10 mRNA. The levels
were below the level of quantification but weak bands were visible on gel
electrophoresis. This was particularly evident with the foetal tissue experiment where
1 pg of RNA was used for the RT reactions compared to the 2.5pg in the adult tissues
experiment. TLR9 has been shown to be very lowly expressed or absent in
mammalian skin (Liu et al., 2003). Expression of TLR2, TLR3, TLR8 and MyD88
were comparable between second trimester foetal skin and adult skin. Expression of
TLR4, TLR6, CARD 15, CD 14, dectin-1 and dectin-2 were significantly higher in
adult skin than foetal skin. CARD15, CD14, dectin-1 and dectin-2 are known to be
highly expressed in cells of myeloid origin and the significant differences in
expression of these PRRs may reflect the differences in the composition of myeloid
derived cells in adult and foetal skin.
Histology of EGA day 70 foetal skin shows that it is well interspaced with numerous
cells. The high cutaneous cell content could translate to high PRR expression since
many cells of the skin such as keratinocytes, Langerhans cells, fibroblasts and dermal
DCs are known to express PRRs (Kollisch et al., 2005). Foetal skin histology also
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showed that the skin has numerous developing hair follicles. Pivarcsi and colleagues
(Pivarcsi et al., 2003) showed that hair follicles have a high expression of TLR2 and
TLR4. This may explain the comparable level of foetal TLR2. The TLR4 in adult
skin was however, significantly higher than foetal skin.
Ligation of PRRs has been shown to have a role in the release of antimicrobial
peptides such as a and p-defensins (Sumikawa et al., 2006; Vora et al, 2004). The
significant level of PRRs expressed in foetal skin could also play a role in the
formation of the vernix caseosa present on foetal skin at birth and possessing
antibacterial properties. Antigenic stimulus may arise from the amniotic fluid in
which the foetus is suspended and encourage the formation of the protective layer.
The spleen is the largest lymphoid tissue accounting for about one quarter of
lymphocytes in humans. Ovine foetal spleen has comparable mRNA expression to
adult spleen for most of the PRRs studied except for TLR7, TLR6 and CD 14, in
which the adult has significantly higher mRNA expression. This may be direct proof
that the foetal spleen (and thus the innate immune system) is almost fully mature in
second trimester sheep foetuses. Work done by Wilson and co-workers (Wilson et
al, 1996) also showed that foetal calves had higher than/or comparable levels of
CD2+, CD4+ and CD8+ T cells in the spleen, thymus, blood as compared to adult
cattle. This may lend further credence to the fact that ruminant foetuses are more
mature at birth and may partially explain the comparable PRR expression. This may
be in sharp contrast to murine foetuses that are known to have a very under
developed immune system at birth compared to humans (Durandy, 2003; Renz and
Herz, 2002). Other workers have found comparable levels of PRRs in other foetal
tissues and cells compared to adult equivalents. Nishimura and Naito (Nishimura and
Naito, 2005) also found comparable levels of TLRs in human foetal and adult liver.
Reid and co-workers (Reid et al, 2004) have also shown positive staining for dectin-
1 on murine spleen at birth, with the staining pattern resembling adult architecture
two weeks after birth. Harju and co-workers (Harju et al., 2001), found that in mice
the levels of TLR 2 and 4 increased constantly in the lung from conception through
birth until adults. In contrasts, the expression in the liver was the comparable
between the foetal, neonate and adult mice. Viemann and co-workers (Viemann et
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al., 2005) also found comparable levels of TLR4 in human neonates peripheral blood
monocytes and adults but found a statistically lower expression of TLR2 in neonates
compared to adults.
The lower expression of CD 14 in foetal tissues as compared with adult tissues would
agree with the findings of Jones and co-workers (Jones et al., 2002) who found a
higher expression of CD14 in adult monocytes compared to third trimester foetal
cells. As CD14 is GPI anchored and has no intracellular signal transduction but
works with TLR4, it was interesting to note that the expression of TLR4 was also
significantly higher in adult skin than foetal skin. TLR4 expression was also higher
in adult spleen although the difference was not significant. This could show the
association of these two PRRs in innate immunity.
Histology of the foetal spleen however may partially explain this - the foetal spleen
has early aggregation of lymphoid cell patches distributed throughout. Although
reticulocytes make up the predominant cell type, there is evident partial
differentiation of white and red pulp and their putative constituent cellular - and this
may account for the full profile of PRRs seen. DCs are among the first cells to
colonise the spleen during development, thus it would be reasonable to assume that
these spleens would have copious quantities of DCs at this stage. This increasing
proportion of lymphoid cells in the ovine foetal spleen agrees with that of Al Salami
and co-workers (Al Salami et al., 1985) who report that white pulp expands from day
70 of gestation to occupy a predominant histological proportion of splenic
architecture at birth. Similarly, foetal skin also seems well-endowed with a rich
cellular infiltrate that could possibly be immune cells expressing high levels of
PRRs.
Comparative immunostaining of the foetal tissues sections to identify the cell types
present would have been of additional value in further characterization of the cell
types that may be responsible for the PRR expression and their relative densities in
comparison to adult tissues.
One possible explanation for the comparable levels of PRRs in foetal tissues
compared to adult tissues (but with an obvious under developed neonatal immune
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response) is that the levels are comparable but the PRR activity is hampered by the
presence of an inhibitory plasma factor in foetuses as described by Levy and
colleagues (Levy et al, 2004). They found inhibitory activity to TLRs in neonatal
blood that could possibly explain the lower TNF-a expression in monocytes after
LPS stimulation compared to adult monocytes. This inhibitory activity was absent in
adult plasma. Unfortunately, this factor has not been identified yet and when it is the
determination of the expression levels over the gestation period may be very
revealing and provide further insight on neonatal innate immune development.
This study showed that foetal spleen has more PRRs that were comparable to adult
tissue than the skin. Deducing from these results in the sheep, it would be plausible
that in primary and secondary lymphoid organs foetuses develop comparable levels
with adults early during gestation but in other tissues the levels increase slowly as the
tissues are seeded with PRR-expressing cells based on need and/or demand. For
example Carolyn (Carolyn, 1989) proposed that Langerhans cell density in human ^
foetal skin only increases to comparable adult levels in the third trimester. The third •
trimester human foetus would developmentally be equivalent to the second trimester
sheep foetus, thus one would expect that the second trimester foetus would have a
full complement of immune cells in the skin. The pre-third trimester skin has
statistically less LC than adult skin and their morphology differs markedly. This may
have an important bearing on PRR expression and antigen recognition and
presentation. The other possible explanation is one based on the findings of
Piotrowski (Piotrowski and Croy, 1996) that maternal cells are distributed in the
foetus and the presence of these cells could rationalize the PRR mRNA expression
seen. This would however require further investigation.
In conclusion, the present study shows that second trimester ovine foetuses have a
significantly developed array of innate immune PRRs despite having generally
under-developed immune responses at birth. These results would indicate that the
repertoire of PRRs expressed by ovine foetuses would enable the foetus to respond to
a large variety of pathogen associated components prior to birth and therefore should
be able to elicit immune responses. The reason for the underdeveloped immune
responses would thus lie beyond the pattern recognition stage and could possibly be
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anywhere from the downstream signalling, antigen presentation or with the effector
arm of the immune system. These studies further suggest that the foetal immune
system is able to recognize and respond to a number of pathogens such as bacteria,
viruses, and fungi via PRRs and alert the adaptive immune system. This would form
the beginning of the process of eliminating and/or controlling the offending
pathogen. The presence of PRRs in the foetus may take place in the development of
and maintenance of foetal/neonatal tolerance since it is now well known that PRRs
may be involved in tolerance induction and maintenance.
These results will contribute towards the more thorough understanding of the
ontogeny of the immune system in sheep and the role that PRRs play therein. They
will also form the basis for future research on the role of PRRs in foetal immunology
and study the inducibility of these PRRs in foetal disease conditions. This will
increase the understanding of the fundamental processes during immune
development in utero and how the foetus is able to selectively detect microbial
infections whilst not mounting an immune response to the mother. This increased
understanding will culminate in our increased ability to treat and prevent neonatal
infections.
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5 PRR expression in Immune cell sub-sets
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5.1 Introduction
Recognition of pathogens by the innate immune system is a decisive step in the
initiation of adaptive immune responses. The primary sensors of pathogens and
PAMPs are PRRs found on cells of the innate and adaptive immune system, and their
activation leads to signalling pathways that culminate in immune and inflammatory
gene induction. DCs are a sparsely and widely distributed heterogeneous leucocyte
population specialized in the recognition, uptake and processing of antigen for
presentation to naive T cells (Hart, 1997; Mellman and Steinman, 2001). DCs subsets
express a wide repertoire of PRRs (Akira et al., 2001; Takeda et al., 2003; Werling
et al., 2006) and the ligation of these PRRs leads to DC maturation and migration to
secondary lymphoid organs where they are able to effectively prime nai've T cells. It
has been proposed that the PRRs engaged on the DC subsets determine the cytokines
released (Gautier et al., 2005; Ito et al., 2002) and together these will influence the
terminal differentiation of T helper cells into Thl, Th2 or Treg phenotypes (Mazzoni
and Segal, 2004). Therefore DCs, by virtue of their sentinel function, are able to
amplify the innate immune response and also determine the quality, quantity and
functional polarization of the adaptive immune response based on the tissue milieu
information gathered via PRRs. Species differences exist in the DC classification
criteria and also PRR expression profiles.
Monocytes and macrophages have a critical role in innate immune response and
possess the capacity to phagocytose pathogens and particulate antigen and are known
to express PRRs. Monocytes/macrophages also utilize PRRs to recognize pathogens
and to facilitate uptake.
Ruminant afferent lymph DC subsets (based on CD172a expression) have been
shown to preferentially produce cytokines that may polarize T responses. Bovine
CD172a^ DCs have been shown to preferentially produce IL-10 and bias towards
Th2 immune responses while the CD172a" DCs preferentially produce 1L-12 and bias
towards Thl immune responses (Stephens et al., 2003). Ovine CD 172a subsets have
also been shown to produce similar cytokines to the bovine subsets (Matthews et al.,
2006). The ovine CD 172a' DCs, that also express CD4 and CD8, seem to be broadly
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aligned to human and murine plasmacytoid DCs (pDCs) and they express 1L-10 but
not 1L-12 and thus potentially skew immune responses towards Th2 bias. I
hypothesized that the two ovine DC subsets (CD 172a" and CD 172a") express
different PRRs and are thus capable of responding to different PAMPs (and
pathogens). This difference in PRR would thus endow each subset with the unique
capacity to prime naive T cells towards Thl, Th2 or Treg polarization. I further
hypothesize that monocytes will express all PRRs to reflect their broad-spectrum role
of antigen recognition and pathogen engulfment in innate immunity.
PRRs have been extensively studied in cells of the innate immune system, mainly
monocyte/macrophage lineage myeloid APCs. However, PRRs are also expressed on
lymphocytes (Zarember and Godowski, 2002). B and T cells are key mediators of
mammalian immunity. Priming of naive T cells by DCs is the first step towards
generating an adaptive immune response. It is known that activated APCs are
capable of priming T cells and TLR ligation is a primary means by which APC
activation occurs (Iwasaki and Medzhitov, 2004). B cells are however able to
directly recognize naive antigen via B cell receptors and are also known to have APC
properties (Rodriguez-Pinto, 2005). PRR expression on B cells thus facilitates their
APC function but the functional importance of PRR expression on lymphocytes is
poorly understood.
The purpose of this study was to determine if ovine T cells and B cells express PRRs
as has been described in other mammalian species.
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5.2 Flow cytometry - Identification of cell populations
DCs and PBMCs were enriched on density gradients and cell subsets separated by
fluorescence activated cell sorting (FACS) (Section 2.2.4.). DCs were identified
based on their characteristic high side scatter and forward scatter profiles and
electronically gated. These cells were separated into CD172a+ and CD 172a-
populations by two-colour FACS based on high MHC class II expression and
expression or absence of positive staining to CD172a. Gradient separated PBMCs
were identified by their characteristic side scatter and forward scatter profiles and
further discriminated as B cells, CD4/CD8 T cells and macrophage/monocytes by
positive staining with relevant fluorescence labelled monoclonal antibodies (Section
2.2.4.5 and Table 2.1). Expression of cell surface markers was determined by FACS
and compared with isotype controls.
Live cells were sorted based on these criteria and the sorted cell populations were
determined to be greater than 96% pure by FACS. Analysis and graphing of FACS
data was performed using WinMDI software.






Figure 5.1 FACS of Afferent Lymph Dendritic Cells
Phenotypic characterization and analysis of ALDCs by two colour immunofluorescence flow
cytometry. Typical morphology and sorting criteria for DCs (A) Forward scatter and side scatter
profiles of ALDCs showing the electronic gate (R1) used to isolate DCs. (B) Dot plot of Rl gated cell
population stained with FITC-conjugated mAb 1L-A24 (anti-CDI72a) and PE-conjugated SW73.2
(anti-MFIC class II) showing the gates for the CD172a- (R2) and CDI72a+ (R3) population (C)
Histogram show ing the expression of F1TC in the F1 gated cells with two merging peaks of events.
Abbreviations: UL-upper left. I R-upper right. LL-lower left. LR-lower right
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Figure 5.2 FACS of immune cell population defined by the FSC and SSC and stained with the
relevant mAb.
Phenotypic characterization and analysis of PBMCs by single colour immunofluorescence flow
cytometry. Typical morphology and sorting criteria for PBMCs derived CD4+ cells (A) Forward
scatter and side scatter profiles of PBMCs showing the position of the electronic gate (Rl) used to
isolate lymphocytes. (B) Histogram of gated CD4 T cell population stained with PE-conjugated
biotiny lated mAb SBU-T4 showing the significant expression of PE in the gated cells. (C) Histogram
of gated CD8 T cell population stained with mAb SBU-T8 showing the significant expression of FITC
in the gated cells. (D) Histogram of gated B cell population stained with mAb VPM30 show ing the
significant expression of FITC in the gated cells. (E) Histogram of gated monocytes stained with mAb
VPM65 showing the significant expression of FITC in the gated cells.
Abbreviations: UL-upper left. UR-upper right, LL-lower left. LR-lower right
Chapter Five - PRRs in ovine DCs and blood subsets 193
5.3 PRR expression in different immune subsets
In order to determine the presence of PRR transcripts in different immune system
cell subtypes, PRR expression in FACS purified cell subsets of blood PBMCs and
lymph was examined using quantitative real time PCR as outlined in Chapter 2.
Due to the low starting amount of RNA, the expression levels of the PRRs was at the
lower limit of quantitation for the qPCR assays, thus quantitative analysis could not
be carried out. Qualitative analysis of the presence of PRR transcripts was performed
using melt curve analysis and gel electrophoresis analysis of qPCR products for the
samples and scored. Figure 5.3 shows a representative sample of gels with qPCR
amplicons from the cells subsets.
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Figure 5.3 Agarose gels showing representative samples of PRR qPCR amplicons
Ethidium bromide agarose gels of representative samples of PRR amplification products from qPCR.
Lane l(plasmid DNA positive control). Lane 2(CDl72a+ DCs). Lane3 (CD172a- DCs), Lane 4
(negative control). Lane 5 (DNA ladder). Lane 6 (blood CD14+), Lane 7 (lymph CD14+), Lane 8 (B
cells). Lane 9 (Blood CD4+). Lane 10 (Lymph CD4+). Lane 11 (blood CD8+). A) SDHA
housekeeping gene B) TLR1 C) CARD 15 D) Dectin-1.
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Table 5.1 PRR expression in different ovine cell sub-sets















TLR 1 +ve +/-ve +ve +ve +ve -ve -ve -ve
TLR 2 +ve +ve +ve +ve +ve -ve -ve -ve
TLR 3 +ve +/-ve +ve +/-ve -ve -ve -ve -ve
TLR 4 -ve -ve +ve +ve +ve +ve +ve -ve
TLR 5 -ve -ve +ve +ve -ve -ve -ve -ve
TLR 6 +ve +ve +ve +ve +ve +ve +ve -ve
TLR 7 -ve -ve +ve +/-ve +ve +/-ve -ve -ve
TLR 8 +ve -ve +ve +ve +/-ve ,+ve -ve -ve
TLR 9 +ve -ve +/-ve +/-ve +/-ve -ve -ve -ve
TLR 10 -ve -ve +ve +ve +ve +ve -ve -ve
MyD88 +ve +ve +ve +ve +ve +ve +ve +ve
CARD15 +ve +ve +ve +ve -ve +ve +ve -ve
CD14 +ve +/-ve +ve +ve +/-ve +/-ve +/-ve -ve
Dectin-1 +ve -ve +ve +ve -ve -ve -ve -ve
Dectin-2 +ve -ve +ve +ve -ve -ve -ve -ve
Key
-ve : nothing detected or below limit of detection
+ : strong expression in all samples
+/- : barely detectable expression or expression in one out of four samples examined
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Table 5.2 PRR expression from present study compared with other referenced findings
Dendritic Cells Blood and lymph derived cells
PRR CD 172a CD172a Blood Lymph B cells Blood Lymph Blood
+ve -ve CD14 CD14 CD4 CD4 CD8
TLR 1 1 1 1.8 1.2.3.4.5.6
TLR 2 1 1 1.7.8 2,4
TLR 3 1 8 L5
TLR 4 9 9 1.7.8 2 3,8
TLR 5 I 1.7.8
TLR 6 1.9 1,9 1.8 2.4,6 3,4,8
TLR 7 8 1,2,4
TLR 8 1 1,7,8 3,4,8
TLR 9 1
TLR 10 1.8 1,2,6 3,8 .
MyD88 8 8 8 8




Colour code (Expression patterns from this study)
□ No expression from present study and references with similar findings
3hssx Strong expression trom present study and references with similar findings
Barely detectable expression or expression in one out of four samples examined
1
(Werling et al.. 2006)
2 (Bernasconi et al.. 2003)
J
(Ignacio et al.. 2005)
4
(Caramalho et al.. 2003)
5
(Dasari et al.. 2005)
b
(Elornung et al.. 2002)
7
(Kokkinopoulos et al.. 2005)
8
(Zarember and Godowski, 2002)
9
(Kadowaki et al., 2001)
10
(Hubert et al.. 2006)
11
(Ogura et al.. 2001)
12
(Willcocks el al.. 2006)
lj
(Gavino et al., 2005)
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Dendritic cell were defined as cells with high forward scatter and high side scatter
and expressing high MHC class II in this study (Figure 5.1A and B). The DCs were
further differentiated into two subsets based on expression or absence of CD 172a
(SIRPa) (Figure 5.IB and C). CD172a+ DCs expressed TLR1, TLR2, TLR3, TLR6,
TLR8, TLR9, MyD88, CARD 15, CD14, Dectin-1 and Dectin-2. Similar to CD172a~
DC population, the CD 172a" DCs expressed TLR2, TLR6, MyD88 and CARD 15 in
all samples examined (Table 5.1).
Blood monocytes were separated based on the expression of CD 14 and characteristic
side scatter and forward scatter profiles as shown in Figure 5.2A and E. They
expressed TLR1-TLR8, TLR10, MyD88, CARD15, CD14, CARD 15, dectin-1 and
dectin-2. Lymph derived CD14 positive cells expressed TLR1, TLR2, TLR4, TLR5,
TLR6, TLR8, TLR10, MyD88, CARD15, CD14, dectin-1 and dectin-2.
Blood B lymphocytes were separated based on positive staining with the mAb
VPM30 and characteristic side scatter and forward scatter profiles as shown in
Figure 5.2. B cells expressed TLR1, TLR2, TLR4, TLR6, TLR7, TLR10 and MyD88
in all samples examined.
Blood CD4+ T lymphocytes were separated based on positive staining with the mAb
SBU-T4 and characteristic side scatter and forward scatter profiles as shown in
Figure 5.2A and B. Blood derived CD4+ T cells showed the presence of TLR4,
TLR6, TLR8, TLR10, MyD88 and CARD15. CD4+ cells derived from lymph
showed the presence of TLR4, TLR6, MyD88, CARD15 and CD14.
No PRR transcripts were detected in CD8+ T cells. Transcripts for the adaptor
molecule MyD88 were however detected.
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5.4 Discussion
The last few decades have seen lymphocytes being progressively subdivided into an
increasing number of phenotypically and functionally discrete subsets. With the
discovery of PRRs, differential expression of these innate immune receptors in the
different subsets has been shown as well as species differences.
This study set out to determine the quantitative expression of PRRs in different
immune cell types and the CD 172a positive and negative DCs. Quantitative
expression of the PRRs could not be carried out due to the resulting low transcript
levels for the amount of RNA used, thus qualitative scoring was used to determine
the presence or absence of PRR transcripts using melt curves and gel electrophoresis
of qPCR products.
In this study the PRR expression of CD172a" and CD172a" dendritic cells, blood
derived CD4+, CD8+ and CD14+ cells, B cells, lymph CD14+ and CD4+ cells was
examined. Analysis of PRR expression from these ovine immune cell subsets
indicates that APCs express the widest range of PRRs.
Dendritic Cells
The expression of PRRs in the two ovine DC subsets is as outlined in Table 5.1
which shows that the CD 172a subset expressed a wider range of PRRs than the
CD 172a" subset. Unlike the CD 172a" subset, the CD172a^ expressed the nucleic acid
sensing PRRs, TLR3, TLR8, TLR9 which would give this subset the capacity to
sense nucleic acids such as viral ds and ss RNA and bacterial CpG DNA from
bacteria. This study did not detect any TLR4 and TLR5 transcripts in both DC
subsets which is in contrast with other workers (Hubert et al., 2006;Werling et al.,
2006) but similar to the findings of Kadowaki and colleagues (Kadowaki et al.,
2001). Both subsets did not express TLR4 despite that the CD172a^ expressed CD14
the co-receptor for TLR4 mediated LPS recognition. The CD172a+ population
expressed the two c-type lectins, dectin-1 and dectin-2, while the CD172a"
population does not. Gavino and colleagues (Gavino et al., 2005) found expression
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of dectin-2 in both myeloid and plasmacytoid DCs with the pDCs having a three fold
higher expression than myeloid DCs. This study, however, only found the expression
of dectin-2 in CD172a! DCs. In contrast to Willcocks and colleagues (Willcocks et
a!., 2006) who found dectin-1 expression in both CD172a" and CD172a" DCs, this
study only found expression of dectin-1 in CD 172a' afferent lymph DCs (ALDC).
However, Willcocks and colleagues (2006), report that although dectin-1 is present
in both ALDCs subsets, expression is variable was detected in 14% of samples C
examined. This variable expression could explain why the dectin-1 was not detected
in the CD172a" DC sub-population in the present study since only four samples were
looked at. The findings from the present study on c-type lectin expression would
confer the CD 172a' the ability to recognize PAMPs such as beta glucans.
The findings from this study show that the CD 172a' and CD 172a" DC subsets
express a wide range of PRR and this may have a bearing on their ability to
recognize particular pathogens in a subset specific manner and drive appropriate
immune responses. The CD172a' DC subset had the widest repertoire of PRRs and
this may confer this subset with a greater ability to recognize more pathogens
modulate more pathogen-specific immune responses compared to the CD 172a" DC
subset. Bovine CD172a^ DCs were also shown to have transcripts for a larger
number of PRRs than the CD 172a" by Werling and colleagues (2006).
Though the ovine CD172a' population tend to bias towards exclusive IL-10
expression, Th2 responses and plasmacytoid DC phenotype (Matthews et al., 2006),
it has a wider TLR expression profile than has been described for human and mouse
pDCs. The PRR expression on CD 172a' DCs, and the predominant cytokine that
they produce (IL-10), would seem to be in sharp contrast with the Th type/IL-10/1L-
12 paradigm. For example, TLR9 ligation by CpG bacterial DNA is expected to
generate protective Thl type immune responses via IL-12 production, but the
CD 172a' DCs that expresses TLR9 does not tend to produce IL-12. Stephens and co¬
workers (2003) did not find specific pDC equivalents in the bovine ALDCs and also
showed that the CD172a+ population, though producing predominantly IL-10,
produced low IL-12 later on following stimulation. This has been attributed to the
fact that the CD 172a DCs are a more heterogenous population than the CD 172a"
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population and may contain cells capable of producing IL-12. In the pig, Jamin and
co-workers (Jamin et al., 2006) were able to further separate cells derived from
CD172a^ DCs in lymphoid organs into plasmacytoid DCs and conventional DC
populations based on co-expression of CD4 and CD11R1 expression respectively.
Translated across species, this would imply the presence of plasmacytoid DCs within
the ovine CD172a^ population. This may explain the wider PRR expression seen in
this population by the present study and that of Werling and colleagues (2006).
CD14 cells - Blood and Lymph
The expression of PRRs in CD14 positive cells (monocytes) as outlined in Table 5.1
shows that these cells express all the PRRs studied. The findings on the expression of
TLR1, TLR2, TLR4, TLR5, TLR6, TLR8, TLR9 and TLR10 in CD 14+ monocytes
agrees with the findings of several workers (Visintin et al., 2001; Werling et al.,
2006; Zarember and Godowski, 2002) (see Table 5.2). The expression of the c-type
lectins on these cells also concurs with the other previous studies (Gavino et al.,
2005; Willcocks et al., 2006). The presence of all the PRRs on these cells would
confer them with the ability to recognize most PAMPs that they would encounter.
The only differences in PRR expression between the blood and lymph derived
CD 14+ was the expression of TLR3 and TLR7 where the blood monocytes
consistently expressed these two PRRs whilst the expression in afferent CD14+
lymph population was inconsistent. Afferent lymph contains some
monocyte/macrophages and some CD14low CD1 l"CD172a~ DCs, but the cells in this
study were FACS gated to excluded the large granular cells (cells with high forward
scatter and side scatter) and thus all the DCs. Thus, the CD 14+ cells gated from
afferent lymph are of the monocyte/macrophage lineage and have similar PRR
expression patterns with the blood monocytes.
Chapter Five - PRRs in ovine DCs and blood subsets 201
('haraclcri/alion ufthine Pattern Recognition Receptor expression
Lymphocytes
The expression of PRRs in B cells is summarised in Table 5.1 shows that these cells
express most of the PRRs studied. Numerous authors concur that B cells have
transcripts for all TLRs, but only TLR1 and TLR6-TLR10 have significant
expression (Bourke et al., 2003; Hornung et al., 2002; Zarember and Godowski,
2002). The expression of PRRs in B cells by this study is in agreement with a
number of other previous studies (Table 5.2).
Similar to the findings of Willcocks and colleagues (2006), this study did not detect
any dectin-1 transcripts in B cells. Gavino and colleagues (2005) found that human
dectin-2 was expressed in resting B cells but down-regulated following in vitro
activation of the B cells. Unlike their finding this study did not detect any dectin-2 on
B cells, and this may reflect that the predominant population of the B cells examined
in this study were in a state of activation. Bernasconi and colleagues (Bernasconi et
al., 2003) also showed differential TLR expression in activated B cells, with memory
B cells expressing TLR6, TLR7, TLR9, TLR 10 at higher levels than naive B cells.
The presence of a large number of PRRs in B cells would be consistent with the dual
role that B cells play in innate as well as adaptive immunity (McHeyzer-Williams,
2003; Rodriguez-Pinto, 2005).
The expression of PRRs in the blood and lymph derived CD4+ T lymphocytes was
similar for all the PRRs detected except that the blood derived CD4+ cells had TLR7
and TLR 10 transcripts and none were detected in the lymph derived CD4+ cells
(Table 5.1). Most afferent lymph CD4 T cells are activated memory CD4 T cells and
express CD45RO, with virtually no nai've T cells (MacKay et al., 1990), while blood
CD4+ T cells are predominantly nai've. Differential expression of TLRs with
activation status has been shown by Xu and co-workers (Xu et al., 2005) who
showed that nai've (CD45RA) CD4+ T cells have a lower cell surface TLR2
expression than activated (CD45RO) T cells in human blood.
In contrast with the findings of the present study, Ignacio and colleagues (2005)
found that CD4 and CD8 cells in cats express all TLRs. The levels of expression of
TLR1 a TLR6 was however very low in their study. Caramalho and co-workers
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(2003) also found strong expression of TLR1, TLR2, TLR6, TLR7 and TLR8 in
murine CD4+ cells and differences in TLR expression in these cells based on
activation status. Pioneer studies on TLR expression in human T cells also reported
the mRNA expression of almost all TLRs (Hornung et al., 2002; Zarember and
Godowski, 2002).
The results form this study agree with the finding of Willcocks and co-workers
(2006) who did not find expression of dectin-1 in bovine CD4~ T cells and B cells.
The lack of expression of dectin-1 in these cells is in disparity with the finding of
Taylor and co-workers (Taylor et al., 2002) in mice who report expression on CD4+
splenic T cells. Gavino and colleagues (2005) show that dectin-2 expression in CD4+
T cells is present in activated cells but absent from resting CD4+ T cells and the
converse being true for CD8+ T cells and B cells. The lack of dectin-2 on blood
CD4+ T cells by the present study could be due to their predominant naive status
leading to abrogation of dectin-2 expression. This would however, not explain the
lack of dectin-2 in the afferent lymph CD T cells, since these are predominantly
activated memory T cells.
CD4 molecule expression has species variations with humans having a wider range
of cells expressing the CD4 molecule. In the mouse, expression is almost exclusively
restricted to the T cell lineage (including the regulatory T cell subset) but in humans
numerous cells including B cells (Moir et al., 1999), CD14+
monocytes/macrophages and CD34+ haematopoetic progenitors (Louache et al.,
1994). This could explain some of the species variations in PRR expression
observed.
The functional importance of PRR expression in T cells is not well defined. Gelman
and co-workers (Gelman et al., 2004) propose that direct ligand interaction with
PRRs CD4+ T cells enhances their survival and allows them to respond directly to
PAMPs in the absence of APCs. They propose that it may be a mechanism by which
CD4+ cells may drive adaptive immune responses when APCs are ineffective at T
cell priming due to pathogen virulence or immune evasion factors. Other workers
(Xu et al., 2005), propose that TLRs may act as co-stimulatory molecules.
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Concluding Comments
Some of the differences seen in the PRR expression in the cell populations may be
due to the different activation states. Activation or maturation is known to change the
PRR expression profiles of cells (Gavino et al., 2005; Gelman et al., 2004;
Kokkinopoulos et al., 2005; Visintin et al., 2001 ;Xu et al., 2005). Cell preparation
techniques, although unavoidable, can activate cells and introduce differences in cell
PRR expression patterns.
The absence of signal for some of the PRRs in the cell subsets could be due to the
fact that most PRRs are known to be expressed in very low copy numbers. It is
known that the efficiency of reverse transcription is dependent on RNA template
abundance and is significantly reduced when such transcripts are rare in the total
RNA (Karrer et al., 1995). Since 1 started with a very low amount of total RNA, this
could explain the absence of the low copy number PRR gene transcripts. Gene
specific primers could have been used for RT to increase the specificity but it has the
limitation that it requires a lot of RNA and an RT reaction for each gene and each
sample. Multiplex gene specific RT reactions can be done but require time-
consuming and rigorous optimization. The use of nested PCR would have probably
yielded better quantitative data than using the two-step qPCR that I used in this
study.
In order to obtain quantitative relationships of PRR expression between the different
cell subsets, this work would need to be performed with a higher amount of RNA
that will result in high transcript levels. The use of the more sensitive Taqman probe
qPCR would also enhance the detection of low copy number transcripts to facilitate
quantitative comparisons of gene expression of the ovine PRRs in these immune cell
subsets.
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6 Pattern Recognition Receptors in ovine paratuberculosis
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6.1 Introduction
Paratuberculosis is a chronic, progressive enteropathy of domestic and wild
ruminants, first described in cattle by Johne and Frothingham in 1895, and caused by
infection with the intracellular bacterium Mycobacterium avium paratuberculosis
(Map). It has a worldwide distribution and in the United States alone, it is estimated
to cost the dairy industry losses in excess of $200 million annually. Ovine
paratuberculosis is present as three clinical forms, namely asymptomatic,
paucibacillary and multibacillary. Each of these clinical forms correlates with the
degree of immunity that the host has mounted against the mycobacterial challenge
(Burrells et al., 1998). There are currently no effective vaccines against Map. It has
been shown that vaccines should be designed to evoke a more specific and most
appropriate immune response rather than the most vigorous in order to be protective
(Brown et al., 1998; Estes and Brown, 2002). Understanding the regulation of innate
immune mechanisms, at a molecular level during Map infections, would allow
potential manipulation of these mechanisms during the formulation of optimal Map
vaccines, and would facilitate the development a vaccine with specific and
appropriate cell-mediated immune protective mechanisms. However, the overall
pathogenesis of JD is poorly understood, but the persistence of Map in the
macrophages of JD cases is well documented. Ovine JD pathology and lesion
development are very similar to human leprosy (Modlin et al., 1988) and the clinical
immunopathology of multibacillary and paucibacillary clinical forms of ovine JD
translates to lepromatous and tuberculoid leprosy in humans respectively. Similarity
to leprosy makes paratuberculosis an ideal disease condition to study mechanisms by
which the innate immune system influences host defence mechanisms and modulates
adaptive immunity to determine outcome of mycobacterial infection/disease. The
paucibacillary and multibacillary forms of the disease represent typical type 1 and
type 2 immune responses respectively. Cases of tuberculoid (paucibacillary) leprosy
are characterized by typel cytokine release and better clinical outcome compared to
the lepromatous type, with patients being able to contain infection and limit spread.
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The ileal histopathology is also different between the paucibacillary and
multibacillary forms of JD, with the multibacillary having more macrophages and
eosinophils in the intestinal lesions and the paucibacillary form having a higher
lymphocyte infiltrate. PRR engagement in antigen presenting cells is know to skew T
cell responses towards Thl (Schnare et al., 2001), Th2 (Re and Strominger, 2001) or
T regulatory responses (Zanin-Zhorov et al., 2006). Different PRRs on APCs are
able to recognize PAMPs on Mycobacteria (Fortune et al., 2004; Tsuji et al, 2000)
and these APCs are capable of initiating and driving polarized responses via CD4+ T
cells. PRRs engaged at this point may be a critical point in determining the outcome
of Map infection. However, continued stimulation of the immune system from long
standing infection would inevitably lead to continued PRR activation and this could
lead to hyperactive immune reactions and pathology. TLR engagement is also known
to increase the differentiation of monocytes into macrophages and DCs (Krutzik et
al., 2005). This would thus imply that APCs engaged in the different clinical forms
of JD as evidenced by the differences in histopathological presentation would result
in different levels of PRRs.
Thus this study approached ovine JD as an ideal disease for studying the role played
by PRRs in determination of the polarization of Thl and Th2 responses in
mycobacterial disease, and therefore pathology. The hypothesis is that the PRR
profiles of the different forms of JD would explain the resultant T helper type
immune response and histopathological pictures. Using the PRR-specific quantitative
real time PCR assays developed in Chapter 2, comparative PRR expression was
quantified in ileum (the target tissue for Map infection) from the three clinical forms
of JD and a further comparison made with uninfected control sheep.
The response to infection varies between individuals and it is increasingly becoming
evident that some of these differences may be due to the host's genetic composition.
Polymorphisms and defects in production of immune molecules, such as PRRs
would have significant effects and a host's ability to recognize and respond to
pathogens and will consequently have relevance to infectious disease susceptibility
and immune disorders (Ting et al., 2006). Amino acid changes due to
polymorphisms in the recognition domains of these PRRs (the LRR in TLRs and
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NODs) would have a more pronounced effect as this would abrogate effective PAMP
recognition. In humans, TLR2 exon 2 and CARD 15 exon 11 mutations have been
described in association with the mycobacterial diseases tuberculosis (Ben-Ali et al.,
2004) and leprosy (Kang and Chae, 2001) that are related to ovine JD and also in
Crohn's disease (Ogura et al., 2001) that has a similar clinical presentation to JD
(Chiodini, 1989; Greenstein, 2003). Direct sequencing was used to search for these
equivalent single nucleotide polymorphisms in ovine TLR2 and CARD 15 genes in
paratuberculosis cases. The hypothesis is that SNPs in either or both CARD 15 exon
11 and TLR2 exon 2 could be linked to the different pathological forms of ovine
paratuberculosis. The identification of disease predisposing SNPs would facilitate the
development of livestock breeding programmes to eliminate predisposed genotypes.
All mycobacterial species express lipoarabinomannan (LaM), a unique,
immunostimulatory, cell wall gylcolipid. LaM is known to bind to leucocytes and
modulate immune responses in these leucocytes; it has thus been postulated to be a
virulence factor. The interaction of LaM with innate receptors like PRRs could
influence the outcome of mycobacterial infections. LaM was used to stimulate skin
in order to simulate one aspect of Map immune recognition and evaluate the post-
LaM ligation innate immune response via differential PRR expression by cutaneous
immune cells.
Improved understanding of the role played by PRRs in GIT infections could lead to
improved prophylactic and therapeutic interventions. This goal will be achieved by
enabling targeted manipulations of innate immune mechanisms early during the
antigen recognition stage and as antigen processing and presentation takes place to
shape the immune response. Effective prophylactic interventions will dramatically
reduce the losses that are currently being experienced by the livestock industry
worldwide and result in improved food security. Although its zoonotic potential is
still very controversial, Map has been implicated as the causal organism or
exacerbating factor in human Crohn's disease and JD results may have a bearing on
the better understanding of Crohn's disease immunopathogenesis.
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6.2 Results
6.2.1 Definition of ovine JD cases
A retrospective study of ovine ileum tissues was carried out from sheep flocks
naturally infected with paratuberculosis. Distal ileum samples from 24 cases of
Johne's disease diagnosed at post-mortem were utilized. There were 8 cases of each
clinical designation and ail cases had clinical histories, typical of Johne's disease and
all case diagnoses were confirmed by gross pathological changes at necropsy, culture
and histopathology at the Moredun Research Institute, Edinburgh. Appendix V has a
table summarizing each case signalment.
Figure 6.1 A and Figure 6.IB shows haematoxylin and eosin stained paraffin sections
of ileum derived from paucibacillary sheep that illustrates the increased lymphocyte
infiltration on the lamina propria in this form of ovine JD. Figure 6.1C and Figure
6.ID shows haematoxylin and eosin stained paraffin sections of ileum derived from
multibacillary sheep. The sections clearly demonstrate the presence of aggregations
of high numbers of macrophages (see black arrows) in the lamina propria of the
ileum that are typical of this clinical form of JD. Figure 6.IE shows Ziehl Neelsen
(ZN) stained paraffin section of multibacillary JD ileum and clearly demonstrates the
red mycobacterial bacilli in the macrophages (see green arrows) against the blue
tissue background.
Genomic DNA samples obtained from the multibacillary, paucibacillary and
asymptomatic ileum samples were all positive for Map 1S900 whilst tissues from the
control sheep were Map negative as determined by the IS900 qPCR assay.
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Figure 6.1 Histopathological presentation of ileum from the clinical forms of JD
Haematoxylin and eosin stained paraffin section of ileum tissues derived from paueibaeillary and
multibaeillary clinical forms of ovine JD showing the different cellular infiltrate characteristic of each
clinical type. A. Paucibacillary x 250, B. Paucibacillary JD x 400, C. Mullibacillary JD x 100, D. and
Multibacillary JD x 400. E. ZN stained paraffin section of ileum tissues derived from multibacillary
clinical forms of ovine JD. Histopathological sections kindly provided by Dr. Susan Rhind, Veterinary
Clinical Studies, University of Edinburgh.
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6.3 PRR expression in paratuberculosis ileum tissue
6.3.1 Comparative PRRs expression in ileum derived from the three clinical
form of ovine paratuberculosis
In order to evaluate the comparative PRR expression in the three different clinical
forms of ovine JD. RT-qPCR was performed using RNA derived from ileum from
asymptomatic, paucibacillary and multibacillary JD as outlined in Chapter 2. Figure
6.2 shows the comparative PRR mRNA expression in the three clinical forms. Each
graph represents duplicate runs of each sample and shows the individual values (red
dots), the mean and 95% confidence interval of the means.
Individual Value Plot of Log TLR1 vs Clinical type ParaTB
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Individual Value Plot of Log TLR2 vs Clinical type ParaTB
95% CI for the Mean
Multbaallary Paucibaallary
Clinical type ParaTB
Individual Value Plot of Log TLR3 vs Clinical type ParaTB
95% CI for the Mean
Multbaallary Paucibacillary
Clinical type ParaTB
Individual Value Plot of Log TLR4 vs Clinical type ParaTB




Figure 6.2 Graphical representation of PRR expression in ovine paratubereulosis ileum
RT-qPCR analysis ofTLRl(A), TLR2(B). TLR3(C) and TLR4(D) transcripts in ileum derived from
asymptomatic (/;=8), multibacillary («=6), and paucibacillary (n=8) clinical forms of ovine
paratuberculosis. Data are expressed as individual value plots of normalized Log10(copy number per
qPCR reaction) of each PRR. The circles on the graphs represent the mean and the whiskers
representing 95% confidence interval of the mean.
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Figure 6.2 Graphical representation of PRR expression in ovine paratuberculosis ileum
(continued)
RT-qPCR analysis ofTLR5(E), TLR6(F), TLR7(G), TLR8(H), TLR9(I). and TLRIO(J) transcripts in
ileum derived from asymptomatic (n=8), multibacillary (n=6), and paucibacillary («=8) clinical forms
of ovine paratuberculosis. Data are expressed as individual value plots of normalized Log10 (copy
number per qPCR reaction) of each PRR. The circles on the graphs represent the mean and the
whiskers representing 95% confidence interval of the mean.
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Figure 6.2 Graphical representation of FKR expression in ovine paratubereulosis ileum
(continued)
RT-qPCR analysis of MyD88(K), CARD15(L), CD14(M). Dectin-l(N) and Dectin-2(0) transcripts
in ileum derived from asymptomatic (/?=8). multibacillary («=6). and paucibacillary (/i=8) clinical
forms of ovine paratuberculosis. Data are expressed as indiv idual value plots of normalized Log,0
(copy number per qPCR reaction) of each PRR. The circles on the graphs represent the mean and the
w hiskers representing 95% confidence interval of the mean.
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Normalized PRR TLR1 TLR2 TLR3 TLR4 TLR5 TLR6 TLR7 TLR8
0.95 0.63 "'113 HCE 1.22Paucibacillarv 1.31 0.93 1.46






1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
TLR9 TLR10 MyD88 CARD15 CD14 Dectinl Dectin2
0.12 0.67 | 2.09 6.36 0.94 1.68 45.73
0.27 0.43| 1.84 6.94 2.43 5.95 87.11
1.00 1.00 1.00 1.00 1.00 1.00 1.00
Legend
n l Expression greater than 2 fold lower
| Expression less than 2 fold lower
□ | Expression greater than 2 fold higher
1 *t . a T Expression less than 2 fold higher
Table 6.1 Summary of comparative means of PRRs expression normalized to asymptomatic
ileum PRR expression.
Table 6.1 summarizes the comparative means of the linear values of PRR expression in the three
clinical forms of .IE). The means have been tabulated normalized to the mean expression of PRRs in
asymptomatic JD ileum (asymptomatic JD given an arbitrary value of 1). The relative mean PRR
expressions have been colour-coded according to the fold-change differences as outlined in the
legend.
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6.3.2 Comparative PRRs mRNA expression in normal ileum, vs. asymptomatic
and multibacillary forms of paratuberculosis ileum
Asymptomatic JD does not represent a normal immunological state of the ileum, as
although it does not show gross or histopathological lesions, it does have Map
infection present. In order to establish if differences in PRR expression between
asymptomatic JD and normal, uninfected ileum exist, a comparative analysis of PRR
expression was undertaken between 1S900 negative control ileum tissues and
asymptomatic and multibacillary JD ileum. Figure 6.3 shows the comparative PRR
expression of the normal control ileum compared to asymptomatic and multibacillary
JD ileum tissues.
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Figure 6.3 Graphical representation of PRR expression in normal ovine ileum compared to
paratuberculosis ileum
RT-qPCR analysis of TLR1(A), TLR2(B), TLR3(C), and TLR4(D) transcripts in ileum derived from
control sheep («=8) compared to asymptomatic (n=8) and multibacillary (n=8) clinical forms of JD.
Data are expressed as individual value plots of normalized Log]0(copy number per qPCR reaction) of
each PRR. The circles on the graphs represent the mean and the whiskers representing 95%
confidence interval of the mean.
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Figure 6.3 Graphical representation of PRR expression in normal ovine ileum compared to
paratuberculosis ileum (continued)
RT-qPCR analysis of TLR5(E), TLR6(F), TLR7(G), TLR8(H), TLR9(I) and TLRIO(J) transcripts in
ileum tissue derived from control sheep («=8) compared to asymptomatic (n= 8) and multibacillary
(«=8). clinical forms of JD. Data are expressed as individual value plots of normalized Log10 (copy
number per qPCR reaction) of each PRR. The circles on the graphs represent the mean and the
whiskers representing 95% confidence interval of the mean.
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Figure 6.3 Graphical representation of PRR expression in normal ovine ileum compared to
paratubereulosis ileum (continued)
RT-qPCR analysis of MyD88(K), CARD15(L), CD14(.Y1). dectin-l(N) and dectin-2(0) transcripts in
ileum tissue derived from control sheep (n=8) compared to asymptomatic («=8) and multibacillary
(n=8). clinical forms of .ID. Data are expressed as individual value plots of normalized Log10 (copy
number per qPCR reaction) of each PRR. The circles on the graphs represent the mean and the
whiskers representing 95% confidence interval of the mean.
Chapter Six - PRRs and o\ ine paratubereulosis 219
Mean PRR expression normalized to normal ileum
TLR1 TLR2 TLR3 TLR4 TLR5 TLR6 TLR7 TLR8
Normal 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Multibacillary 1.31 8.68 2.62 3.79 1.22 1.81 2.50 5.89 1
Asymptomatic 2.35 2.40 3.62 2.79 3.18 3.98 2.83 1.58




TLR9 TLR10 MyD88 CARD15 CD14 Dectin-1 Dectin2
1.00 1.00 1.00 1.00 1.00 1.00 1.00
6.00 0.98 1.47 4.45 12.95 5.31 46.89
40.89 2.24 1.31 0.98 6.05 1.48 0.75
Legend
l Expression greater than 2 fold lower
I Expression less than 2 fold low er
□ | Expression greater than 2 fold higher
3 | Expression less than 2 told higher
Table 6.2 Summary of comparative means of PRRs mRNA expression normalized to normal
ileum PRR expression
Table 6.2 summarizes the comparative means of the linear values of PRR expression in control ileum
and the asymptomatic and multibacillary clinical forms of JD. The means have been tabulated
normalized to the mean expression of PRRs in the control ileum (given an arbitrary value of 1). The
relative mean PRR expressions have been colour-coded according to the fold-change differences as
outlined in the legend.
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TLR1 expression in ovine JD
Differences in TLR1 expression are not significantly different between the three
clinical forms of JD (Figure 6.2A). Multibacillary JD had slightly less TLR1
transcripts than the asymptomatic JD and the paucibacillary JD has 1.3 times more
TLR1 mRNA expression than the asymptomatic from. There were also no significant
differences in TLR1 expression observed between the control ileum and the
asymptomatic and multibacillary clinical forms although they had a higher mean
expression of TLRI than control ileum (Figure 6.3A).
TLR2 expression in ovine JD
Paucibacillary JD had comparable levels of TLR2 mRNA expression with the
asymptomatic form of JD (Figure 6.2B) whereas the multibacillary form has greater
than three fold more TLR2 than both of the other forms. The difference in TLR2
expression is significantly different between the multibacillary form and the
asymptomatic but there is no significant difference between the pauci- and the
multibacillary form of JD. Asymptomatic JD had a greater than two fold higher
expression of TLR2 than control ileum but this difference was not statistically
significant (Figure 6.3B). Multibacillary JD had a greater than eight fold higher
expression of TLR2 than the control ileum tissue and the expression was
significantly different from both the control ileum and asymptomatic JD.
TLR3and TLR4 expression in ovine JD
TLR3 expression between the three clinical forms of JD is not significantly different
(Figure 6 2C). Multibacillary and asymptomatic form had a higher expression of
TLR3 than the control ileum but there was no significant difference in TLR3
expression between the control ileum and these two forms (Figure 6.3C).
Multibacillary JD has an approximately 1.8 fold higher TLR4 expression than both
asymptomatic and paucibacillary forms (Figure 6.2D). However, the differences in
TLR4 expression are not statistically significant. Asymptomatic ileum had a higher
expression of TLR4 than control ileum, but the differences were not significant
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(Figure 6.3D). Multibacillary JD however, had a significantly higher expression of
TLR4 than control ileum.
TLR5 expression in ovine JD
TLR5 expression in asymptomatic sheep is higher than both multibacillary and
paucibacillary JD (Figure 6.2E). The multibacillary form has a greater than 2 fold
lower mean TLR5 expression than the asymptomatic form of JD and the
paucibacillary form has a greater than 1.5 fold lower mean TLR5 expression than the
asymptomatic form. The differences in mean TLR5 expression between the three
clinical forms are however, not significant. Asymptomatic JD had a higher
expression of TLR5 than both control ileum and multibacillary JD (Figure 6.3E).
There was no significant difference between the normal control ileum and the
multibacillary JD, but the differences between normal and asymptomatic JD were
statistically significantly different.
TLR6 and TLR 7 expression in ovine JD
TLR6 expression in the three clinical forms of JD had very minor differences that are
not significant (Figure 6.2F). Asymptomatic JD ileum had an almost four fold higher
expression of TLR6 than normal control ileum and a two-fold higher expression than
multibacillary JD. There was however, no significant difference in TLR6 expression
between the control ileum and these clinical forms (Figure 6.3F).
Similarly mean TFR7 expression levels between the three clinical forms were
comparable w ith no significant differences (Figure 6.2G). The asymptomatic form of
JD had a higher mean TLR7 expression than both multibacillary and paucibacillary
forms, being almost three fold higher than the multibacillary and about 1.3 fold
higher than the paucibacillary from. Asymptomatic and multibacillary JD had a
higher expression of TLR7 than control ileum (Figure 6.3G). Multibacillary JD had a
significantly higher TLR7 expression than control ileum. The difference between the
control ileum and the asymptomatic JD were not significant.
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TLRS expression in ovine JD
TLR8 transcripts level in the multibacillary form was significantly higher (j)>0.05)
than the other two forms (Figure 6.2H). The multibacillary form had a greater than
two fold higher expression of TLR8 than both asymptomatic and paucibacillary
forms of JD. The mean TLR8 expression was comparable between the asymptomatic
and paucibacillary forms of JD. There was no significant difference in TLR8
expression between the control ileum and the asymptomatic JD (Figure 6.3H).
Multibacillary JD had an almost six fold higher expression of TLRS than the control
ileum and the difference was statistically significant.
TLR9 expression in ovine JD
Asymptomatic JD had a higher expression of TLR9 than both pauci- and
multibacillary forms (ca 8 fold and 3 fold respectively) although there was no
significant difference in transcripts between the three clinical forms (Figure 6.21).
Asymptomatic and multibacillary JD both had a higher expression of TLR9 (Figure
6.31) than control ileum. The difference was statistically significant with the control
ileum having a six fold and forty fold lower TLR9 expression compared to the
multibacillary and asymptomatic JD respectively.
TLR10 expression in ovine JD
Asymptomatic JD also had a slightly higher mean expression of TLR10 than both
paucibacillary and multibacillary JD (ca 1.5 fold and 2 fold respectively). These
differences were however, not significant (Figure 6.2J). TLR10 expression levels of
control ileum were comparable to asymptomatic and multibacillary JD (Figure 6.3J).
MyDHR expression in ovine JD
Pauci- and multibacillary JD had a slightly higher mean expression of MyD88 than
asymptomatic JD (ca 2 fold and 1.8 fold respectively). The paucibacillary MyD88
expression was significantly higher than the asymptomatic JD. The differences in
M_vD88 expression between the multibacillary form and the other forms was
however, not significant (Figure 6.2K). The clinical forms of JD had slightly higher
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MyD88 transcripts level than control ileum but this difference was not significant
(Figure 6.3K).
CARD15 expression in ovine JD
Paucibacillary and multibacillary JD had a significantly higher expression of
CARD 15 than asymptomatic JD (greater than six fold). There was however, no
significant difference between the paucibacillary and the multibacillary forms
(p>0.05) (Figure 6.2L). Asymptomatic JD has comparable expression levels of
CARD15 with control ileum (Figure 6.3L). Multibacillary JD however, has a
significantly higher expression ofCARD 15 than both control and asymptomatic JD.
CD 14 expression in ovine JD
CD 14 expression levels between the paucibacillary form of JD and the asymptomatic
were comparable (Figure 6.2M). Multibacillary JD had a higher expression of CD14
than both asymptomatic and paucibacillary forms (greater than two fold). The CD 14
expression was significantly different between the multibacillary and the
asymptomatic JD but not statistically different between the multibacillary and
paucibacillary forms of JD. Multibacillary and asymptomatic JD had a significantly
higher expression of CD14 than control ileum (Figure 6.3M). Asymptomatic JD and
multibacillary JD have a six fold and 12 fold greater mean expression of CD14 than
the control ileum and these differences are statistically significant between all
groups.
Dectin-1 and Dectin-2 expression m ovine JD
Asymptomatic JD had a significantly lower mean expression of dectin-1 than both
pauci- and multibacillary forms (ca 6 fold and 1.5 fold less respectively) (Figure
6.2N). There were also statistically significant differences in the mean expression
levels of dectin-1 between the pauci- and multibacillary forms of JD. Similar to
dectin-1. the asymptomatic form of JD had significantly lower dectin-2 transcripts
than both pauci- and multibacillary forms of JD (ca 87 fold and 46 fold less
respectively) (Figure 6.20). There was however, no significant difference in the
expression levels of dectin-2 between the multibacillary and paucibacillary forms.
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Control ileum has comparable expression levels of dectin-1 with asymptomatic JD
(Figure 6.3N). Multibacillary JD however, has a five fold higher mean expression of
dectin-1 than control ileum and the difference is statistically different. Control ileum
similarly, has comparable expression levels of dectin-2 with asymptomatic JD
(Figure 6.30). Multibacillary JD however, has a greater than forty six fold higher
mean expression of dectin-2 than control ileum and the difference is statistically
different.
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6.4 Lipoarabinomanann (LaM) stimulated skin
6.4.1 Preliminary LaM dosage test experiment
LaM, a major antigenic component of the Map cell wall, was to be used as a ligand
to stimulate skin in order to evaluate cutaneous immune responses to this important
mycobacterial component. In order to determine the dose of LaM to use, three
concentrations of LaM were evaluated. Intradermal injections of lOOpl of I 00 tig/ml,
200pg/ml and 400|tg/ml LaM in sPBS were tested in a single test animal. As a
control, lOOpl of sPBS were similarly injected. Skin biopsies were collected as
outlined in the materials and methods (Section 2.2.6) and gene expression evaluated
for selected genes using qPCR.
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Figure 6.4 Graphical representation of selected PRRs expression in skin stimulated with
different doses of LaM
RT-qPCR analysis of TLR1(A). TLR2(B). TLR3(C) and TLR4(D) mRNA expression levels in skin
biopsy samples treated by intradermal injections of lOOgl of lOOgg/ml. ?00|ig/ml and 400gg/ml LaM
in sPBS. Data are expressed as mean values of duplicate samples normalized Logic (copy number per
qPCR reaction) of each PRR. lOOpl of sPBS was injected over the same time periods as a control. The
colour-coded circles on the graphs represent the mean for each treatment shown in the legend. Normal
represents the mean mRNA expression from untreated skin.
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Interval Plot of Log TLR6 vs Hours, ug/ml
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Interval Plot of Log TLR8 vs Hours, ug/ ml
1 Hour 2 Hours 4 Hours 8 Hours Normal
Interval Plot of Log MyD88 vs Hours, ug/ml
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Figure 6.4 Graphical representation of selected PRRs expression in skin stimulated with
different doses of LaM
RT-qPCR analysis ofTLR6(E). TLR8(F). MyD88(G), CARD15(H). CD14(I) and dectin-l(J) mRNA
expression lex els in skin biopsy samples treated by intradermal injections of lOOpl of lOOpg/ml,
200pg/ml and 400pg/ml LaM in sPBS. Data are expressed as mean values of duplicate samples
normalized LogI0(copy number per qPCR reaction) of each PRR. lOOgl ofsPBS was injected over the
same time periods as a control. The colour-coded circles on the graphs represent the mean for each
treatment shown in the legend. Normal represents the mean ntRNA expression from untreated skin.
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Figure 6.5 Representative histopathological sections of skin from ligaiul stimulated biopsies
1 laematoxylin and eosin stained paraffin Sections of normal skin and representative samples of LaM
stimulated skin biopsies. Tissues fixed with zinc sulphate fixative. (A) showing normal epidermis and
(15) showing normal dermis with minimal cellular infiltrate. (C) showing sI'BS stimulated skin at 4
hours with a very mild cellular infiltrate in the dermis. (I)) showing LaM (200pg/ml) stimulated skin
at four hours with a marked inflammatory cellular infiltrate in the dermis.
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Figure 6.5 E and F
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G
Figure 6.5 Further representative histopathological sections of skin from ligand stimulated
biopsies
I hematoxylin and eosin stained paraffin sections of representative samples of LaM stimulated skin
biopsies. Tissues fixed with zinc sulphate fixative. (F) showing LaM (dOOpg/ml) stimulated skin at
four hours with a marked inflammatory cellular infiltrate in the dermis (100 x magnification). (F)
showing LaM (200pg/ml) stimulated skin at eight hours with a marked inflammatory cellular infiltrate
in the dermis (100 x magnification). ((J) and (II) showing LaM (400pg/ml) stimulated skin at eight
hours with a marked inflammatory cellular infiltrate in the dermis (100 x magnification and 200 \
magnification respectively).
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Intradermal injection with the three different doses of LaM in sPBS generally
resulted in similar response curves in the selected PRRs studied over an eight hour
period (Figure 6.4). In seven of the 10 genes selected for the dosage trial, the control
samples gave a lower expression of the PRRs but there was always a parallel
increase over time and a drop in PRR expression after four hours. Most of the PRRs
examined seemed to show a peak expression at 4 hours and then a drop in PRR
expression by eight hours. For all PRRs examined, other than TLR3, in the LaM-
stimulated skin the expression rose to greater than three fold compared to normal
unstimulated skin. For TLR3 there was no discernible pattern or trend in the
expression between the three different doses and the control and the levels of
expression were mostly lower than normal skin. MyD88 expression also rose in the
three LaM dosages to levels much higher than the sPBS treated control skin and
untreated skin. There was however a slight increase in expression in sPBS treated
control skin that was lower but paralleled that of the LaM treated group.
Histopathological examination demonstrated a clear difference in inflammatory
cellular infiltrate between the LaM treated skin biopsies and the control sPBS treated
skin (Figure 6.5). The LaM treated skin biopsies had very high cellular infiltrates
increasing over time while the sPBS control biopsies had only very mild cellular
infiltrates at all time points studied.
6.4.2 LaM stimulated skin experiment
Based on the findings from the preliminary dosage test (Section 6.4.1) where the
three dosages gave comparably higher expression of most PRRs it was decided to use
a lower concentration and volume to mimic a more likely natural low-dose infection
situation and to reduce the tissue damage resulting from high infusion volumes. A
dosage of 50pl of 50pg/ml LaM in sPBS per injection site was adopted, and four
sheep were utilised with five time points (lhr. 2hr, 4hr, 8hr, and 24hr). As a control,
50pl of sPBS were similarly injected at each time point. Skin biopsies were again
collected as outlined in the Chapter 2 (Section 2.2.6) and PRR gene expression
evaluated for using qPCR. Figure 6.6 shows transcripts expression of a selected
panel of PRRs from one animal.
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Figure 6.6 Graphical representation of PRR expression over 24 hours in skin stimulated with
50pl (50pg/ml) LaM intradermally
RT-qPCR analysis of T1.R1 (A). T1.R2 (B). T1.R3 (C). TLR4 (D). TLR5 (E) and TLR6 (F) mRNA
expression levels in skin biopsy samples treated bv intradermal injections of 50pl (50gg/ml) LaM in
sPBS. Data are expressed as mean values of duplicate samples normalized Log]0 (copy number per
qPCR reaction) of each PRR over time. 50gl of sPBS was injected over the same time periods as a
control. The black circles on the graphs represent the mean PRR expression in LaM treated skin at
each time point and the green circles representing the mean PRR expression in control sPBS treated
skin. Time point 0 represents the mean mRNA expression from untreated skin.
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Figure 6.6 Graphical representation of PRR expression over 24 hours in skin stimulated with
50pl (50pg/ml) LaM intradermally
RT-qPCR analysis ofTLR8 (G). MyD88 (H), dectin-1 (I) and dectin-2 (J) mRNA expression levels
in skin biopsy samples treated by intradermal injections of 50pl (50pg/ml) LaM in sPBS. Data are
expressed as mean values of duplicate samples normalized Log|0(copy number per qPCR reaction) of
each PRR over time. 50gl of sPBS was injected over the same time periods as a control. The black
circles on the graphs represent the mean PRR expression in LaM treated skin at each time point and
the green circles representing the mean PRR expression in control sPBS treated skin. Time point 0
represents the mean mRNA expression from untreated skin.
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These results generally showed an unexpected decrease in PRR expression after 50pl
(50pg/ml) injection of LaM. PRR expression levels in treated biopsies fell to levels
lower than untreated skin with most levels subsequently rising after the two or four
hour point. These results did not show marked differences with the sPBS which was
meant to be the control and in some cases the sPBS treated skin had higher PRR
expression than the LaM treated skin (Figure 6.6 C, D, E and F). There were
however differences in cellular infiltrates between the sPBS treated and LaM treated
skin samples (data not shown) similar to the ones observed in the dosage trial
experiment.
Due to results from the 50pl (50pg/ml) dose experiment being markedly different
from the initial dosage test experiment it was decided to discontinue further real time
PCR analysis of these samples and concentrate on other possibly more fruitful
experiments.
I concluded that the dose that was chosen, in an attempt to mimic a low dose
physiological infection model, was below the threshold to significantly activate
PRRs in a reproducible manner.
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6.5 Analysis of Mutations: TLR2 Exon2 and CARD15 Exon 11
Mutations in ligand binding sites of receptors can lead to defective ligand
recognition, while mutations in the intracellular region may lead to defective
signalling. Several SNPs (that predispose to mycobacterial diseases and intestinal
inflammatory disease) in humans and murine models have been described in the
literature. Using direct sequencing, I investigated TLR2 exon2 and CARD 15 exonl 1
for equivalent SNPs in ovine paratuberculosis ileum from the three clinical forms of
JD.
6.5.1 Mutation analysis of the partial sequence of TLR2 Exon2
Table 6.3 shows the location and distribution in the JD clinical types of the SNPs that
were identified from the partial sequencing of TLR2 from 40 cases of
paratuberculosis.
Change Conserved Frequency in ovine paratubereulosis type
Nucleotide Amino acid Asymptomatic Multibaeillary Paueibacillary
ai82c Asp —» Ala No 2/12 3/16 3/12
c1245g Silent N/A 5/12 4/16 3/12
ti:57g Silent N/a 3/12 1/16 2/12
t1516c Leu —► Phe No 4/12 5/16 4/12
Ti545C Silent N/A 3/12 2/16 3/12
t1563 Silent N/A 7/12 3/16 4/12
^ 1740p Silent N/A 6/12 3/16 4/12
Table 6.3 Summary of ovine TLR2 SNPs from ovine paratuberculosis ileum tissues
Table showing the distribution of the SNPs found from direct sequencing of the partial sequence of
ovine TLR2 e\on2. Nucleotide numbering based on submitted sequence of ovine TLR2 (Accession
AMI 17123). Abbreviation: N/A = not applicable.
Chapter Six - PRRs and ovine paratuberculosis 236
Sequencing data of the partial sequence of TLR2 exon2 demonstrated two amino
acid changing SNPs located at position 182 and 1516 ( see Figure 6.7) relative to the
submitted sequence of ovine TLR2 (Accession AMI 17123). Five other SNPs were
identified in the sequence, but they were silent mutations. Heterozygosity was also
observed in various DNA samples in the SNPs outlined in Table 6.3. Representative
chromatogram tracings of the amino acid changing SNPs are in Appendix X.
The distribution of all the SNPs identified in this study was however, almost equally
distributed between the three clinical forms and not skewed towards any one group.
Ovine TLR2 Exon2
5'-CTTAGAT (Asp) AACCCTCCTTT (Phe)
5'-CTTAGCT (Ala) AACCCTCCCTT (Leu)
SNP182
| , , , , || ,
SNP1516
0 500 1000 1500 1802
Figure 6.7 Ovine TLR2 amino acid changing SNPs
Position of the locus of the two amino acid changing SNPs identified within the sequenced region of
the sheep TLR2 Fxon2 (Genbank Accession AM117123) SNP182 Asp/Ala and SNP1516 Leu/Phe.
On the sequence fragments shown, the bold represents the nucleotide changes and the underlined
nucleotides represent the codon.
For further verification of the two amino acid changing SNPs of the TLR2 gene,
tetra-primer amplification refractory mutation system (tetra-primer ARMS) assays
were developed as outlined in Section 2.8.4.
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6.5.2 Tetra-primer Amplification Refractory Mutation System (tetra-ARMS)
The expected product sizes from the SNP 182 tetra-primer ARMS PCRs were; outer
common primers 194 bp. A allele 145bp. C allele 1 lObp. Homozygous alleles would
be identified by two bands (common primers band and the allele specific band), thus
the A allele would have a 194bp band and a 145bp band, whilst the C allele would
have a 194bp band and a 1 lObp band. A heterozygous sample would exhibit all three
bands (see Table 2.9 in Section 2.8.2).
100bp 123456 7 8 9 10 11 12 13 14 100bp
DNA ladder DNA ladder
Figure 6.8 2% Agarose gel showing SNPI82 tetra-ARMS PC'R products
Agarose gel electrophoresis of tetra-primer amplification refractory mutation system PCR amplicons
visualized with ethidium bromide staining on 2% TAE agarose gels w ith lOObp DNA ladder. Lanes 1-
5, 9-14 showing the A allele; lane 6 and 7 showing an A/C heterozygous and lane 8 showing a C
allele.
Tetra primer ARMS of SNP Alx:C showed the expected bands for the different
alleles but there was evidence of non-specific bands as well. Lane 8 of Figure 6.8
representing the C allele had evidence of a non specific band just below the 194bp
outer band but larger than the A allele band. A allele DNA samples demonstrated
two distinct bands of the expected size for most samples. Non-specific bands were
more evident where there was a stronger signal for the outer common product
indicating that it could be due to higher concentration of starting amount of DNA
template. Assay optimization would probably eliminate non-specific banding and
increase the usefulness of this assay.
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6.5.3 Mutation analysis of CARD15 Exon11
CARD 15 is a LRR containing PRR and mutations in the LRR region have been
described associated with the human inflammatory bowel condition, Crohn's disease
(Ogura et al., 2001). Crohn's disease has similar clinical immunopathological
presentation as ruminant Johne's disease and, although controversial, some
researchers consider Map as the causative agent of the disease (Greenstein, 2003;
Naser et al., 2004).
No CARD 15 exon 11 SNPs were identified in the forty samples of genomic DNA
derived from clinical JD cases that were examined. However, an interesting
observation was the presence of a 5 base insert in the intron portion of the ovine
sequence (Accession AMI 17124) consistently seen when compared to the closely
related bovine genomic DNA sequence (Accession AY518747) (Figure 6.9). The
importance of this difference in bovine and ovine CARD 15 between these two


















TTCATTGGGAATCTCAGACAGGAAAGGG C TGCTGAAAGGGCAGGTGGGCTTCAGGAGTCCAGC CC
* 100 * 120 * 140 * 160
CAAAG CTC TTTAATTGAATAGACTAGCC AAAA CAAGCATCCTCAAAGTTC CCATTCT TCTTCCTCTCTAGGCTG
180 * 200 * 220 * 240




TCTAACAACCACATCA CTCCCT GGGGCAGAGGCCCTCCTG GGGCCCTTGAAAAGAATGACACCATTCTGGAAGTCTG






GTAAGA CC GGCAGGCCTCTTTAACCTCTCTGAGCCTC GTTTTCCAAC TATAA TTGAGGTGAAGGGAGAGAGGAA








CTTTAGAATTTCTAAGATCC TTATG CTCAGACCT A TCCTGTTCTGCATGGGATGAATCTGGTTC
Figure 6.9 Alignment of ovine and bovine CARD15 Exon 11 genomic DNA nucleotide sequences.
ClustalW alignment and Gendoc® presentation of the ovine CARD 15 exonl 1 genomic DNA sequence
(Accession AMI 1712-1) compared to the bovine CARD15 exonl 1 genomic DNA sequence
(Accession AY518747) showing the location of the 5 base insert in the intron sequence part of the
sequences (Ovine CARD 15 exon lies between position 149-232).
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6.6 Discussion
Johne's disease is primarily an enteric infectious disease and the type of immune
responses mounted in the gut play a critical role in the determination of the outcome
of natural infection. The gastrointestinal tract also has a large commensal microbiota
and immune mechanisms in the gut thus have to comprise a steady balance between
immune reactivity and homeostasis. Little work has been done to dissect the exact
innate immune mechanisms involved in JD pathogenesis, but extrapolating from
work on other mycobacterial diseases such as tuberculosis and leprosy, supports the
premise that the innate immunity and an effective cell-mediated immune response is
critical for host defence against paratuberculosis . The ability of the innate immune
system to recognize pathogens is mediated by PRRs and engagement of these PRRs
activates host defence mechanisms that include the regulation of phagocytosis,
maturation of DCs and specific antimicrobial action. These signalling pathways are
thus able to generate effector responses that may include either Thl or Th2
responses. In the case of mycobacterial infections, Thl responses tend to be
protective and Th2 responses tend to be ineffective. The role played by PRRs in
chronic infections such as JD is poorly understood. I undertook this study to
elucidate the role played by selected PRRs in the determination of clinical outcome
to Map infection in sheep. This study has shown the role of various PRRs in the three
different clinical forms of JD.
Differences exist between the three clinical types in lymphocyte distribution (Little et
al., 1996) and this has a bearing on the differential PRR expression since different
immune cells are known to exhibit different levels of PRRs (Dasari et al., 2005;
Taylor et al., 2002; Werling et al., 2006; Zarember and Godowski, 2002). Gamma
delta T (y5T) cells play role in improved immunity to ruminant mycobacterial
infections (Beard et al., 2000; Kennedy et al., 2002). Beard and colleagues (Beard et
al., 2000) showed that y5T cells increase in the ileum during early Map infection,
prior to the onset of gross pathology. The latency ofMap infection in calves has been
attributed to the high level of yST cells during this stage in their development (50-
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70% of peripheral blood lymphocytes). Kennedy and co-workers (Kennedy et al.,
2002) demonstrated a role of yST cells early in bovine M. tuberculosis infection,
where animals experimentally depleted of y8T cells showed lower IFNy production
possibly leading to poor Thl development. Most studies show an increase in the
proportion and absolute numbers of macrophages and CD4+ T cells and
CD4+CD25+ Treg cells infiltrating the Mcip infected ileum (Bassey and Collins,
1997; Weiss et al., 2006) although in contrast Koets and colleagues (Koets et al.,
2002) reported a decrease in CD4+ cells and an increase in yST cells. Multibacillary
JD also has a higher content of macrophages and eosinophils in the garanulomatous
lesions, while the paucibacillary form has a high CD4 T cell infiltrate in the ileal
lesions.
Granuloma formation is an important protective mechanism in mycobacterial
infections that limits the spread and dissemination of bacteria. Contrary to earlier
belief that the granuloma walls form a permanent barrier to the animals body and
thus immune system, it has been revealed that a granuloma is in a constant state of
communication with the immune system and may be modified (Chiu et al., 2004).
The granulomata are likely sites where innate and adaptive immune responses merge,
regulated by APCs such as dendritic cells. Changes in PRR expression in the /
granuloma lesion may thus reflect the mild immune sampling being permitted by the
granuloma immune exchange mechanisms. As PRRs are critical in the initiation of
the early immune mechanisms by directly sensing PAMPs, their expression in
advanced mycobacterial granuloma may be lower than non-granulomatous disease.
No differences in TLR1 expression were demonstrated by this study in the clinical
forms of JD and the control ileum.
This study showed that TLR2 mRNA expression was significantly higher in
multibacillary JD than in asymptomatic sheep. The higher TLR2 signalling in the
multibacillary form could have two possible broad explanations; it may exclusively
reflect the increased stimulation of TLR2 in response to the high Map infiltrate in
multibacillary JD ileum. However, if the TLR2 expression is proportionally higher
compared to the paucibacillary and asymptomatic JD, one would logically expect it
to be proportionally protective and therefore to be no differences in disease outcome
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and pathology between the three clinical forms. The higher TLR2 expression in the
multibacillary form of JD would be expected to lead to an elevated Thl type
response that would be able to eliminate the Map or limit the dissemination of
infection. This however, is not the case as evidenced by the severe Th-2 mediated
pathology and Map infiltration in the multibacillary JD. The other possible
explanation is that the TLR2 signalling is responsible for the differences in pathology
by some other mechanism other than that of a proportional antigen recognition
leading to a proportional protective immune response. In this case, the elevated
TLR2 expression would be directly responsible for the increased pathology seen in
multibacillary JD, that is known to result from a predominantly Th2 type immune
"It RJ ? - J-
response. The high TLR2 in the multibacillary form of disease may also reflect the ' J***
high macrophage content in this form of disease and macrophages have high TLR2
expression (Flo et al, 2001; Muzio et al., 2000; Zarember and Godowski, 2002).
The role of TLR2 activation and signalling in driving either pro-inflammatory or
anti-inflammatory responses or Thl/Th2 polarization is controversial. Disparate
reports have been published that indicate that TLR2 signalling can initiate both Thl
and Th2 cell differentiation (Dillon et al., 2004; Re and Strominger, 2004; Redecke
et al., 2004; Sieling et al., 2003; Thoma-Uszynski et al., 2000). It has been shown
that different TLRs lead to pathogen-specific pro-inflammatory Thl type immune
responses, but there has been growing evidence that TLR2 signalling may lead to an
anti-inflammatory and a predominantly Th2 type response (Dillon et al., 2004; Re
and Strominger, 2004). The significantly higher expression of TLR2 in the
multibacillary JD would be explained by this although it goes against the logical
explanation that TLR2 is needed for the recognition of mycobacteria by the immune
system. TLR2 driven Th2 polarized immune response to Map in the multibacillary
JD would best explain the findings of this study. This could be further exemplified
by the fact the TLR2 signalling has been shown to be used by some pathogens to
evade and/or inhibit immune responses by promoting ineffective Th2 responses and
directly suppressing Thl responses (Netea et al., 2004; Re and Strominger, 2001; Re
and Strominger, 2004). Th2 responses mediated by TLR2 may also arise from Heat
shock protein (Hsp) initiated signalling in Tregs (Zanin-Zhorov et al., 2006) and Hsp
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has been shown to be released during tissue damage which may be the case with
multibacillary JD. More specifically, via TLR2, Map was shown to inhibit IFN-y
signalling via STAT 1 beta expression (Alvarez et al., 2003) as has the suppression
of IL-12 expression via c-Fos by Pam3Cys, a synthetic TLR2 ligand (Agrawal et al.,
2003) and schistosome egg antigen (Dillon et a/., 2004). These actions inevitably
lead to Th2 type immune responses. The paradoxical role of whereby TLR2
signalling is able to drive both Thl and Th2 immune responses has been shown by
other workers (Mancuso et al., 2004).
Recently, TLR2 signalling has been shown to have an effect on Treg function (Liu et
al., 2006; Sutmuller et al., 2006) and this may have a bearing on immune
effectiveness of such a pathogen driven response and on the eventual disease
outcome. During early infection, TLR2 signalling was shown to initially expand the
Treg population whilst abrogating their suppressive effect. After the clearance of the
infection, the suppressive effect of the expanded Treg population returns to prevent
excessive inflammation and achieve homeostasis. This is postulated to be a
protective mechanism, but in relation to Map infection, any disturbance in this finely
balanced homeostatic mechanism would probably lead to the increased proliferation
of Map present in the macrophages when the expanded Treg population starts to
express suppressive effects again.
Map survival may be further enhanced by the immune evasion in a TLR2 dependent
mechanism. TLR2 dependent inhibition of macrophage expression of MF1C II has
been described (Noss et al., 2001) during antigen processing. This inhibition occurs
late during infection and may promote the intracellular survival of mycobacteria in
macrophages leading to chronic disease. In the case of the multibacillary JD, this
may then inhibit effective CD4 T cell driven immune responses and could promote
the proliferation and dissemination ofMap in this form of disease.
Other than being involved in mycobacterial recognition, TLR2 expression in the
mutilbacillary form of ovine JD could be involved in the promotion of antigen
capture by cells of the intestinal epithelium. This role has been shown by Chabot and
colleagues (Chabot et al., 2006) who showed that in mice there is an increased
transepithelial transportation of microspheres by M-cells in a TLR2 dependent
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mechanism. A higher antigen capture and transcytosis would consequently be
responsible for the higher Map infiltrate seen in the lamina propria of multibacillary
JD with the higher TLR2 expression.
The findings in this study are however in sharp contrast with the findings by other
workers working with DCs and leprosy in humans. Thoma-Uszynski and co-workers
(Thoma-Uszynski et al., 2000) found that TLR2 activation on DCs led to increased
1L-12 and not IL-10 which would preferentially promote a Thl type response. In
addition, Krutzik and colleagues (Krutzik et al., 2003) found a greater expression of
TLR2 in paucibacillary leprosy by immune staining, while my data show greater
mRNA expression in multibacillary ovine JD ileum. The same authors also found
that the TLR2 signals co-localized with CD 14 expression indicating the presence of
monocyte/macrophage lineage cells where there was high TLR2 expression. The
current study showed a significantly higher CD 14 mRNA expression in
multibacillary JD. This is most probably due to the infiltration of macrophages into
the lamina propria of the infected ileum in response to Map infection (see Figure
6.1). It is known that Map infected ileum has a higher proportion of CD14+
macrophages than uninfected ileum in cattle (Weiss et al., 2006). The differences
could be that the ileum normally has very low CD 14 and resident macrophages are
known to have low expression of PRRs such as CD 14 and TLR4 (Abreu et al., 2001;
Smith et al., 2001; Smythies et al., 2005) and this was demonstrated in this study by
the significantly lower CD14 expression in the control ileum (Table 6.2M).
The other possible difference with the TLR2 expression in leprosy (Krutzik et al.,
2003) and JD could be due to the differences in immune mechanisms of the skin
and that of the gastrointestinal tract mucosae. The skin has high regenerative and
repair capabilities and thus is be able to tolerate acute inflammation without very
severe consequences whilst in the ileum severe inflammation would lead to a breach
in the integrity of the mucosal epithelium and would usually have very severe
hyperinflammatory consequences. This heightened immune reactivity is partly due to
the higher number of microrganisms in the gut and poor regenerative capacity with
lesions that would heal very poorly and tend to form erosive lesions. Thus, whereas
skin would tend to promote and tolerate a DTH inflammation, the GIT would tend to
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promote Th2 type immune responses with dampened inflammation. Krutzik and co¬
workers (2003) also showed a concurrent higher expression of TLR1 in leprosy
possibly suggesting a heterodimerization. Ovine JD TLR1 expression in this study
was not significantly different in the different ileum tissues.
On the other end of the spectrum looking at the function and necessity of TLR2 in
mycobacterial pathology, some workers have demonstrated that TLR2 signalling
may not be necessary for protective immune responses to mycobacterium. Jang and
colleagues (Jang et al., 2004) showed that M. tuberculosis in murine DCs tends to
produces IL-6 and IL-10 via TLR2 and 4 and also that IL-12 can be produced by
these cells independently of TLR2. This would tend to strengthen the case that the
TLR2 signalling would have immuno-modulatory effects via Th2 polarization, while
Thl responses may occur independently of TLR2 engagement. Working with TLR2,
TLR4 and TLR6 knock out mice, Nicolle and associates (Nicolle et al., 2004)
concluded that these PRRs are not required for long term control of Mycobacterium
bovis BCG infection. Drennan and colleagues (Drennan et al., 2004) were able to
show that TLR2 deficient mice were able to generate an antigen-specific cell
mediated Thl type immune response to aerosol M. tuberculosis, although it was not
protective and the mice succumbed to infection. It thus brings into question when
the need for the TLR2 begins and ceases, since it is known to be required for the
recognition of Mycobacterium, and Mycobacterium granulomata are understood to
be active interfaces with the immune system; constantly providing stimulus to the
host's immune system.
Although it has been traditionally believed that TLR signalling preferentially
initiated Thl immune responses, it is becoming increasingly evident that this may not
always be the case. TLR signalling is known to drive adaptive immune responses and
it was initially proposed to exclusively favour Thl development (Schnare et al.,
2001) and later shown to also drive Th2 responses, but now known to be capable of
activating both. Th2 development was thought to occur as a default pathway in the
absence of TLR engagement and signalling. Netea and co-authors (Netea et al.,
2005) proposed that Th2 type responses that result from the activation of TLR2 are
important for the resolution of inflammation and return to homeostasis. Other than
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the intensity of expression of TLR2 in advanced disease, it has been shown that the
regulation, time of onset and the duration of PRR expression all seem to have a
critical effect on the progression of leprosy in humans.
A compromise would be the view that is growing in acceptance, that prolonged low-
dose stimulation of TLRs promotes Th2 whilst acute (and/or initial) stimulation
would evoke a protective Thl type response as advocated for by numerous workers
(Eisenbarth et al., 2002; Mancuso et al., 2004). Colonic IEC have been shown to
have very low expression of TLR2 (Melmed et al., 2003) and then increased
expression in disease. This study with the different clinical forms of JD did not show
marked difference between the 'normal' control animals and the asymptomatic
animals.
The disparate role of TLR2 in Map pathogenesis may be reconciled by concluding
that acute and early TLR2 signalling leads to Thl type responses and late, chronic
and/or low key TLR2 signalling leads to Th2 type response; this begs the question as
to what exact intracellular mechanism tips the balance? It may be possible that when
the Map infection reaches a particular threshold it would tend to promote Th2
responses by default. It may be a dysfunction in the immune modulation effect and
timing in relation to Map bacterial load at the time that the immune modulatory
mechanisms are taking effect. The other possibility is that the causative agent in the
three clinical forms is different and that each clinical form has a different genotype
with different virulence, and consequently leading to different pathology. Manca and
associates (Manca et al., 2001), demonstrated that different clinical isolates of M.
tuberculosis have varying virulence, ascribed to strain-specific abilities to drive Thl
immune responses. Janagama and colleagues (Janagama et al., 2006), demonstrated
Map genotype-dependent differences in virulence in an in vitro bovine macrophage
model. They showed that certain Map strains had higher intracellular survival and in
macrophages and a significantly up-regulated IL-10 expression.
No differences in TLR3 expression were observed between the three clinical forms
of JD, all of which show significantly higher levels than control sheep. A possible
explanation of this finding could be that TLR3 expression is linked to the
intracellular release of nucleic acids due to tissue degradation during Map infection.
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Endogenous, mRNA freed following cell death or degradation has been shown to be
a ligand for TLR3, TLR7 and TLR8 (Kariko et al., 2004). This would explain the
higher TLR3 and TLR7 expression in asymptomatic JD and multibacillary JD
respectively, compared to normal control ileum. Endogenous ligands such as RNA
are normally sequestered from the immune system and may become accessible due
to apoptosis or cell death.
The significant difference in TLR8 expression between the multibacillary ileum and
both paucibacillary and asymptomatic ileum came as a surprise finding since TLR8
is strongly reported to have guanosine and uridine-rich viral ssRNA as the natural
ligand. Other synthetic ligands include imidazoquinolone, an antiviral/anti-tumour
compound. 1 speculate several possible mechanisms to explain the higher TLR8
expression in multibacillary JD than the other forms. It could be a regulatory
mechanism to counteract the high proinflammatory cytokines that have been shown
to be released during Map infection in ruminants. Zarember and Godowski (2002)
showed that PMA differentiated THP-1 cells increased expression of TLR8 by forty
fold in response to IFNy treatment. The high TLR8 expression in the multibacillary
ileum may be in response to the high IFNy that is present during Map pathogenesis.
However, paucibacillary sheep are known to express more IFNy than the
multibacillary form (Burrells et al., 1999) but the expression of TLR8 was higher in
multibacillary ileum than pauci and the levels between pauci and asymptomatic were
comparable. TLR8 synergy with other TLRs has also been shown to promote a Thl
type response in DCs (Napolitani et al., 2005) and the high TLR8 expression in
multibacillary JD may be an attempt to revert the immune phenotype into a
protective Thl from the ineffective Th2 type that predominates in multibacillary JD.
However, a more plausible explanation may be that the TLR ligand may be the self-
nucleotides that result from tissue and cell degradation acting as auto antigens.
Numerous workers have shown that self RNA may activate TLR8 (Vollmer et al.,
2005).
Further, TLR7 and TLR8 have common ligands such as ssRNA from viruses and
imidazoquinolones (Heil et al., 2004) and would therefore be expected to have
comparable expression patterns. However, the TLR7 expression was not significantly
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different in the three clinical forms of paratuberculosis. Multibacillary JD however
had a significantly higher expression of TLR7 than control ileum. This may implicate
self nucleic acids as the ligand in the clinical forms that leads to higher expression in
response to tissue damage. Recently, functional differences between TLR7 and
TLR8 have been demonstrated (Gorden et al., 2005), thus the expression patterns of
this two TLRs may differ. Recently, TLR8 signalling has been shown to reverse
regulatory CD4+ T cells (Tregs) function (Peng et al., 2005) and this could have
significant implications to disease outcome. Regulatory CD4+ T cells are known to
modulate the inflammatory response (Wraith et al., 2004) of a host towards
commensals and opportunistic infections (Caramalho et al., 2003). Tregs have the
ability to suppress a host's immune function and also suppress autoimmunity. Thus,
when CD4+ Tregs are suppressed, for example by TLR8 signalling, this may lead to
autoimmune disease (Hori et al., 2003). An increase in infiltration of ileal tissues
with CD4+ CD25+ T regulatory cells has also been described in subclinical Map
infection (Weiss et al., 2006). This increased Treg infiltration may be a protective
mechanism of dampening down the initial inflammatory response to Map infection
as Tregs have been shown by Taams and co-workers (Taams et al., 2005) to suppress
the proinflammatory properties of monocytes/macrophages.
Thus I propose that during the pathology of multibacillary JD, there is an increase in
macrophages that lead to excessive inflammation to eliminate or contain Map
infection leading to sustained inflammation over prolonged time periods. Tregs also
increase at the inflammatory site to modulate the immune response in an attempt to
return to physiological homeostasis. Prolonged Treg activity could lead to an
immunosuppressive state, thus the increased TLR8 expression may be due to a
negative feedback mechanism towards the Tregs to counteract the immune
regulatory effect of Tregs that was initially triggered by tissue destruction, cell death
and an increased number of macrophages infiltrating the ileum (as evidenced by the
ileal histopathology (Figure 6.1C and D) and higher CD 14 expression in the
multibacillary from (Figure 6.2M and Figure 6.3M)) and prolonged inflammation.
This however does not elucidate the specific ligand during ileal Map pathogenesis
that leads to the increased TLR8 expression in multibacillary JD. Tissue nucleic
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acids following tissue destruction are a strong candidate leading to the increased
TLR8 signalling leading to Treg suppression that may explain the hyper-
inflammatory pathology in multibacillary JD despite an increase in Treg infiltration
that has been described. Immune suppression of the intestinal mucosa during Map
infection that could be ascribed to Tregs has been reported recently in cattle with
subclinical infection (Weiss et al, 2006).
The three clinical forms of JD had statistically comparable expression of TLR9 and
TLR10. Clinical forms of JD had comparable levels of TLR10 to control ileum but
they had a significantly higher TLR9 expression. Bacterial DNA is the natural ligand
for TLR9, and the higher expression of TLR9 in clinical JD may reflect the fact that
control ileum has intact ileal epithelium and thus no active subepithelial immune
response is being mounted against any bacteria whilst the clinical forms of JD have
breaches in the integrity of the epitheliae and are actively responding to various
bacterial challenges.
MyD88 is a critical adaptor molecule for the downstream signalling of all TLRs
except TLR3. Its engagement leads to intracellular signalling cascades that culminate
in immune responses. The minor differences in MyD88 levels of expression
observed between the three different clinical forms of JD were rather unexpected.
With expected higher inflammatory status and the higher expression of TLR2, TLR4
and TLR8 in the multibacillary JD, a significantly higher expression of MyD88
would have been expected. Though the expression was higher than the asymptomatic
JD, the difference was not statistically different. There was a significant difference in
MyD88 expression between the asymptomatic and paucibacillary JD which may
reflect a more active inflammatory state during this clinical form. The multibacillary
JD had slightly lower expression of other TLRs (TLR1, TLR5, TLR6, TLR7, TLR9,
and TLR10) than both asymptomatic and paucibacillary and this may explain the
lack of large differences in the MyD88 expression between the clinical types. This
would be assuming that the overall tissues MyD88 expression is a cumulative total of
each TLRs proportional contribution. This study's finding would also concurs with
findings by Shi and co-workers (Shi et al., 2003) who found that in M. tuberculosis
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infection, a host marshals its immune responses in a largely MyD88-independent
manner.
CARD 15 has been reported to be either a specific intracellular PRR for muramyl
dipeptide (MDP), a break down product of PGN, (Girardin et al., 2003) or a negative
regulator of TLR2 signalling (Watanabe et al., 2004). This study demonstrated a
significantly higher expression of CARD15 in the pauci- and multibacillary JD
compared to the asymptomatic JD and control ileum with comparable expression
between the asymptomatic JD and the control ileum. The higher CARD 15 expression
in the paucibacillary and multibacillary forms could be a reflection of the innate
immune recognition of the intracellular presence ofMap in the macrophage infiltrate
of these two forms of JD. However, multibacillary JD has a higher macrophage
infiltrate than the paucibacillary JD and it would then be expected that it would have
a significantly higher CARD 15 expression. In spite of this difference in macrophage
infiltrate, the expression levels of CARD15 were not statistically significantly
different between these two clinical forms of JD. Berrebi and associates (Berrebi et
al., 2003) showed that other than lamina propria macrophages, during inflammation,
colonic epithelial cells produce copious amounts of CARD15. They also showed that
uninflammed colonic epithelial cells express very little or no CARD15. Thus the
similar expression of CARD 15 between the pauci- and multibacillary sheep could be
more likely attributed to epithelial cell expression in response to ileal inflammation
and this would also explain the lower CARD 15 in the asymptomatic JD.
Ferwerda and co-workers (Ferwerda et al., 2005) demonstrated the synergistic role of
TLR2 and CARD15 in the immunity to M. tuberculosis. They concluded that TLR2
and CARD 15 are independent and non-redundant PRRs for M. tuberculosis and that
both are necessary for the effective pro-inflammatory responses. However, in this
study, despite there being a comparable CARD 15 expression, there was a
significantly higher TLR2 expression in multibacillary JD than paucibacillary JD. In
contrast to the findings of Ferwerda and co-workers, Tada and colleagues found that
CARD15 was synergistic with TLR3, 4 & 9 and not with TLR2 (Tada et al., 2005)
in producing pro-inflammatory immune responses in cultured DCs.
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CARD 15 expression has been shown to increase in response to the cytokines TNF-a
and IFN-y (Gutierrez et al., 2002; Iwanaga et al., 2003; Rosenstiel et al., 2003), and
the high expression of CARD 15 in the pauci- and multibacillary sheep could be in
response to the release these cytokines during Map infection. This could be in a
regulatory mechanism to prevent excessive hyperactivity effects of these potent
proinflammatory cytokines on tissues. CARD 15 expression has also been shown to
increase production of defensins by Paneth cells (Voss et al., 2006), and this may be
an attempt to hasten mucosal repair by reducing the access of lumen microbes to the
underlying lamina propria. If indeed the high CARD 15 expression is due to the
cytokines TNFa and IFNy, and is regulatory, it could be a similar mechanism to the
one proposed for the high TLR8 expression in the multibacillary ileum that may also
be in response to these cytokines. However excessive CARD 15 may also exacerbate
the inflammation, in a positive feedback loop, by further increasing proinflammatory
gene expression viaNFxB.
Taking into account these findings of CARD 15 over-expression in the multibacillary
form and the postulated role of TLR2 signalling in Th type polarization, I propose
the following explanation. Early CARD 15 expression would tend to augment Thl
polarization in the absence of concurrent TLR2 expression. The concurrent over-
expression of TLR2 would inhibit Thl polarization due to IL-10 production and
promote a Th2 type response as a default. This would explain the differences shown
in this study in both TLR2 and CARD 15 expression in the paucibacillary and
multibacillary forms of JD. This would agree with the conclusion reached by Tada
and co-workers on CARD 15 synergism with various TLRs (Tada et al., 2005). Then
again, there may also be a temporal relationship in this synergism as TLR2 signalling
at late time points itself has been shown to lead to a shift towards Th2 immune
responses (Zanin-Zhorov et al., 2006) with, for example, endogenously derived
ligands. Late CARD 15 expression, which may be due to prolonged proinflammatory
cytokine release, would similarly lead to Th2 type responses to dampen protracted
inflammatory immune responses.
In human blood, the highest expression of CARD 15 is seen in CD14r monocytes
CD15" granulocytes and CD40VCD86 DC populations (Gutierrez et al., 2002). It
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would also imply that these CD 14+ CARD 15+ expressing cells are most likely
newly recruited haematogenous monocytes rather than resident macrophages, since
resident intestinal macrophages are known to have very low CD 14 expression.
Extrapolating from this could explain the higher level of CARD 15 and the
concurrent high level of CD 14 seen in multibacillary JD where there is a high
infiltration of macrophages compared with the paucibacillary and asymptomatic
forms.
The findings of Berrebi and co-workers (Berrebi et al., 2003) of higher CARD15
expression in Crohn's disease mononuclear cells of the colon than in uninflamed
colon and the similar finding in this study would further increase the similarities of
the immunopathology of Crohn's and JD. It however, does not give any further
insight into the exact molecular mechanisms involved in the determination of disease
outcome.
This study showed a significantly higher CD 14 expression in multibacillary JD
compared to asymptomatic JD. Asymptomatic ileum also had a significantly higher
expression of CD 14 compared to control ileum. These differences are most likely
due to CD 14 expression by newly recruited extra-mural myeloid derived cells of the
monocyte/macrophage lineage since normal uninflamed intestinal mucosal
macrophages have been shown to have very low or no CD 14 expression (Smith et
al., 2001; Smythies et ah, 2005). The control ileum in this study showed very low
CD 14 expression as compared to the asymptomatic JD ileum, and this may show that
the presence of Map in the asymptomatic cases may have already triggered the
recruitment of macrophages into the ileum in response to the pathogen.
Asymptomatic JD ileum has a low Map burden (as evidenced by the positive IS900
PCRs) but is ZN negative and has no visible pathology. The presence ofMap would
activate macrophages and induce haematogenous monocyte recruitment into the
ileum. Control ileum was IS900 negative, implying the absence of Map, and this
could explain why asymptomatic JD has a markedly higher expression ofCD 14 than
the controls. However, other than macrophages/monocytes, CD 14 is also highly
expressed on granulocytes (Ziegler-Heitbrock and Ulevitch, 1993). Thus, the
increased CD 14 levels could be due to monocytes that have recently migrated from
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blood into infected tissues due to their chemotactic recruitment after resident
APC/epithelial activation and not due to an exclusive increase in the expression of
CD 14 by resident cells. In a study of inflammatory response mechanisms in Crohn's
disease, Berrebi and co-workers (Berrebi et al., 2003) also demonstrated that most of
the monocyte/macrophages were located in the perivascular area and this would tend
to imply that these cells are being immediately actively recruited.
In terms of pathology in multibacillary JD, the higher level of CD 14 could lead to a
hyper-responsiveness to LPS in the GIT mucosae (Cario et al., 2000), which would
lead to the characteristic type of lesions seen in this type of JD. Underhill and co¬
workers (Underhill et al., 1999) showed that the cooperation between TLR2 and
CD 14 led to a marginal increased in Mycobacterium induced NFkB activation.
CD 14 is reported to recognize LPS in conjunction with MD-2 and TLR4. However,
the TLR4 expression levels between the three clinical forms were not significantly
different although it was slightly higher in the multibacillary type JD. It would have
been of value to look at MD-2 mRNA expression as well in order to determine
whether the CD 14 expression is purely due to the high macrophage infiltration.
Dectin-1 and dectin-2 are C-type lectins recently identified as PRRs that have been
increasingly studied in the area of innate immune recognition of yeasts and antigen
uptake. Their precise physiological functions remain to be fully elucidated.
Multibacillary and paucibacillary JD had significantly higher expression of both
dectin-1 and dectin-2 than did asymptomatic and control ileum. Dectin-1 and dectin-
2 expression was comparable between asymptomatic JD and control ileum.
The high dectin-2 expression in the multibacillary form may simply reflect the
arrival of activated cells of the macrophage/monocyte lineage as proposed by Taylor
and colleagues (Taylor et al., 2005). In an adoptive transfer experiment in mice,
Taylor and colleagues (2005) showed that dectin-2 expression at inflammatory sites
is due to novel recruited macrophage dectin-2 expression rather than resident
macrophages. It would concur with previous literature on other PRRs expressions
and cells of the GIT. These publications show that normal intestinal mucosal tissue
has very few activated macrophages, with low expression of PRRs, and that in
Chapter Six - PRRs and ovine paratuberculosis 253
Characlcri/at un of (>v ine Pattern Recognition Receptoi expression
diseased and inflammatory states of the intestine the macrophages are mostly novel
haematogenously derived (Berrebi et al., 2003; Smith et al., 2001; Smythies et al.,
2005). This may be corroborated by the findings of Heinsbroek and colleagues
(Heinsbroek et al., 2006), who concluded that the alpha isoform of murine dectin-1 is
increased in monocytes during the maturation process and reduces over time as
inflammation subsides. Gavino and co-workers (Gavino et al., 2005) showed that
Con A activated CD4+ T cells had an induced expression of dectin-2. Part of the
dectin-2 seen in the clinical forms of JD may be due to the high CD4+ cellular
infiltrate that has been documented. Dectin-1 was initially shown to be exclusively
expressed by DCs later shown to be only lowly expressed in macrophages.
However, since the infiltrates of the multibacillary JD ileum were predominantly
macrophages and not DCs, the high level of dectin-1 mRNA would further
emphasize the fact that dectin-1 is also expressed in cells other than DCs.
Dillion and co-workers (Dillon et al., 2006), also found that zymosan induces
tolerance via Tregs by increasing TLR2 and dectin-1 expression in macrophages. It
may therefore be possible that in ovine multibacillary JD, a degree of tolerance to the
Map was due to the concurrent increased TLR2 and dectin-1 expression observed in
this study. Yadav and Schorey (Yadav and Schorey, 2006) showed a specific
cooperation of dectin-1 and TLR2 in the activation of macrophages by
Mycobacterium spp leading to induction of TNFa production. The specific ligand for
dectin-1 on mycobacteria is unknown since mycobacteria do not have P-glucans.
However, dectin-1 has also been shown to bind on an undefined molecule on T cells
(Ariizumi et al., 2000) and thus it does not preclude the possibility that dectin-1 may
bind to other molecules other than P-glucans. Similarly, dectin-2 has been proposed
to have a yet unkown ligand on CD4+ CD25+ Tregs.
A remote possibility is that the increased dectin expression observed in the clinical
forms of JD could be as a result of the exposure of the immune system to commensal
and pathogenic yeasts in the gut lumen as a result of the breach in epithelial integrity.
These yeasts would lead to immune activation via increased TLR2 and dectin-1
expression. Gantner and colleagues (Gantner et al., 2003) have shown that dectin-1
and TLR2 cooperate to respond optimally to zymosan by producing TNFa via NFkB.
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However, heat killed yeasts have been shown to activate DCs towards and Th2
phenotype producing 1L-10 (Edwards et al, 2002).
From the findings of PRR expression described in this chapter, I propose the
following events for the three different clinical forms of JD with the caveat that PRR
expression in chronic and late-stage GIT disease may not represent a classical clear-
cut "text book' role of single individual PRRs, but a summation of their activities.
The complexity of the PRR profile in the ileum may also reflect the complex
microbiota that can potentially activate GIT innate immune mechanisms in a
homeostatic or pathogenic manner.
These data would infer that Map pathology is a result of both a change from the
protective Thl to Th2 but is also due to an increase in the local immune reaction
possibly due to the ileum epithelial barrier being breached by the pathology and
subsequently bringing the GIT microflora in contact with the immune system. This
would then result in a hyperinflammatory state that is typified by the lesion in
clinical JD cases. It may however bring out the 'chicken and egg' question as to the
order and importance of these two proposed mechanisms in relation to the role of
PRRs. Thus the PRR transcript expression seen may be responsible for the protective
innate sensing of the Map and also to the furthering of intestinal pathology.
The dectin-1 and dectin-2 expression possibly represent de novo haematogenous
recruitment of monocytes into the lamina propria and their maturation into
macrophages during the process of heightened inflammation. This is partially
corroborated by the increased CD 14 expression in the multibacillary form.
TLR2 expression is initially increased in response to recognizing Mycobacterium and
this drives a predominantly Thl response. However, over time this continued TLR2
ligation, due to continued Map presence and proliferation, changes and starts driving
a Th2 response resulting in multibacillary JD. Thus, multibacillary JD may not be as
a result of a deficiency in Map recognition by TLR2 (as evidenced by the high TLR2
corresponding to the high Map in the macrophage infiltrate of multibacillary JD) but
due to a yet-unknown switch in the downstream signalling following the TLR2
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ligation that leads to the now well-documented switch from a protective Thl type
response to an ineffective Th2 type response.
A concluding remark is that, PRR expression in disease states is very complicated as
the immune responses (or needs) are a sum of all the PRRs that are marshalled
against a specific pathogen. Because of redundancy in innate immune recognition via
PRRs, Map would most probably engage multiple PRRs that would result in the
differential activation of multiple anti-microbial effector pathways and mechanisms.
This extremely complicated nature has been further exemplified by the fact that
combinations of different TLR ligands for example lead to unique cytokine milieu
and Th type responses and the intracellular signalling pathways would also involve
many positive and negative regulatory molecules with very subtle changes in
expression patterns leading to specific immune responses. Further work looking at
selected critical signalling pathway molecules and negative regulators of TLR
signalling (such as SIGIRR, A20) in relation to the different forms of ovine
paratuberculosis would be of value to further understand the hyper-inflammatory
state (or lack) of the ileum in JD pathogenesis.
Expression of the different isoforms of dectin-1 and dectin-2 is immune-cell specific
and tissue specific (Heinsbroek et al., 2006). This study has shown a differential
expression of the long form of dectin-1 and dectin-2, thus it would be of value for
future researchers to look at whether the short/p isoform of dectin-1 and dectin-2
have different mRNA expression patterns in the different forms of ovine
paratuberculosis. This would also be important in order to rule out compensatory
expression of the alternative isoform in one clinical form of JD to compensate for
differences seen in another clinical from.
It would be of benefit, in future to further breakdown the PRR expression in ovine
paratuberculosis to the cellular level in the ileum using techniques such as laser
capture dissection. This is because the RNA we have is the overall RNA of intestinal
epithelial cells and that of the cells of the lamina propria and strikingly different
immune activities may be taking place at the epithelial cell level and lamina propria.
Numerous studies have shown that there is a differential expression of PRRs in these
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different constituents of the ileum and the differing expression patterns may have a
significant bearing to outcome of infection and intestinal immunity.
Mutations in paratuberculosis genomic DNA samples
Screening for mutations in CARD15 exon 11 was carried out because mutations have
been described in human Crohn's disease, which has similar immunopathological
presentation to paratuberculosis. The first mutation described was the 3020InsC, that
results in a truncated protein that is unable to recognise ligands (Ogura et al., 2001).
Two more mutations have recently been described (Arg702Trp, Gly908Arg) that
together with the 3020insC (Leu'007fsinsC) account for 80% of all Caucasian cases
of Crohn's disease (Siminovitch, 2006). Where CARD15 mutations exist together
with the TLR4 mutation (Asp299Gly) this increases genotype relative risk by 81 to
88% than having either mutation separately (Franchimont et al., 2004). Other
CARD 15 mutations located in the NBD region have been described associated with
Blau syndrome but not with Crohn's disease, and it has been postulated that genetic
variants in the LRR region are ligand dependent, and that resultant disorders would
be in mucosa in contact with bacteria (Miceli-Richard et al., 2001). Spliced variants
of CARD 15 have also recently been described (Leung et al., 2007) although their
role in immunopathology remains elusive. Ethnic differences exist with all described
CARD 15 mutations; being predominant in Caucasian Crohn's disease patients but
absent from Japanese (Sugimura et al., 2003) and Chinese (Leong et al., 2003)
Crohn's disease patients.
CARD15 has been mapped to the 16q 12 chromosome in humans and this has been
identified as the susceptibility locus 1BD1 for Crohn's disease. Similarity in
pathology between ovine JD and human Crohn's disease would tend to make this a
leading candidate in mutation analysis for SNPs that may possibly explain the
discrimination of the three clinical forms of JD. The fact that no SNP was identified
in exon 11 of ovine CARD 15 gene (Accession AMI 17124)) may be due to the small
sample size examined or possibly that the important relevant SNPs may be located
elsewhere on the LRR region ofCARD 15 gene.
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TLR2 (as a homodimer or heterodimer) recognizes the largest variety of described
PAMPs amongst the TLRs. TLR2 maps to chromosome 17 in the bovine genomic
contiguous sequence. Seven SNPs were detected in the ovine TLR2 exon2 from
genomic DNA samples derived from the three clinical forms of ovine JD, and of
these seven, five were silent and two were amino acid changing. When mapped to
our submitted TLR2 exon2 partial sequence (Accession AMI 17123 ) these are;
Ai82C and Tl5l6c and bring about an amino acid change from an aspartic acid to
alanine and a leucine to phenylamine respectively (Figure 6.7). However, the
distribution of these SNPs between the different clinical forms of JD was not
significantly different, suggesting that they do not contribute to JD pathological form
differentiation. None of these SNPs correspond to any of the susceptibility SNPs
described for human TLR2 and mycobacterial diseases (Bochud et al., 2003; Kang
and Chae, 2001; Ogus et al., 2004). Recently, Bhide and co-workers (Bhide et al.,
2006) described the identification of the TLR2 Arg667Trp mutation associated in Map
infection in cattle. They were also able to identify the TLR2 Arg753Gln mutation
although its contribution to susceptibility was not significant. Like this study, they
also found numerous silent mutations within the bovine TLR2 gene that was
sequenced. Unlike this study, they had access to genomic DNA from a large study
population of 1636 cattle.
Malhotra and co-workers (Malhotra et al., 2005) re-examined the TLR2 Arg677Trp
polymorphisms associated with leprosy and concluded that the possible SNPs
identified in TLR2 exon2 by Kang and Chae (2001) were possibly due to sequence
variations arising from the presence of a highly homologous duplicated sequence
(pseudo-gene) from exon3 of the TLR2 gene. This could explain the numerous SNPs
seen from the direct sequencing and expose the possible shortcoming using this as a
sole method of detecting SNPs.
An attempt was made to develop tetra primer amplification refractory mutation
system (tetra-ARMS) assay for SNP validation and to discriminate the two amino
acid changing SNPs. Encouraging results were obtained (see Figure 6.8) but this was
abandoned due to limitations of time and to difficulties in assay optimization. It
would still be a worthwhile avenue to take in conclusively coming up with definite
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TLR2 SNPs in any future SNP analysis project. The 3' end of the TLR2 gene was
sequenced from mRNA in order to identify the end of TLR2 exon2 and compare the
sequences with the putative exon three and see if it could account for the spurious
SNPs. The full ovine TLR2 mRNA sequence has recently become available
(Accession DQ890157). Aligning the 3' end of this sequence with all the SNPs
described here did not give any match that would uphold the impression that the
SNPs could be due to a similar sequence on the three prime end (the putative exon3).
The TLR2 mutations associated with leprosy described by Kang and Chae (2001)
also seem to be ethnically related as they were initially described in Koreans but
have not been found in any other ethnic groups.
As this is a new area of science, disparate number of exons for TLR2 in mammals
have been reported; two exons (Takeda et al,, 2003) or three (Haehnel et al., 2002;
Malhotra et al., 2005; Wang et al., 2001) with Haehnel and co-workers proposing
that the TLR2 exon 2 is non coding. Moore and co-workers (Moore et al., 2004) did
not find any correlation between TLR2 Arg677 polymorphisms with susceptibility to
Staphylococcus aureus infections.
Due to the limited sample size and the difficulties in ascertaining that the
'asymptomaytic' case would have never developed into clinical cases, it was difficult
to exclude the possibility that the results of the mutations seen are frequent
anonymous polymorphisms and were observed by chance alone.
In summary, two productive SNPs in TLR2 exon 2 were identified via direct
sequencing and partially verified by tetraprimer ARMS. These reported mutations of
TLR2 will need validation in large unbiased populations in order to ascribe an
accurate risk they pose to predisposition to the clinical forms of ovine JD.
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7. Summary Discussion
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7.1 Summary
This thesis deals with the expression and immunopathological importance of PRRs in
ovine tissues and cells. PRRs play an important role in the maintenance of
homeostasis and immune responses against pathogens. Tissue and cellular expression
of PRRs has an effect on the type of immune responses elicited and thus has a
bearing on the outcome of host-pathogen interactions. A fundamental pre-requisite to
fully understand the role played by PRRs in health and disease is the elucidation of
their expression in different normal tissues and cell types.
Chapter Three is concerned with the identification of the sheep homologues of the
common PRRs and their adaptor molecules. This formed the basis for developing
ovine specific quantitative real time PCR assays for the accurate measurement of
sheep PRR transcripts used throughout the rest of the study. Chapter Four deals with
the characterization of expression patterns of these PRRs in selected adult tissues and
a comparative study of their expression in second trimester foetuses and adult spleen
and skin. Chapter Five looks at the PRR expression in immune cell subtypes; APCs,
DCs and T cells. Consistent with the role that they play in immunity, PRRs were
expressed at higher levels in mucosae that are directly exposed to the externum (and
thus have a higher risk of pathogen entry) and also in immunologically important
tissues such as the spleen and lymph nodes. The skin however, had low PRR
expression and 1 speculate that it may be a homeostatic mechanism to prevent
hyperinflammation or may reflect the lack of PAMP stimulation due to the effective
barrier by keratinized squamous epithelia. The leukocyte subsets showed diverse
PRR expression profiles, with the CD172a DCs, monocytes and B cells showing the
greatest range of PRRs detected.
Diverging from the baseline data obtained from normal tissues and cells, the
functional role of PRRs was studied in Chapter Six that examines the role of PRRs in
the pathology of ovine paratuberculosis. Mutations have been described associated
with mycobacterial diseases and Crohn's disease that might have functional
implications on the pathology of ovine paratuberculosis. An attempt to examine more
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closely functional aspects of in vivo PRR engagement by a specific PAMP was made
in the same chapter by carrying out Lipoarabinomannan stimulation of skin and
measuring the cutaneous PRR response. Chapter Six of this study clearly
demonstrates functional differences in PRR expression between the clinical forms of
ovine paratuberculosis that may have implications on the pathogenesis of clinical
disease. No disease discriminating mutations were conclusively identified, and
disappointing results were obtained with the cutaneous ligand stimulation study.
7.2 Future Work
This study examined PRR expression in immune cell subsets, but due to low starting
RNA and resultant low transcripts, quantitative analyses could not be performed
between the subsets. Performing this experiment with adequate number of cells and
higher concentration and quantity of RNA, or using nested PCR to enable
quantitative comparisons to be performed would be a future research area that would
yield useful functional data on the innate immune functions and potential of these
cells. The in vivo stimulation of APCs, such as macrophages and DCs by a specific
ligand and examining the resultant PRR expression would be a beneficial follow up
experiment to elucidate functional quantitative PRR expression in these cells.
In order to assess the functional role of PRRs to mycobacterial ligands in
experimentally stimulated skin, performing this experiment with a proven
concentration of LaM or M. bovis BCG with the concurrent examination of the PRR
expression in the draining superficial lymph node could possibly yield more practical
data. This will enable a comparative analysis of changes in stimulated skin and also
the lymph node that drains it to which stimulated APCs migrate with antigen.
As other workers have shown the presence of TLR2 SNPs in cattle infected with
Map from large scale studies, carrying out similar large scale studies with more study
subjects examining the full TLR2 gene may show disease discriminating SNPs in
ovine paratuberculosis. The development and optimization of SNP specific real time
PCR tetra primer ARMS assays would facilitate rapid turnover of such large
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numbers of samples since this would be a high through-put method since it obviates
the need for gel analyses of amplicons.
7.3 Concluding Remark
In conclusion, I have obtained nucleotide sequences of TLR1-TLR.10, MyD88,
CARD15, CD14, Dectin-1 and Dectin-2. I have demonstrated that mRNA for these
PRRs and MyD88 is expressed in the kidney, lung, mesenteric lymph node,
prescapular lymph node, skin, spleen and urinary bladder of normal sheep. 1 have
further demonstrated PRRs and MyD88 in cells of the immune system and a
functional role or PRRs in disease as established by the differences in PRR
expression in the different form of ovine Johne's disease.
As this 'decade old' renewed area of immunology expands and the importance of
PRRs takes more centre stage it would be important to have more thorough
mechanistic dissection of the role that PRRs play in disease onset, progression and
resolution. As complete species' genomes become available it would also be of value
to mine these genomes for all putative PRRs, their accessory molecules, signalling
pathway molecules and negative regulators in order to design custom microarrays
that would enable simultaneous in vivo analysis of the role played by PRRs in these
disease situations. This would allow the in-depth understanding of the role that each
PRR plays, how specificity is achieved via adaptor molecules, negative regulation,
pathway choice and possible interconnection between various aspects of pathways of
innate immune recognition.
Summary 263
C Iramcieri/ation nl ()\ inc Pattern Recognition Receptor expression
8. Appendices
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8.1 Appendix I
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8.2 Appendix II
Enrichment ofDendritic Cells from Afferent Lymph using Optiprep®
Protocol, adapted from K. Mattews.
Preparation
• Remove Optiprep from the fridge and allow it get to room temperature (RT)
• Make up Buffer B (see below)
Solutions
• Keep all solutions at RT
Hepes buffered saline (HBS)
• 0.8% NaCl
• lOmM Hepes
• 0.45 pm filtered
• Alternatively, can use sPBS instead of HBS
Buffer A Buffer B
HBS(orsPBS) • Make fresh!
ImM EDTA • Buffer A + 0.5% (w/v) BSA
0.2 pm filter the buffer • 0.2 pm filtered
Optiprep® solution 1(1:3) 1.078g/ml
• 1ml Optiprep®: 3m 1 Buffer A
Optiprep® solution 2 (1:4) 1.068 g/ml
1 .8 ml Optiprep®: 8.2ml Buffer A
The Optiprep® solutions must be well mixed after constitution. Every time,
immediately prior to use they must be mixed well again.
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1. Mix lymph end over end 6 times
2. Optional: Remove 10p.l of lymph and count cells (lOpl lymph: lOpl trypan blue)
3. Transfer lymph to 50ml Nunc tube. Note the volume!
4. Spin down the lymph: 1300rpm (300xg) @ 4°C for 5 mins (RT in original
protocol)
5. Remove supernatant
6. Re-suspend cells in residual supernatant and add a few mis of Buffer B. Pool
cells and add Buffer B up to 45ml
7. Count cells
8. Spin down the lymph: 1300rpm (300xg) @ 4°C for 5 mins (RT in original
protocol)
9. Re-suspend cells in buffer B ~ 2 xl07/ml or less in multiples of 2.5ml OR 10ml
(i.e. if you have loads of cells). Do not exceed 2 x 107 cells/ml
10. Optional: Count again
11. Transfer cells (2.5ml volume or 10ml volume) to a sterile universal. N.B. 5 xlO7
is the optimal celi number
12. Add 1ml Optiprep® to 2.5 ml cells OR add 4rnl Optiprep® to 10ml volume.
13. Mix by gentle swirling
. (r)
14. Prepare Optiprep solutions 1 and 2 (easier to do in universals). Remember to
mix solutions well
15. Carefully overlay 4m 1 (or 7.5ml) Optiprep solution 1. Use the autopipettor at
the lowest setting to do this using a wide bore pipette
16. Overlay 1 Ornl (or 20m 1) Optiprep0 solution 2. Use a 25ml pipette (wide bore)
18. Overlay with I ml HBS or sPBS using a pasteutte
19. Spin at 600 x g for 25 minutes at RT with no brake: 1800rpm at RT in Jouan®
centrifuge, brake set on 1)
20. Remove upper fraction (1 5ml; DC rich fraction) with a sterile pastette (leave
interphase cells) and transfer cells to a sterile universal
21. Add 5m 1 sPBS to collected cells
22. Spin at 200 x g, 5 minutes at RT: 1 lOOrpm 5' at RT
23. Remove supenatant (carefully, as pellet may dislodge)
24. Re-suspend cells at the required concentration in the desired buffer (e.g. FACS
buffer, usually 1 -2ml and then count cells).
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8.3 Appendix III
Isolation of Peripheral Blood Mononuclear Cells Using Histopaque®
1. Remove Histopaque® from the refrigerator and allow it to get to room
temperature
2. Collect 20ml ofwhole blood and put it into a clean universal
3. Put and equal volume of PBS solution to the blood and mix by gently
inverting the universal several times.
(§)4. Pipette 9ml of Histopaque into each of four universals
5. Reduce the speed of the automatic pipettor to the lowest possible and use the
(r)
pippetor to overlay 10ml of the blood/PBS over the Histopaque .
6. Spin the layered universal at 800G, 20°C for 20 minutes with no brake stop.
7. Using a Pasteur pipette, remove the white interface layer of PBMCs and put it
into a clean universal.
8. Remove lOp.1 of this cell solution and count cells (lOjetl lymph: 10pl trypan
blue) and assess the viability percentage.
9. Wash the cells by adding sPBS to and centrifuging them at 250G, 4°C, for 5
minutes
10. Decant the supernatant and re-suspend the cell pellet in sPBS
11. Repeat the washing stage
12. Re-suspend the cells to desired concentration with appropriate media
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8.4 Appendix IV
PROCEDURE FOR IMMUNOLOGICAL STAINING OF CELLS FOR FACS
ANALYSIS (SINGLE STAINING).
Consumables/Chemicals/Materials
Previously labelled FACS tubes with corresponding written down entry of contents
Buffer A: 1% BSA in sPBS, 0.1% Na azide, 0.2pm filtered - Stored at 4°C
Procedure
1. Wash cells in ice-cold Buffer A
2. Spin cells at 1500 rpm for 5 min at 4°C
3. Count cells and make up to. 2 x 106 per ml). Cells should be >90% viable as
determined by dye exclusion during the counting (e.g. trypan blue).
4. Dispense 50pl of cells into FACS tubes (in duplicate for each antibody)
5. Add 25pi of primary antibody at correct concentration.
6. Incubate at 4°C in a fridge for 15 minutes or on ice for 30 min.
(R)
7. Using a Nichipet Stepper with a 12.5 ml syringe add 2 x 1.25 ml of ice cold
buffer
8. Spin at 1500 rpm for 5 min and 4°C
9. Remove supernatant and resuspend cells in residual volume
10. Using a Nichipet® Stepper with a 12.5 ml syringe add 2 x 1.25 ml of ice cold
buffer
11. Spin at 1500 rpm for 5 min at 4°C
12. Remove supernatant and resuspend cells in total volume of 50 pi of ice cold
buffer A
13. Incubate cells with secondary fluorochrome conjugated antibody lOpl per lx
106 cells (for PE) to be stained, for 15 minutes in the dark, in a fridge at 4°C.
14. Wash in buffer A twice as before in steps 7 to 12.
15. Re-suspend cells in 500pl of Buffer A, cap tubes and go to step 18 OR
16. If cells are to be stored re-suspend in 250pl of Buffer A and 250pl of ice-cold
4% paraformaldehyde.
17. Cap the FACS tubes, and cover with foil and store in a dark fridge at 4°C
until analysis (within 7 days)
18. Take to FACS machine.
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Double Indirect Fluorescence Staining for FACS Analysis
Procedure * ( For step by step protocol Look at procedure in conjunction with other procedure for
single staining)
1. Wash cells in Buffer Twice
2. Count cells and make up to 2 x 106 per ml (This will give 1 x 10" cells per
50p,l)
3. Add 25 pi of each monoclonal Ab (Biotinylated and non-biotinylated)
4. Add 50jul of cells and mix
5. Incubate at 4°C for 30 min. up to an hour
6. Wash cells in Buffer Twice
7. Add 25pl of FITC/SA-PE (may need to be titred) and incubate at 4°C for 30
minutes to an hour
8. Wash cells in buffer Once
For storage up to a week, use 200p.l of buffer and 200 ptl of 4% paraformaldehyde
1 % PARAFORMALYDEHYDE
a. Heat 50ml of PBS to 60°C
b. Add lg of paraformaldehyde
c. Add 1M NaOH, slowly titrating until paraformaldehyde dissolves
d. Make up to 100ml and cool under running cold tap water flow
e. Adjust pH to 7
f. Label and Date then store at 4°C (May be used up to SEVEN DAYS TO THE
DATE OF FACS ANALYSIS INCLUSIVE)
N.B. For 4% paraformaldehye, make appropriate adjustments to the amount added to
the 50 ml of PBS.
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8.5 Appendix V
Ovine Paratuberculosis Cases
ID Breed Age (years) Sex JD clinical Type
SH.062 Blackface 5 F Multibacillary
SH.081 Blackface ->J F Multibacillary
SH.029 Blackface X Bleu du Maine 4.5 F Multibacillary
SH.100 Blackface J F Multibacillary
SH.101 Blackface 2 F Multibacillary
SH.102 Blackface 4 F Multibacillary
SH.103 Blackface 4 F Multibacillary
SH.104 Blackface J F Multibacillary
SH.030 Texel 5.5 F Paucibacillary
SH.027 Blackface X Bleu du Maine 4.5 F Paucibacillary
SH.032 Blackface x Bleu du Maine 2.5 F Paucibacillary
SH.033 Lleyn X Roussin 3.5 F Paucibacillary
SH.083 Bleu du Maine 4 F Paucibacillary
SH.085 Blackface x Bleu du Maine 6 F Paucibacillary
SH.107 Texel 2.5 F Paucibacillary
SH.108 Blackface 2.5 F Paucibacillary
SH.084 Blackface X Bleu du Maine 7 F Asymptomatic
SH.086 Blackface X Bleu du Maine 7 F Asymptomatic
SH.106 Texel 1 F Asymptomatic
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Ovine Paratuberculosis Cases (continued)
ID Breed Age (years) Sex JD clinical Type
SH.lll Blackface 2.5 F Asymptomatic
SH.113 Greyface 2-4 F Asymptomatic
SH.115 Greyface 2-4 F Asymptomatic
SH.116 Greyface 2-4 F Asymptomatic
SH.118 Greyface 2-4 F Asymptomatic
1 Dorset x 4.5 F Control
2 unknown unknown Control
14 Dorset unknown F Control
15 unknown unknown Control
26.1 Suffolk 3.5 F Control
27.1 Dorset 3.5 F Control
28 unknown unknown Control
A unknown unknown Control
B unknown unknown Control
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8.6 Appendix VI
Zinc salts Fixation of Biopsy Material
N.B Make up Zinc Salts fixative fresh each time
Day 1
1. Place sections of fresh tissue (5-6 mm thick) into universals containing fresh
Zinc salts Fixative (0.1M Tris base buffer with 0.05% Ca acetetae (pH 7-7.4)
containing 0.5% Zn acetate and 0.5% Zn chloride).
2. Fix sections for 6-8 hours at room temperature.
3. Trim sections to 2-3mm thickness.
4. Fix sections in fresh ZSF for another 24-72 hours at room temperature. Send
samples to Histology Lab at Easter Bush for paraffin embedding and
sectioning.
Preparation of Zinc-salts fixative (1 litre)
Reagent
0.1M Tris base 12.1 g
0.05% Calcium acetate 0.5g
0.5% Zinc chloride 5g
0.5% Zinc acetate 5g
Adjust pH of the Tris-Ca acetate buffer to 7-7.4 with concentrated HC1 before
addition of zinc salts, otherwise the zinc salts will not dissolve.
Reference: Gonzalez L., Anderson I., Deane D., Summers C. and Buxton D (2001).
Detection of Immune System Cells in Paraffin Wax-embedded Ovine Tissues.
Journal ofComparative Pathology. Volume 125, Issue 1, Pages 41-47.
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8.7Appendix VII
Optimal percentage agarose used for different DNA sizes.
% Agarose DNA Size (bp)
2.0-2.5 <200
1.5-2.0 200 - 500
1.0-1.5 500 - 1,000
© 1 b 1,000-4,000
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8.8 Appendix VIII
Optimized working concentration of the qPCR primers
Gene Primer Working cone Gene primers Working cone
TLR1 30 Mm TLR9 30 Mm
TLR2 30 Mm TLR10 30 Mm
TLR3 50 Mm MyD88 30 Mm
TLR4 30 Mm CARD15 25 Mm
TLR5 25 Mm CD14 25 Mm
TLR6 25 Mm Dectin-1 30 Mm
TLR7 30 Mm Dectin-2 30 Mm
TLR8 30 Mm
Appendices 275
Characterization of Ovine Pattern Recognition Receptor expression
8.9 Appendix IX
Multiple Sequence alignment of ovine nucleotide and amino acid sequences
compared to bovine, human and murine sequences.
Each nucleotide sequence comparison is followed by the respective amino acid
identity comparison. Identical nucleotide residues for all four sequences are shaded
black, three sequences dark grey and two sequences light grey. On the consensus
sequences upper case letters further represent agreement of all four sequences and
lower case letter represents agreement of three sequences. For the amino acid
sequences comparison, Genedoc® graphical presentation is based on
similarity/conservation (conserved mode) where black (100%), dark grey (80%) and
light grey (60%) amino acid conservation.
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Toll-like receptor two nucleotide sequence identity comparison
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fp 1 1 lk t nk f lpsl ldl rn lsf gees d gt
MSg
ilRH>«»)«ftreTiGA»ilMSA






ia:.[iil: Wi:: waafewsBia: piSlTiisnvibant

















520 * 540 * 560 * 580
vac| |h ns m aggns ESS lBepbhsbr i B
LgPjitffiy S-" j® fF&^R^phk cm: . .w.S j H: : 5I"WGVHD~1i:-:;-iw!: ji-'gg.: sHBxqH-"He E § S3 HPTMG-1B<HFB
S taF sL sLQvLNMSHN llsLDtf Y L SL IDcSfNrI SK qeLq P sL INLTqN fAC CEHQsFLQWvK




/emntslBIT Nfrfigav TgTffi B sffl: V—THAFB : H: IOT5HI |:ffteSl [ffisg
DQrQILV EqM CA P d mpVL f n TCqm KTIIsVSVv'vi VSvV vLvYkFYFHLmLlAGCkKYgRGEs YDAFVI















I IiaueUn/alinii < 1 < A He Palletn IVcoj' lilion Receptor expression











































3280 * 3300 * 3320 * 3340
3380 * 3400 * 3420
700 * 720 * 740 * 760
Ovine : 1 B LHPIKIRSjsgtH afcfcjMija SJSS2S2E. H : 1^3533250--3335 5 SiB S iSJSSi
Bovine : I n LHBpik|r B s -;pjf';B| | SB® s a «
Human : B fflHPQgT |§tA$8I 3 3 S g §|j? STWNHsRTSfife?
Murine : g s v gggKVWSL| [PGAg * 3522 11 if n
Q L FKD g E d YkYDAYlcFSSKDFeWvQNALLKHLD qYs qNRfnLCFEERDF PGENhlaNIQdAvW SRK VCLVS
780 * 800 * 820 * 840
RHFLrDGWCLEAFsYAQsRcL DLn aLImVWGSLSQ LM HqsIRGf qk qylrwpedlqdv wfl kls ilk ek k
Appendices 284
Chaiucteri/alion ofOvine Pattern Recognition Receptor expression





























GGT CTTGAtCTTCACAa AAcAgaATAA GAGCaTcCCTAAAgAtGTCac CT gAa CtTTGCAaGAACTCAA TtGC
1520 * 1540 * 1560 * 1580
rS3?
TTTcAAaa TGT cAC TTA tA ATTGgAGACACTTATcTTACAAAaGAATG TTaAAagACcTTTTcAAA A gTCT
* 1280 * 1300 * 1320
"gBBBBBK't
CATGACtAAGgaTATGc tTCTtTGGAAAcacTGGATGTTAGcTgGAATTCTTTGgAaT Tga agA T A ggaAa TGC C
* 1360 * 1380 * 1400 * 1420
tTGGGtTG GAGtATAgTGGTGTTaAATTT TCTTCaAAT CT ACtGaCTCTGTtTTCAGATGtTTACCTCC GaTCAA













Ovine Biisim TCTTCI GCC ens
-
S CTCTGT1TTCAGATG ffiE3335S3 £ j : 319
Bovine TCTTC GCAi ss 1 CTCTGT [TTCAGATG 'CGB : 1358
Human TCTTC | AATATGm m ; CTCTGT TTCAGATG IJEESSL £ Prri : 1425
Murine W SEE S& - TCTTC ■ AATATGB SGCTCTGT1 TTCAGATGc:1BBS0ftra8cAAlGlB^ : 1391
ccraI I 403ccB [ I 1442I 1 1509





tTcCAAtTCtTTA C Accttcctgg tgtgg ctt agcagcctttc t tg teat ga ca aa tea tttcc a























lmtkgffllsle1 ldvsIn : 66
lmtkd|lsle ldvs n : 413
lmtk SmBsle ldvs n : 413
lmtkS!sle ldvs n : 424
LMTK M SLEtLDVSwN
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ccagaaaa gtcctcaacaatctg a at ttg tt t catca aatcg tttct tgca ctgtgaTGCTGTGTGGTTTGT





CTGGTGGGTTAACCATAC GAgGTgACTATTCCtTAC TGGCCACaGATGTGACTTG TgGG CCAGGAGCACACAAgGGcCA













AGTGT TcTC CTgGATCT TAtACcTGTGAGTTAGATcTgACtAAC T AT CTGTTCTCAcTTTCCATATCagcAgttCT
* 2700 * 2720 * 2740 * 2760 *





















GGTTTTGga GAGCTGGTGGCcAAAtTGGAAGAcCCaAGAGAgAA tTTtAATTTaTGTCT GAgGAAAG GACTGGtTACC
* 2960 * 2980 * 3000 * 3020
AGGgCAGCC GTTCTgGAAAA CTTTCCCAGAGCATACAGCTtAGCAAAAAGACAGTGTTTGTGATGACAgAcAAgTA GCaAA





GACTGA AaTTTTAAGATaGCATTTTAcTT TCcCATCAGAGGCTCaTGGATGAAAAAGTgGATGT AT ATCTTGATATTccT




























aCa gctcaccc tacttctggcagtg ct aa aa gccctg ccacagacaatca gtg c ta agtca tgttcaa ga
Appendices 286
L'haractcn/alion nfOvine Pattern Rccopnilion Receptor expression













qlr Id ssnkiq iqktsfpenvlnnl 1 lhhnrflc cdAVWFVWWVNHTeVTIPYLATDVTC GPGAHKGQSV SLDLY
Ovine : I ldltnB l 3y s
Bovine : tce ldltnh ilfslsisSv s
Human : tce ldltnB ilfs lsisvs a
Murine : |tceldltnl ilfs5sis gv
k
13
tce ldltn ilfs1sis vL
* 940
ta HLyFWDvWY yhFcKAKIKGY rLiSp sCYDAFIVYDTKdpAvTEWVL ELVAK



























FLQLRKRLCgSSVLEWPtNPqahpyfwqclknal tdnhv ysq fket
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tcacca t GTTTTACTGGGATG TTGGTTtATcTA cAtgTGTGcTtaGCtAAGgTaAAAGGCTACAGGtCTct TCCACATC
* 2700 * 2720 * 2740 * 2760 *
CCA ACTTTCTAtGATGCTTAcaTTTCTTATGACACCAAAGA GC TCTGT AC GACTGGGTgAT AATGA cTGCGCT CCA
2780 * 2800 * 2820 * 2840 *
VTH
: 5C8 BBaaan: aBBB lnfefefefeftfcr; TgAfflAtfcc 88
CCT GAAGAGAGtga GACAA Aa GT CTCCT TGTtTAGAGGA AGGGATTGGGAcCCgGG TagCCATCATcGAcAACCT
2860 2880 2900 2920 2940


























Human RTMSjjJggPfc • *
Murine ^rriL |3 : iSeWS « 4' BS


















( hiinicicriA'iliui' u( f )\inc Pattern Recognition Receptor e> prcssion


























CgCCTcCAGTGcCTgcGCCTGAGCCACAAC gCATctCgCAGGC GT AATGGCTC CAGTTC TGCCGCTGACc g CTGC
* 1740 * 1760

































Sl ASraffl: 583:0: :!SB1 tmeiimc t caclBTMBt?aBBwTaa :BfoY-;HBlAlB:;ttta







GA CAA GGCAgCCTGCC cTGGCAcCCggCTCCaGAagCTGGA GT AGCaGCAACAGcATCggCTt GTG CCC GgCTT
2300 * 2320 * 2340 *
iC!wTT^T|li
_ — jffiGcfflcHFl TGH8.-f;Tc"flBBH8 BSH? HltOSS BBS-..-..BBS SH ITBH8 BBSS 8 B :gc§AI>
















C C CTG GCCa ATGTGGGccGAGGGaGaCCTcTATCTc cTTcTTC AAGGC TGAG CCTG Tc aGCTGGACcTGTC
2020 * 2040 2060 * 2080 * 2100
Bc-H 02 MohWfl 0 Miwm Hgj; IgtcgIBB
^C^g-CGjAGA^wBT^I
c AgAAccacCTGCAcAcCCTCCtGCC C aCCTggaCAACCT CCCAAGAGCCTgc Gc GCTGcGtCTCCG GACAAt A
* 2120 * 2140 * 2160 * 2180
j 3
" a " F33 JggS J9? 88l Tli










Characterization oFOvine Pattern Recognition Receptor expression















£r ' ^aseL-tStMg3sj|gGEKVWLQPGD: ^raVDTPSgEDgRPNSSTLNbjL'givlV,i,.JSpSTLSEiJTPEi3<ASDfiEOEELLSAD ^LSTPA§KNS^DR3KNFK§2M'
dlsdnrisg a e d • p s f
LDAVSgKDgMPSgN-LN^VDTPS§ED^n™T*oa,TXT '
520
r|Bail M :| 1





ft dlSRNNLVTiq EMF LSrLQCLrL
560 *
VLDLShNKLDLYh SFtELPqLeALDLSYNSQPFsMqGvGHN SFVA L Lr LSLAHN I
* 640 * 660 *
Ovine : mT\ 31on
Bovine : 1TV1
Human : iHFI









|:.r dnBLIFFIW^K 192Srai 1 dnBlIffIwrB 669
vfflE 2S a S3 2 671
3 33dnhlBff|w^R 672
SL LP LE LDLAGNQLKAL NGsLP GtrLqkLDVSsNSI fV PgFF A L EINlSaNaLKTVD swfg
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catttacatattttgtagtattgtta g c g gtgatgCTtcaGAGctGCCcgAAGaAagGGaattgAtgaccaactt
* 600 * 620 * 640 * 660 *
2-/
TBTGG!cMHAACWKCGBl3CTGCTCBTBA5BTTAg!TBATTAGAC^4BBtaG5MBHniGTHlaACBr:3-BAGBr.BTfiBGBAGAACBG
cTccagCAtgtCTttaAgaaaggtTcC tG agacTTgaccccaaccACAacgACAttgGAttTatC tAtAatCtCcttttTc





g5 wmmacatW TGTT 8»r7jBHA~
agACCTttgaATtCaacaAGGAgtTAAg
* 860






gTcTCAg taTTtAgaTCtgTcctTt AAtgacTtTgAcAct TgcCtatcaG ga gaA cTgGCAAcatgTcAcaccTggA
I O| pliPcimH f§ :- - -liGWTGlHiCWT C C tHSBHt T GTH- VCgTA^AAAAg AA TAABgaBBgABr. TA
AA ccTaGgCTTgAgtggGGCAaaaaTacAaAAatCagAttt CaGAAAAttGCTCAt TGCa ctAAAtac GtcTT tTagg
1020 1040 1060 1080
1180 1200
jjGTjjGGJj













aTt AgaACtcTaccTcAttAtgA aGAAggTagC TgcCcATcTtAAACacAaCaagaCTgcacATTgttTtACcagTg acA







ttct tt cttaataaagttga tta





JSLgY f%::jai^?BitSu£tki£ Saaaa^Saa;- BbiSBhkmII






t IrtraJtcri/win>n >1"(>\ 111c Pattern Reeuani a n Re 'cptui exprassii n



























23St 3a222T t32raa1,1lail'tatggccS3gS!a BBB Hffl ~^BSHcgH
gcc t gca tgatg tgg aagaa ct ga gaactctgCCTgGAGGAgAACCA TCcagGAtGAAGGtGTaTgT
3040 3060 3080 3100
T CTCGC AAGGACT AgAAA TCAAgTtTGAAA TCcTGAAgcTGTC AAcAAc CATCAcCT CCt GGgGCAGA
* 3120 * 3140 * 3160 * 3180 *
GCCCTCCTGc GGCCCTtgaaA GAAtgacaCCATtCTGGAaGTcTGGCTcCGAGG AACAC TTCTCTc GAGGAaaTtgA












g t tgc a caaTa gt
3380 * 3400
GCCCTGTCCTGCCTAAGGCj
££2gt2^CCSt333SG3C§GCC|3 8 0c B .mGsrifoT^agSc'ci










t c gA tC A tt cc t a tT tt
fjjATGGAjjGjjCAjj'
g AGGcCc c t c c gagtAt
OTB&gHGliGGAMAGCT BBCA l^g^GGWlWeiO .CM Afflfr*&-.CTGT


































dhq 1 wlslvgnnigs ga alalml kn leelcLEENH qDEGVc LA GL rNSsLK LKLSNN It 1GAEALL ALe








NdtILEVWLRGNTFS EEi kLs DtRLLL
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CT • C^TgATGflT!SiggA^SffiT<TgffiTCBgG3BT£!*!!SG7gGG MBBBAUB CTB
etc t ctcc t ccc tgg gc ct aac t gagtg ggcgccgCCTgTCgCT TTC T AACgtgCGG C
180 * 200 * 220
gCcgGTGGCGGCCGACTGGACCgtGCTGGCGGAGG GATGGaCTTcGAGTACTTGGAGATCC gcAgCTGGAgA g acgC
260 * 280 * 300 * 320
tnxKiiwsw: icwftW. . ii tbbtSCMUMcwmci :Sy5Bic; a: ggi BB iiHI BBS BgW. Bi [ttitcpMtiL dwtTWWKttWM 5 SB: 7
GACCCCAC GCAGgcTgcTGGAcG CTGGCAG GaCG CC GGcGCcTC GT GGCcG CTGCTcGAGCTGCT gCCaa
340 * 360 * 380 * 400
GcT GgCCGcGA GAcgTgCTGatGGA CTGggacCcaGCATcGAGGAGGAcTGCCAaAAgTAtaT tgAAGCAGCAGcA
420 * 440 460 480
ggAGG tCtGAGAAGCCTTTACAGGTGG C Ct TaGAcAGCAG TccC CggA Aaa GA TGGcaGGCATCACcA




C GA GACCCCCTaGGgCAaA GCC GAg TTT GATGCCTTcATCTGCTAcTGCCCCAgCGAtAT gAGTTTGT CA
* 580 * 600 * 620 * 640
&SBaB>aauK



































m g p gs s pi aln vrrrLSLFLNvR pVAADWT LAE MdFEYLEI qLE aDPT rLLD WQ RpGAS
Human : Q EG
Murine : 5'
Ovine :
Bovine : i JJ::
VGRLLELLakLgR DvL ELgpsIEEDCQKYilKQQqe sEKPLQV dSS pr









GIT DDPLGhx;PE 3 FDAFI.CYCP
ARVE® GIT DDP-LG 7t|PE FDAFTCYCP
osir gg IjgINDM[:ITglNDM^
GIT IRDDPLG KPE FDAF.ICYCP













DIeFV EMIRQLEQTnYRLKLcvsdrdvlpgtcvwsiaseliekrcrrmvvvvsd ylqskecdfqtkfalslspg qkrlipi
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TGAC■ctl iS I TSMAGBTAAC9GGCj
TGACI I NI : H;-, 1 TAAC1GGCl
TGAC|CT|( H 1 Kg . iBTAACIGGC!
TGACBeT1GABABCTHA C ;1TAAC1GGCJ*&
cTGACgCTtGAggAcCT gAGgTAACcGGC C acGCC CCg cGCcTCTGGAAGCCaC GG Cc
tGc CTcacCA C T ag CTcCG AACGTgTCGTGGgCaACAgG ggTgCcTGGCTCG cGAaC
1900 1920
Ovine : jTGCAGCAGTGGCT AAGCC ■ggKCTCA c CCjCTGAA.JAT
Bovine : iTGCAGCAGTGGCT AAGCC IggSCTCA [1g|CTGAA 1AT
Human : TGCAGCAGTGGCT AAGCC SggBCTCA GG ACTGAcglAT

















Ovine Cggcga i|g|gg|ctgat|g,;g gc
Bovine CggcgaSI IggIctgatH £gc
Human gggcgaacm s gc















T CGcAACgCgGGgATGGAGACGCC AgcGGCGTGTGCgC GCgCTGGCgGCaGC aGgGTgCAG
2180 * 2200 *
. ISJTAAASaCab
|tGBrill' g!8aB88aI8H88W~SB : : igSBSJeWg A^J
CccCAaaGcCT GACCTcAGcCACAAcTCgCTGCGcG caCcGc ccc gGcGCT C GaTG
2220 2240 2260
tgtcTGGcCCAGtgc CtaA cTC CTCAAT TGTCgTTCgCTGGGCTGgAgCA GTgCCTAAaG




GaCTGCC CcAAGCTCAGcGTGCT GATCTCAGcTgCAACA gCT a cAGGgagCC cggC a
2400
Ovine : £ g
Bovine :
Human :
Murine : S cS
GA GAGCTGCCcgAgGT at aCCTGaC CTggAcGGaAATC
* ?4?0 + 2440
































■ cag : 396
cag : 2134
























( haractcri/alion ol Dviny I'aflcrn Rccoymlion Receptor expression






b|qf" j--gadtnpk . yactisa ?rvr®cl(^qvgaqlilvavra&ggygrh^pf®rvdadadpr|yaStv|a rvr®tvg®qvSaql3vga^SvSayPr3SBYLBRVDTEADLG; ftgiigs2slku5tvr§§rl|sri2fga gvggigggqgggjgnji






Ovine : t pp t leatG
Bovine : t ppt| lea3G
Human : Mppl| leat G








e§0 8 : 1963 : 197
pSi s : 193
PP pLEAtGpaL L LRNVSWaTg aWL ELQQWLKPGL vL IAQAHSlaF C F ALt
00 220 240
Ovine : jjjLDLSDNP LGIds]GLMAALCPnKFPjA^Qg LALRNAGMETP sGVC
Bovine : £ LDLSDNP LGmGLMAALCPNRFpU LALRNAGMETP SGVC
Human : S LDLSDNP LGERGLMAALCPHKFPknJ LALRNaGMETPaGVC





VQ l ;nnd : 259


























sg 1 11 g r f
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ic tBabcbhbbrbghc Eroaas tat a a
g get catc CtC TTGGcG Ct ATTGCtGTga T TgGG A
j^B0 F° 5 ^ j
T TaTGCT GTg T cTgGTGaTa CTGtgGTcCTG GTaCC tgG taTTTGGaGAtcCA TTCAGGgA cAAcc tt
260 280 300 320




G AGA tGaCagCTTtC ATCAAGAAATAAAGA AACCA AgtcAaCCCACAcAATCATCTTTAGAaGA AgtGTGa CCt
* 340 * 360 * 380 * 400 *
gjljefe H ill ftgra ■iT^MRr^HHTBrgTEI
5BEE3 .ggATcHC'AAB-BM flcg yRlCAGTWBcaTTBHB^TWSBR ITGOtfapG^Al











AAAaGA TTgGagTTtATa AAg CaAgtgTCtTCcCA CcTgaT ATtCATTTTGGATAGG CTTTCtCGcc tCAGAc
580 * 600 * 620 * 640 *
m
I !^^I^T^^^^^e»ii!^ejcASAG§A^clTCCIC^^TCGMT^AGI^^^ATG^^Tic^clGGi^AGiT








































iWRs SG N 1 dsF SR
NTL §3 GSKRRMFQLG 8SKID
§TLj?FgE5 GSKRqSFQLG^hJ■kid
SmsJ:^ GSKRpBwQLG xffl■KID|fsgnHyGSKRg gQLGahJ(kid
240
s1lEi2stvtekdsshS®
1<N UHHHHfi S gygWL TTrss-'xiigiiaitAluMirhrllRIHABBBa:-'Bs"-:-MFSCj§AFFp"sW?v"NAVPOESLLHS!V?I<:"f;SEVHHgiaNTS5.'>.-»V...;SEL-
pd sFWIGLSR QtE PW wedgs n fq r nc wih s y q c sysicek
,,.jDigD|!;LgSVHaJ3SWSjR(KLSv











ES 7^ 1 173
1 SWdGSKR C QLGs L1KID SkEleFI qvSSq
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gtgC tGtTTCATTGtGAGCTGTGTgGTgACTTA AtTTTAca atGgc A aCtgGcAaaAGgCTgT TGAACT CACaCA
340 * 360 * 380 * 400 * 420
mm
cc[\5Eg|






























m k mmasm m't
ASfeWcfcM gg gg :
TtGGtTCCAGcTGCTACtT ATTTCt ctgAaGAGAA tTcTGG ctAagAGTGAGCAGAAcTG gTTg GATGGGaGCtCA t
520 540 560 580
TGGTgGTGaTCAAcACaGAA CaGAGCAG ATTTCATtatCCAGCAGCTGAAT A CAtTTTCtTAtTTtCTGGG CT TCaG





AcCCACAAGG AATggcAA TGGCAATGGATtGAT AgAC CCTTacaag AAAATGTCAGaTTtTGGCACC a aTGAaCCCA
680 * 700 * 720 * 740 *
tmiTniwr small Baam r*
iccTgc^i-
:ttcgaa|

























ggAA TCAATATGTGAgATGAAgAAGATTTACCTATGAGT Gaa TTatTca tAA Atctttaaa tt aga c a













( Iriracieri/alion cf< )\ inc I'altern llccoynitio Rcccplur expression
Deetin-2 amino acid sequence identity comparison.
rRftGNAE SC FRM^^C IgVLG LAjj:q|qqpqstekrgwlsl^Jsv2gisiamrO^RQSOGK—GVCWTL^^BsAwVISMLfl SgJJJB g: MDQPSRgg-





















Sequence Chromatograph tracings of SNP182
SNP analysis of TLR2 exon2. Automatic sequencer chromatograph tracing showing the two
nucleotide variations of the SNP 182 (relative to ovine TLR2 genomic sequence Accession
AMI 17123). A showing the A allele and B showing the C allele. The amino acid changing SNPs are
annotated according to the ovine TLR2 amino acid sequence (Accession CAJ65513).
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Sequence Chromatograph tracings of SNP1516
SNP analysis of TLR2 exon2. The automatic sequencer chromatograph of the 1516 SNP (relative to
ovine TLR2 genomic sequence Accession AMI 17123). C showing the T allele and D showing the C
allele and E showing a C/T heterozygous. The amino acid changing The SNPs are annotated
according to the ovine TLR2 amino acid sequence (Accession CAJ65513).
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